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Ruthenium(II)-cobalt(III) heterodinuclear systems are of interest as potential 
photoactivated cytotoxins. 
This thesis describes synthetic approaches to the preparation of ruthenium(II)-
cobalt(III) heterodinuclear prodrug systems.  
The majority of work described in this thesis explores the coordination chemistry of 
amino alcohol ligands with cobalt(III), and use of the amino alcohol cobalt(III) 
complexes in safer synthetic approaches to nitrogen mustard complexes. 
This thesis presents the successful synthesis and characterisation of twenty four 
complexes and twenty three X-ray crystal structures. 
Twelve different cobalt(III) complexes of 2-((2-aminoethyl)amino)ethanol, L1, and its 
derivatives are presented in chapter 02, including ten that have been characterised by 
X-ray crystallographic methods. A reaction web has been developed for the 
interconversion of a number of these complexes. 
Chapter 03 presents the successful synthesis of ten new cobalt(III) complexes with 
series of more complicated amino alcohol ligands, including some that also include 
zinc(II) or manganese(II). The utilisation of these amino alcohol complexes for the 
synthesis of potentially bis-alkylating cobalt(III) nitrogen mustard complexes is also 
discussed, and a total of sixteen X-ray crystallographic studies are presented in this 
chapter. 
The synthesis and characterisation of new ruthenium complexes [Ru(4,4’-
dmbpy)2(pytp)]2+ and [Ru(4,4’-decbpy)2(pytp)]2+ are presented in chapter 04, along 
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with NMR experiments that examine the synthesis of ruthenium(II)-cobalt(III) 
complexes. 
The chemistry discovered in this project extends the coordination chemistry of these 
amino alcohol complexes and use of them as precursors for the synthesis of nitrogen 
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Cancer is presently a major cause of mortality in developed countries and will become 
even more so in low-income countries as the global population increases.[1] Although 
some cancers occur in the young, most are associated with the elderly.[2] 
The global burden of cancer continues to increase largely because of the ageing and 
growth of the world population, alongside an increasing adoption of cancer causing 
behaviours, particularly smoking in economically developing countries. Based on the 
GLOBOCAN 2008,[3] about 12.7 million cancer cases and 7.6 million cancer deaths are 
estimated to have occurred in 2008, of these 56% of the cases and 64% of the deaths 
occurred in the economically developing countries. Breast cancer is the most frequently 
diagnosed cancer and the leading cause of cancer death among females, accounting for 
23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading 
cancer site in males, comprising 17% of the total new cancer cases and 23% of the total 
cancer deaths. According the Ministry of Health, New Zealand reports published in 
2016, statistics shows cancer registration rate of 335.7 per 100,000 populations in NZ.[4] 
1.1  The beginnings of chemotherapy 
 
This thesis will explore chemistry that may prove useful in the development and 
synthesis of new anti-cancer drugs. The next sections of this introduction will therefore 
describe approaches that have been taken in chemotherapy and provide a context for 
the work that was undertaken in this project. 
During a military operation in World War II, some soldiers were accidentally exposed to 
mustard gas.[5] They were later found to have very low white blood cell counts. While 
Chapter 01  3 
 
white blood cells usually regenerate very quickly, cancer cells also divide and grow very 
quickly. The doctors wondered whether the effect of mustard gas, slowing down the 
rapid growth of white blood cells, may have the same effect on cancer cell growth.[6]  
Doctors tried treating patients with advanced lymphomas by injecting them with bis(2-
chloroethyl)sulfide, the active chemical compound in “mustard gas”. Even though the 
effect was temporary, the patients did experience a remarkable improvement in their 
health.[7]  
Development of the nitrogen mustard, N,N-bis(2-chloroethyl)ethylamine, led research 
into other nitrogen mustard derivatives such as mustine, N,N-bis(2-chloroethyl)-
methylamine, that might slow down or stop the division and growth of cancer cells. 
It would be another decade before it was discovered that N,N-bis(2-chloroethyl)-
methylamine works by attaching to the DNA of the cancer cell in a way that prevents the 
DNA from functioning, leading to cell death.  
These findings influenced the researchers to investigate new chemotherapeutic drugs 
as well as to improve existing drugs. There are more than 100 different types of 
chemotherapy drugs today which are used to treat many different cancers. 
1.1.1  How chemotherapy works 
 
When our cells are damaged or dead, we rapidly produce new ones to replace them. Cell 
regeneration in our bodies is a meticulously controlled process. Cancer cells have lost 
the ability to control this regeneration; their reproduction (division and growth) is out 
of control. This leads to uncontrolled growth of cells and they start to occupy more and 
more space, until eventually they invade the sites of useful cells. This eventually leads to 
destruction of normal functional properties of relevant tissues and organs. 
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Most chemotherapeutic drugs (anti-proliferating drugs) interfere with a cancer cell's 
ability to divide and reproduce. Chemotherapeutic drugs may be administered into the 
bloodstream to attack cancer cells throughout the body, or they can be delivered 
directly to specific cancer sites. 
Most chemotherapeutic (anti proliferating) drugs cause cell death by interrupting many 
cell cycle processes.  
Some drugs are less damaging, to the point where the cell is too damaged to divide, but 
not so damaged that it will die. These drugs are known as cytostatic chemotherapeutic 
drugs, and examples are tamoxifen or hormone treatments. The effect of these drugs is 
to stop the growth and spread of the cancer, without necessarily shrinking the cancer.[8] 
 
1.2  Mechanisms of chemotherapeutic agents 
 
One interesting class of chemotherapeutic agents used in cancer therapy is comprised of 
molecules that interact with DNA. Research in this area has revealed a range of 
molecules that act as antitumor agents, including groove binders, alkylating agents, and 
intercalating compounds.[9] The mechanistic features of each drug category are related 
to their chemical nature or activity. The chemical nature of some of the anticancer drugs 
in relation to their cytotoxic activity is discussed below. 
 
1.2.1  DNA intercalators as cytotoxic agents  
 
DNA intercalators are flat molecules that insert between planar bases of DNA, without 
forming covalent bonds. This DNA binding mode was first proposed by Lerman.[10] The 
only recognized forces that maintain the stability of the DNA intercalated complexes are 
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Van der Waals, hydrogen bonding, hydrophobic, and/or charge transfer forces[11], [12], 
[13], [14] however, a frontier orbital interaction has also been suggested.[15]  
Intercalation has the effect of lengthening the duplex by around 3 Å per bound drug 
molecule, causes unwinding of DNA. The degree of unwinding depends on the structure 
of the intercalating molecule and the site of intercalation.[16] This distortion can prevent 
replication and transcription by interfering with the action of topoisomerases. 
Topoisomerase I and II are enzymes that control the changes in DNA structure by 
catalysing the breaking and re-joining of the phosphodiester backbone of DNA strands 
during the normal cell cycle.[17], [18]  
The stable complex is formed, due to π stacking of flat components of the intercalated 
drug and the DNA, Figure 1.1 to Figure 1.4. Ellipticine, 1.01, shown in Figure 1.1, 
consists of a planar heterocyclic ring system that intercalates between the base pairs of 
helical nucleic acids as a possible mode of action.[19] Ellipticine has been observed to 
interact with DNA and to increase its melting temperature through intercalation. These 
intercalator drugs interrupt the cell cycle. Therefore intercalators are often more toxic 
to cancer cells and other rapidly proliferating cells than to normal cells. 
 
Figure 1.1. X-ray crystal structure showing the binding of ellipticine, 1.01, to a DNA 
oligomer, by intercalation.[20], [21]  
            
1.01 
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Figure 1.2. Representative DNA intercalators[22], 1.02, ethidium, 1.03, proflavin, 1.04, 
R=H; daunomycin, R= OH; adriamycin, 1.05 nogalamycin. 
 
The compounds shown in Figure 1.2 are some of the organic intercalators. Many DNA 
intercalating transition metal complexes are also reported in literature, such as those 
from Barton’s group.[23] Some octahedral metallointercalators and metalloinserters 
shown in Figure 1.3 and Figure 1.4. 
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Figure 1.3. Platinum metallo-intercalators; terpy = 2,2’,6’,2’’-terpyridine; phen = 1,10-
phenanthroline; bpy = 2,2’-bipyridine; phi = 9,10-diaminophenanthrene; HET= 2-
hydroxyethanethiolate. 
 
Figure 1.4. Octahedral metallointercalators containing planar aromatic ligands: phen, 
phi, dppz, phzi. dppz = dipyrido[3,2-a:2,3-c]phenazine, phzi = benzo[a]phenazine-5,6-
quinonediimine. 
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Metallointercalators are composed of a metal component and the coordinated flat 
aromatic ligands as shown in Figure 1.3 and Figure 1.4. The flat aromatic component 
can intercalate between the nitrogen bases of DNA and lead to cell death.[24], [25], [26], [27]  
The Pt(II) complexes containing heterocyclic aromatic ligands, shown in Figure 1.3, 
binds to DNA duplexes non-covalently, intercalating between the base pairs.[16] 
1.2.2  DNA major and minor groove binders 
 
In a detailed analysis of DNA structure, there are two types of grooves that can be seen; 
the major groove has the nitrogen and oxygen atoms of the base pairs pointing inward 
toward the helical axis, whereas in the minor groove, the nitrogen and oxygen atoms 
point outwards as shown in Figure 1.5. 
 
Figure 1.5. Base pairing of major and minor groove of DNA double helix. 
 
Minor groove binders of DNA constitute an important class of derivatives in anticancer 
therapy. These compounds form hydrogen bonds and non-covalent interactions, with 
DNA[28] through electrostatic and hydrogen bonding interactions, Figure 1.6.[29] 
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Acetylaminofluorine, 1.14, is one of the examples for minor grove binders as shown in 
Figure 1.6. These ligands generally consist of arc shaped, planar and unfused aromatic 
hydrocarbons with a positive electrostatic potential that attracts them to the negative 
potential of the minor groove, with the arc matching the curvature of the DNA double 
helix. The N2 amino group of guanine generally blocks binding of these drugs by steric 
hindrance but also by widening the minor groove. For these reasons, most minor groove 
binding drugs are AT-specific.[30] 
  
Figure 1.6. Acetylaminofluorine , 1.14, is one of the minor groove binders.[20] 
 
Hydrogen bonds and Van der Waals contacts are important forces for the interaction of 
distamycin, netropsin and tallimustin with DNA. These compounds consist of 
characteristic oligopeptide-pyrrole-carbamoyl frameworks, Figure 1.7. The compounds 
shown in Figure 1.7 demonstrate a strong preference for adenine-thymine (AT)-rich 
sequences; containing at least four AT base pairs in the DNA double helix.[31] 
Among the minor groove binders shown in Figure 1.7, Tallimustin, 1.17, is structurally 
different by having a nitrogen mustard component at one end of the molecule. This 
 
1.14 
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nitrogen mustard component has potential DNA alkylating properties. More detail 
about DNA alkylating nitrogen mustards can be found in section 1.2.3.1. 
 
Figure 1.7. Examples of minor groove binders.[31] 
 
There are cytotoxic compounds that act as major groove alkylators such as 
Nitrosourea.[32] But to date, there is no solid evidence about drugs which target direct 
major-groove binding.[30]  
 
1.2.3  DNA alkylating agents 
 
Alkylating agents comprise a major class of therapeutics used in the treatment of 
different types of cancers.[33] Alkylating agents are highly reactive molecules that react 
with nitrogen bases of DNA and ultimately cause cell death.[34] The unwinding of the 
DNA double helix during the cell cycle facilitates easy access of DNA alkylating agents 
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and therefore their reaction with DNA base pairs. This means that cells that divide 
rapidly, such as cancer cells, are more likely to be affected. Unfortunately, due to the 
nonspecific nature of these DNA alkylating agents, severe side effects can arise where 
rapid cell division take place under normal conditions (e.g. in hair follicles and the 
stomach lining).[35] 
In oncology, the term alkylating agent refers to any antineoplastic compound that 
irreversibly binds to a variety of susceptible biomolecules such as nucleic acids, 
proteins, amino acids, and nucleotides. This covalent interaction mediates cell death 
through interference with DNA structure and function, inactivation of DNA repair 
enzymes, or cell membrane damage. 
DNA alkylating agents can be mono-functional or bi-functional. Mono-functional agents 
make adducts with target molecules, while bi-functional agents can form cross-links 
(inter-or intra-strand), Figure 1.8, in DNA or between DNA and proteins.[36], [37]  
Figure 1.8. Schematic representation of DNA alkylation by mono- or bi-functional 
alkylating agents.[33], [36] 
There are preferential sites of alkylation in DNA depending on the nature of the 
nucleophile and of the alkylating agent.[38], [39], [40] The most frequent sites of base 
alkylation in DNA are the guanine N7 and O6 positions, adenine N1 and cytosine N3.[39], 
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[41], [42] Alkylation on other sites such as adenine N6, N7, thymine O2, N3, O4, or cytosine 
O2 have also been observed, but to a lesser extent, Figure 1.9.[43] 
 
Figure 1.9. Different sites of base alkylation are shown in red arrows. The size of arrow is 
roughly proportional to the frequncy of alkylation.[33]  
 
The alkylation on guanine O6, N1, N2 and thymine O6, N1, N2 or O4 results in stable 
DNA adducts.[44] Alkylation on other positions leads to chemically unstable adducts that 
are converted to do DNA damage by opening of the base ring.[40], [44] That is especially 
the case for the most common base alkylation at guanine N7 position which is readily 
converted into a 5-alkyl formamidopyrimidine (fapy) by opening of the imidazole ring, 
Figure 1.10.[45] Similar observations have been reported for adenine N3 alkylation, 
leading to an abasic site formation.  
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Figure 1.10. Mechanisms of conversion of N7 alkylated guanine into a cytotoxic DNA 
lesion. 
 (A) Conversion of an abasic site following depurination. This is initiated by the π electron 
delocalization of N7-C8 double – bond of the imidazole ring (red arrows). 
(B) Conversion into 2,6-diamino-4-hydroxy-5N alkyl formamidopyrimidine (Fapy-7alkylG) 
by hydrolysis of the imidazole ring in basic conditions as an example. 
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Puyo et al.[33] reported seven classes of alkylating agents. The chemical structures of the 
corresponding compounds are shown below, Figure 1.11. 
 
 
Figure 1.11. Seven classes of alkylating agents. 
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Figure 1.12. Intrastrand DNA cross linking cisplatin, 1.25. 
 
The traditional alkylators such as the nitrogen mustards react with nucleophilic sites in 
DNA (usually the guanine N7 and O6 positions) through one or more electron-deficient 
alkyl groups. Both cisplatin, Figure 1.12, and carboplatin, act in a similar way, as they 
both bind directly through the platinum atom, most commonly to guanine bases. The 
loss of both the chloride ligands of cisplatin leads to the formation of intra-strand cross-
links causing unwinding of the helix, Figure 1.12, preventing transcription, and leading 
to cell death. 
 
1.2.3.1  Nitrogen mustards as DNA alkylating agents 
 
Mustin, discovered by Gilman and Goodman in 1946, is the first alkylating agent for 
showing remarkable chemotherapeutic activity in the treatment of lymphomas. Mustin, 
1.26 was the first alkylating agent to obtain FDA approval in 1949.[33] 
Nitrogen mustards represent the earliest, and perhaps the most extensively studied 
DNA interstrand cross-linking agents, in Figure 1.13. Mustin 1.26 and chlorambucil 
1.27 are two of the most heavily employed clinical anticancer drugs today, along with a 
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Figure 1.13. Two clinically important DNA cross-linking nitrogen mustards. 
 
Mechanism of Action 
 
Figure 1.14. A mechanism for the alkylation of guanine N7 via production of a reactive 
aziridinium ion. The mono-alkylation product can lead to Alkyl-N7G:T base mispairing or 
can be the target of a second alkylation leading to N7G-N7G inter-strand cross-links. The 
chemical structures of R groups are shown below. 





The Figure 1.14 shows the mechanism for the alkylation of DNA by nitrogen mustard 
compounds. Most nitrogen mustard compounds share a common N,N-bis(2-
chloroethyl)amino motif that leads to the formation of an aziridinium ion, the 
electrophilic entity responsible for the establishment of the covalent link with the 
nucleophilic centre of the base, mainly the guanine N7 and O6 positions.[47]  The 
resulting products of monoalkylation can lead to base mispairing that is potentially 
mutagenic. Povirk et al.[48] reported a wide array of mutations as a result of 
monoalkylation, including base substitution at both G-C and A-T base pairs. 
The DNA cross linking nitrogen mustard compounds show a high degree of cytotoxicity 
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1.3  Side effects of chemotherapeutic agents 
  
A principal downside of chemotherapeutic drugs is the non-specificity for cancerous 
cells. When developing novel chemotherapeutic agents a delicate balance between 
poisoning as many cancer cells as possible while sparing healthy cells is a key factor. 
The side effects of such chemotherapies also mean that there is a limitation to the 
number of times, and/or the length of time a treatment can be administered.  
It is highly likely that chemotherapy with such anticancer drugs can effectively destroy 
most cancer cells in the body if sufficiently high doses can be administered for enough 
time; however this comes at the cost of near total destruction of the body. 
Therefore science has been faced with a challenge to find anticancer drugs that are 
more selective, which minimise their harmful side effects, making these 
chemotherapeutic drugs more tolerable for the patient. 
 
1.4  Targeted therapies and anticancer drug design 
 
Prodrugs systems are one of the popular treatments to achieve selective activity of the 
cancer drugs. Prodrugs undergo chemical conversions by metabolic processes to release 
active drug. 
As researchers learn more about other chemical or biochemical markers of cancer cells 
that cause cancer, they have been able to develop drugs that target these changes, a 
treatment often called targeted therapy. The targeted therapy drugs are often able to 
attack cancer cells while doing less damage to normal cells, by exploiting the natural 
mechanisms of cancer cell activity; the programming that sets them apart from normal, 
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healthy cells. These drugs tend to have different (and often less severe) side effects than 
those of standard chemotherapeutic drugs. 
Hypoxia selective drugs and photoactivated cytotoxins can be categorised as targeted 
therapies and are relevant background for this research. The work described in this 
thesis is mainly about the synthesis of cytotoxic nitrogen mustard compounds attached 
to the cobalt(III) inert metal centre and attempts to use these cobalt(III) nitrogen 
mustard compounds in the synthesis of heterodinuclear complexes that may exhibit 
photoactivated cytotoxicity  
1.4.1  Hypoxia selective cytotoxins; classification and mechanism of 
activation 
 
Tumour hypoxia is the situation where tumour cells have been deprived of oxygen. As a 
tumour grows, it rapidly outgrows its blood supply, leaving portions of the tumour with 
regions where the oxygen concentration is significantly lower than in healthy tissues, 
Figure 1.15. Hypoxic microenvironments in solid tumours are the result of available 
oxygen being consumed within 70 to 150 μm of tumour vasculature by rapidly 
proliferating tumour cells, thus limiting the amount of oxygen available to diffuse 
further into the tumour tissue.[49], [50], [51], [52] 
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Figure 1.15. Development of hypoxic region when cells get pushed away from blood 
vessels.[53] 
The first drug in the hypoxia selective category to enter clinical testing is tirapazamine, 
1.28 shown in Figure 1.16.[51],[54] Further information on tumour hypoxia can be found 
in the review article published by Hockel et al.[55] 
Treatment of cancer through hypoxia selective prodrugs is an important therapeutic 
target. This exploits major differences between tumoral and normal tissues. A drug 
active only to hypoxic cells would be selectively toxic to tumour cells in hypoxic 
regions.[56], [57] Also, within the tumour, it is the hypoxic cells that develop resistance to 
standard therapy, due to lack of blood and oxygen supply and therefore by targeting 
these hypoxic cells, reduce the development of resistance to standard therapy of the 
tumour as a whole.[51] 
Tirapazamine (TPZ) is an excellent substrate for various intracellular reductase 
enzymes which deliver a single electron to the molecule, thereby producing a free 
radical intermediate. In the presence of oxygen, this free radical is rapidly oxidised back 
to the parent molecule with the formation of a superoxide radical. However, in regions 
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of reduced oxygen concentration, as in the situation with hypoxic cells, this does not 
occur. Instead, the highly reactive TPZ radical, Figure 1.16, will remove a hydrogen atom 
from nearby macromolecules, resulting in structural damage. If this nearby molecule is 
DNA, then the TPZ radical produces both single and double strand breaks leading to cell 
death.[58] 
 
Figure 1.16. The metabolism of tirapazamine (TPZ) to its free-radical moiety causing 
preferential toxicity to hypoxic cells by damaging the DNA double helix.[59], [60], [61]  
 
The bis-N-oxide banoxanthrone (AQ4N), shown in Figure 1.17, is another bio-reductive 
drug which was developed as an analogue of mitoxantrone, Figure 1.18. Similar to other 
bio-reductive compounds, AQ4N is reductively activated, in this case to AQ4. The 
reduction product, AQ4, has a high DNA affinity constant which stabilizes the DNA 
double helix as measured by a large increase in DNA melting temperature.  
AQ4N is the only bio-reductive drug entered in to clinical trials. AQ4N targets the  
topoisomerase which is crucial to cell division.[62] 
When AQ4N was tested, in oxic conditions, of 60 tumour cell lines little or no 
cytotoxicity was observed (IC50 >100 µM).[62] Furthermore, the drug has been shown to 
have greater toxicity when applied in combination with other chemotherapeutics, and 
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is, to date, the most promising compound for treatment of hypoxia induced chemo-
resistance.[63] 
 
Figure 1.17. Reductive activation of AQ4N to AQ4. 
 
Figure 1.18. Chemical structure of Mitoxantrone. 
 
1.4.1.1  Cobalt(III) complexes as hypoxia selective anti-cancer compounds 
 
This concept is based on less toxic compounds which release the corresponding active 
drug under hypoxic conditions in cancerous tissues.[64] For prodrug activation several 
cancer targeting mechanisms have been reported, one of which is activation by 
reduction in the inherently hypoxic tissue found in most solid tumours.[65] 
Chapter 01  23 
 
Cobalt(III) compounds have been explored as such bio-reducible prodrugs due to the 
significant difference in the ligand lability of the two oxidation states.[65], [66] While 
octahedral d6 low-spin cobalt(III) complexes are kinetically inert, labile d7 high-spin 
cobalt(II)complexes are formed after reduction. In the presence of oxygen, this would 
immediately lead to re-oxidation; cobalt(II) complexes easily undergo ligand 
substitution reactions, enabling the release of biologically active ligands.[67] This 
concept has already been used as a trigger for release of several cytotoxic compounds, 
such as nitrogen mustards[66] and DNA minor groove alkylator[68] by complexing them 
to cobalt(III) metal centres. 
Karnthaler-Benbakka et al.[69] reported the synthesis of a novel epidermal growth factor 
receptor (EGFR) inhibitor that is specifically activated in malignant tissues. This 
prodrug strategy is based on the assumption that the intact complexes would be too 
bulky and, therefore prevent binding of the inhibitor to the ATP binding pocket of the 
EGFR molecule, Figure 1.19. This enables the selective activation of the drug only after 









Figure 1.19. Synthesis of cobalt(III) complex containing quinazoline derivative, shows 
selective release of ligand under hypoxic conditions.  
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Activation of the prodrug, 1.35, was studied using fluorescence spectroscopy. 
Karntheler-Benbakka et al.[69] reported that the fluorescence was diminished in treated 
cells with the complex 1.35 under normoxic conditions, suggesting an intact cobalt(III) 
complex. Under hypoxic conditions, a strong increase of fluorescence was observed in 
treated cells indicating activation of the prodrug with subsequent ligand release. 
Cobalt(III) complexes containing 8-hydroxyquinoline (8-HQ) 1.36, Figure 1.20 and 
cyclen based auxiliary ligands were also reported in the literature.[69] Ahn et al.[68] 
synthesised [Co(III)(cyclen)(azaCBI)]2+, 1.37, Figure 1.21 to demonstrate selective 
release of azaCBI, (1-(chloromethyl)-3-[(5,6,7-pyrolo[3,2-f]quinolin-5-ol), under 
hypoxic conditions.  
 
Figure 1.20. Chemical structure of Co(III)(cyclen)(8HQ). 
 
Figure 1.21. Chemical structure of [Co(III)(cyclen)(azaCBI.)]2+ 
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Ahn et al studied complex 1.37 to show the release of highly potent azaCBI cytotoxin, by 
both radiolytic and non-radiolytic pathways under hypoxic conditions. 
Investigation of complexes 1.38 and 1.39, Figure 1.22 was reported by  
Lu et al.[70] The bridging variation is highlighted in red. 
 
Figure 1.22. Complex containing N bridged cyclam ligand.  
Synthesis and hypoxia activity of similar cyclam cobalt(III) complexes were also 
reported by Chang et al.[71], [72]  
 
1.4.1.2  Hypoxia selective cobalt(III) complexes with a cytotoxic nitrogen mustard 
ligand 
 
Nitrogen mustards are well known for their DNA alkylating ability and non-specific 
toxicity in their active form. One of the strategies to target their cytotoxicity is by using a 
hypoxia activated cobalt(III) inert metal centre. This is achieved by complexing the 
nitrogen mustard to the cobalt(III) metal centre.[73] 
Coordination of the nitrogen lone pair of the nitrogen mustard to cobalt(III) should 
supress its toxicity since the electron pair is no longer available to activate the nitrogen 
mustard by making the highly strained aziridinium ion, Figure 1.14. Such cobalt(III) 
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complexes are kinetically inert. The nitrogen mustard ligand can then be released 
following reduction of the cobalt(III) metal centre to a labile cobalt(II) state. The 
cytotoxic nitrogen mustard will presumably be released by rapid ligand exchange with 
surrounding water molecules.[74] The activation can be largely confined to regions of 
hypoxia, hence providing tumour selectivity.[75] 
A range of cobalt(III) complexes of nitrogen mustard ligands have been synthesised and 
investigated for their cytotoxic activity. 
Ware et al. with his co-workers reported the synthesis and characterisation of range of 
different cobalt(III) complexes containing nitrogen mustard ligands. Most of the 
complexes studied by Ware et al., contain N,N-bis(2-chloroethyl)ethane-1,2-diamine 
(DCE), 1.40 or N,N’-bis(2-chloroethyl)ethane-1,2-diamine (BCE), 1.41 nitrogen mustard 
ligands, Figure 1.23.[74] 
 
Figure 1.23. Chemical structure of DCE and BCE nitrogen mustards. 
 
The other auxiliary ligands around the cobalt(III) centre were modified during different 
synthetic approaches to tune the reduction potential and kinetic stability of the 
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complexes as hypoxia selective anticancer drugs. Changing auxiliary ligands resulted in 
positive, negative and neutral complexes.  
To ensure hypoxic selectivity, the reduced cobalt(II) complex containing the nitrogen 
mustard ligand must be sufficiently stable to allow re-oxidation in oxygenated cells to 
compete effectively with ligand loss. The kinetic stability of the reduced 
cobalt(II)complexes were greatly enhanced by coordinated chelating ligands.[74], [76] 
Figure 1.24. Chemical structures for the complexes with chelating ligands 1.42, 
[Co(acac)2(BCE)]+, 1.43, [Co(acac)2(DCE)]+, 1.44, [Co(Meacac)2(DCE)]+, 1.45, 
[Co(Clacac)2(BCE)]+ (Claca = 3-chloropentane-2,4-dionato anion). 
The acetylacetonate (acac) ligand was successfully used as a bidentate monoanionic 
ligand, which coordinates to cobalt(III) through the two oxygen donor atoms to form 
delocalised chelate rings, Figure 1.24.[77]  
Denny et al.[77] reported novel cobalt complexes of nitrogen mustard alkylating agents 





Figure 1.25. Chemical structures of complex 1.46 and complex 1.47. 
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X =Y= H / lower alkyl (optionally substituted with hydroxyl and / or amino functions) 
containing from 1 to 6 carbon atoms, phenyl (optionally substituted with Me, OQ, CONHQ, 
and / or NHCOQ).  
R = H, lower alkyl (optionally substituted with hydroxyl and / or amino functions), phenyl 
(optionally substituted with Me, OQ, CONHQ and / NHCOQ. 
 Q = lower alkyl (optionally substituted with hydroxyl and / or amino functions) and 
containing from 1 to 6carbon atoms) or halogen. 
 
Both of the Denny et al.[77] and Ware et al. research outcomes confirmed that the 
cytotoxicity of the complexes 1.43, 1.44, 1.45, 1.46 and 1.47 was indeed due to release 
of the respective nitrogen mustard ligands under hypoxic conditions.[74] 
Ware et al.[76] further investigated complexes in a similar class with tropolonates (trop) 
as ancillary ligands, Figure 1.26. Tropolonates are flat molecules when they coordinated 
to the cobalt(III) centre, and minimises the steric hindrance in complexes with bulky 
tertiary amine nitrogen mustard ligands. 
 
Figure 1.26. Chemicals structures of [Co(trop)2(L)]+ (L = BCE, BEE, DCE, DEE).  
(BCE = N,N’-bis(2-chloroethyl)ethane-1,2-diamine; DCE = N,N- bis(2-chloroethyl)ethane-
1,2-diamine; BEE =N,N’-diethylethane-1,2-diamine; DEE= N,N-diethylethane-1,2-diamine) 
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The tropolonato complexes have significantly higher reduction potential than the 
corresponding acac complexes, suggesting more facile cellular reduction. The 
tropolonato ligands therefore facilitate the cellular reduction of the coordinated 
cobalt(III) centres hence release of the mustard ligand. 
Ware et al.[78] also synthesised the cobalt(III) complexes with electron rich sulfur 
containing dithiocarbamate ligands. The dithiocarbamato (R2dtc-) ligand replaced 
Racac- as alternative bidentate, monoanionic chelating ligands. These coordinate 
through two sulfur atoms, and complexes of the formulae [Co(R2dtc)2(DCE)]+ retain an 
overall cationic charge. 
The different R substituents tailor properties such as redox potential and lipophilicity of 
the [Co(R2dtc)2(L)]+ complexes. Different alkyl groups with increasing number of 
carbon atoms (CH3, (CH2)2, (CH2)4) were introduced as different R groups to create 
hydrophobic character to the complex hence facilitating the easy travelling across the 
cell membrane. 
The sulfur donors on R2dtc are capable of making a huge difference in electron transfer 
properties conferred on the cobalt(III)/cobalt(II) couple, Figure 1.27.[78] The 
coordinated electron rich sulfur donors reduce the reduction potential of cobalt(III)/ 
cobalt(II) couple. The small size of the four membered chelate rings minimises the steric 
bulk for tertiary amine nitrogen mustard ligands. 
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Figure 1.27. Chemical structures of bis(dialkyl)dithiocabamato)cobalt(III) complexes of 
BCE and DCE bidentate nitrogen mustard. 
 
It was also found that the ligands containing sulfur atoms increase the kinetic stability 
of the complex.[79], [80] Lower potentials were expected for dithiocarbamate systems 
compared to oxygen donor systems for example Co(R2dtc)3 and Co(Racac)3.[80]  
Cobalt(III) nitrogen mustard complexes containing an overall positive charge have been 
reported in literature. [73-74], [77-78] Taking different approach for the synthesis, Craig et 
al.[81] reported cobalt(III) DCE complexes containing oxalate(ox) and carbonato ligands, 
[Co(ox)2(DCE)]¯ and [Co(CO3)2(DCE)]¯. These were the first DCE complexes to be 
prepared which bear an overall negative charge, Figure 1.28.[81] These complexes were 
synthesised to study their properties in relation to the overall negative charge created 
by oxalate and carbonate ancillary ligands. Possibly the overall negative charge lowers 
the reduction potential of these complexes. 
The ancillary ligands present on the cobalt(III) metal centre are also important to tune 
the physiologically and chemically important properties of the complex such as 
cobalt(III) / cobalt(II) reduction potential, overall charge, solubility and hydro-or 
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lipophilicity. These factors place a major role for entering the prodrug into the 
biological system and also in releasing the active nitrogen mustard into the target sites. 
 
Figure 1.28. Anionic carbonate and oxalate cobalt(III) nitrogen mustard, DCE and BCE.  
 
1.4.2  Photo-activated cytotoxins 
 
The fields of phototherapy and inorganic chemotherapy both have long histories. 
Inorganic photoactivated chemotherapy offers both temporal and spatial control over 
drug activation and has remarkable potential for the treatment of cancer. 
Photoactivated cytotoxins (PACT) provide the opportunity for control over when and 
where a drug is activated, using light energy, and resulting in a greater specificity of 
drug action. The use of an inactive precursor or “prodrug” is an important strategy in 
drug targeting.[82], [83] 
For biological systems, light is a convenient trigger, as it provides control over the 
location and timing for the creation of an active agent;[84] and if longer wavelengths are 
used (visible and near-IR), the light itself is generally not damaging to cells or tissues. 
Thus, such photo triggered agents can be used in both basic research and for clinical 
applications. 
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There is a great deal of interest in the field of photoactivated metal complexes, with a 
special focus on compounds that damage DNA.[85] Farrer et al.[83] reviewed a series of 
investigations of PACT for cancer treatment using metal complexes; mainly Ti, V, Cr, Mn, 
Re, Fe, Ru, Os, Co, Rh, Pt and Cu metal complexes. 
Aqueous solubility, cell uptake and stability in biological media are common 
considerations for any potent drug. But photoactivated metal anticancer agents should 
have additional key features like:  
 A large difference between cytotoxicity in the presence and absence of 
irradiation is desirable in order to limit unwanted side effects, which may also 
reduce drug efficacy. 
 The wavelength of activation preferably lies within a phototherapeutic window 
of 620-850 nm. This range has the maximum depth penetration into mammalian 
tissue.[86] However, other wavelengths could prove useful to initiate the desired 
photochemical reaction. For example, some ruthenium(II) polypyridyl systems 
have well-established and characterised photochemistry in the 420-450nm 
range that could be used to demonstrate the potential of photoactivated 
cytotoxin systems.[83]  
Photodynamic therapy (PDT) is more controllable and has the potential to selectively 
destroy malignant cells while sparing the normal tissues. 
PDT elicits phototoxic reactions that selectively destroy tumour cells and spare normal 
cells.[87], [88]  
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Hematoporphyrin derivatives have been investigated for the treatment of tumours, 
which led to the first clinically approved PDT agent, Photofrin, Figure 1.29, for diseases 
such as bladder cancer.[89] 
 
Figure 1.29. Molecular structure of Photofrin consists of up to nine monomeric units 
(shown above) connected via ester linkages. 
 
Mackowiak et al.[90] explained the use of nanoparticles in combination with 
photosensitizers for targeted drug delivery. Apart from photosensitizing, light energy 
can be used to activate the drug to furnish the cytotoxic activity. This photosensitizer 
and nanoparticle prodrug combine system together increases cytotoxicity. 
Platinum(II) diamine complexes such as cis-platin are effective anticancer drugs, 
however they also have accompanying side effects. Kasparkova et al.[91] investigated the 
design of platinum complexes with low toxicity that could be photoactivated selectively 
at the target site. Pt(IV) azide complex cis,trans-(Pt(en)(N3)2(OH)2] 1.65, Figure 1.30 
was unreactive towards DNA until irradiated with light. 
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Figure 1.30. Chemical structure of [Pt(IV)(en)(N3)2(OH)2]. 
 
Octahedral Pt(IV) complexes are remarkably stable in the dark even in the presence of 
cellular reducing agents such as glutathione, but readily undergo photoinduced ligand 
substitution and photoreduction reactions.[92] A number of photoactivated platinum(IV) 
prodrug systems have been reported in the literature.[93], [94], [95] Karatochwil [96] 
explored the feasibility of photolyzing the Pt(IV) complex trans,cis-[PtCl2I2(en)] to its 
cytotoxic species by visible light. Further information about Pt(IV) prodrug systems can 
be read in Balzani et al. and Gandioso et al. publications. [93, 95, 97-100] 
For Pt(IV) to be active, it must first be reduced by biological reductants (e.g. ascorbate 
or glutathione (GSH)) to the corresponding Pt(II) antitumor agents.[101] Thus Pt(IV) 
complexes may be considered as inactive prodrugs, some of the Pt(IV) drugs are 
reported to be hypoxia active.[102] 
 
1.5. Photochemistry of polypyridylruthenium(II) complexes 
 
Polypyridylruthenium(II) systems are probably the most extensively studied class of 
transition metals complexes in relation to their photochemical properties.[103], [104-106] 
Polypyridylruthenium(II) complexes are popular for their triplet metal- to-ligand 
charge transfer (3MLCT) excited state with a relatively long life time at room 
temperature (~1 μs) and the ability to facilitate easy electron transfer reactions.[107] The  
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photochemistry of the [Ru(bpy)3]2+ complex can be explained by Jablonski diagram, 
Figure 1.31. 
 
Figure 1.31. Jablonski diagram, showing various photochemical processes due to the 
absorption of light by the fluorophore. 
 
When the electron in lowest energy state received the right energy, the electron is 
excited from the lowest energy singlet ground state (S0) to singlet excited state (S1). By 
changing the spin state of the electron, the energy of the electron lowers to its triplet 
(T1) excited state. The complex shows strong emission from (T1) state.[108] 
Komatsuzaki et al.[107] reported the photochemical properties of ruthenium-cobalt and 
ruthenium-nickel dinuclear complexes. Ruthenium(II) works as a photosensitizer 
according to previously discussed electronic processes and cobalt(III) and nickel(II) 
moieties as electronic acceptors. Also, further information on use of photochemistry in 
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heterodinuclear systems such as Ru/Co, Ru/Rh, Ru/Ir, Ru/Mn and Ru/Pt are reported 
by Song et al.[109]  
Photo electronic excitation and electronic transfer of bimetallic systems can be 








Figure 1.32. Energy level diagram showing possible electron travel pathways in Ru(II)-
Co(III) heterodinuclear complexes. 
 
The energy diagram contains an extra energy level compared to the [Ru(bpy)3]2+ 
system. The electron transfers (LMCT) from the bridging ligand to the cobalt(III) 
causing the reduction of the metal centre. At this stage, rapid exchange of ligands takes 
place due to the labile nature of cobalt(II) metal centre, and the recovery to the ground 
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1.6  Ruthenium(II)-cobalt(III) heterodinuclear systems as potential 
photoactivated cytotoxins. 
 
Holbrook et al.[110] reported the photoactivated electron transfer system using a 
ruthenium(II)-cobalt(III) heterodinuclear complex and we aimed for a  similar 
mechanism to be employed to develop a photoactivated cytotoxic system. 
The mechanism of photoinduced ligand release can be explained using the following 
diagram. 
 
Figure 1.33. Graphical representation of photo-activated ligand release. Photo-induced 
electron transfer from donor (D), through linker (L), to acceptor (A) causes cytotoxic 
ligand (C) release. Polypyridylruthenium(II) system will act as an electron donor system 
and cobalt(III) complex with coordinated nitrogen mustard will act as an electron 
acceptor system. 
 
When polypyridylruthenium(II) complex is irradiated with visible light, it is 
subsequently oxidised to ruthenium(III) via a metal to ligand charge transfer type 
process. The electron is then transferred through the bridging ligand to the cobalt(III) 
metal centre, reducing it to cobalt(II). The labile nature of cobalt(II) facilitates the 
release of the attached cytotoxin, thus forming the basis of light induced drug release 
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Connection of the cobalt(III) centre to a group which can donate an electron upon 
excitation by an external light source should allow selective release of a cytotoxic 
molecule at the tumour site using relatively non-invasive techniques. 
Our proposal involves using polypyridylruthenium(II) photochemistry to trigger release 
of a ligand from a cobalt ion.  
Such electron transfer reactions have been observed before in Ru-Co systems. [110], [111], 
[112], [113], [114] Among these, only Downward et al. [113], [114] and Holbrook et al.[110] have 
reported subsequent ligand exchange reactions. Ligand release occurs due to the 
reduction of the cobalt(III) metal centre.[114] 
The work reported in this thesis discusses the synthetic strategy of a heterodinuclear 
metal complex in order to study its photo-activated cytotoxicity. Research work 
reported here is based on preliminary studies performed by Downward et al.[113] It was 
demonstrated that photo-induced ligand release could be achieved in the model system 






Figure 1.34. Ru(II)-Co(III) heterodinuclear model system. 
 
Upon irradiation the complex 1.66 in 1:1 solvent mixture of D2O and CH3CN using white 
light at room temperature, photo-induced ligand release of the above complex was 
 
1.66 
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observed. The release of the ethane-1,2-diamine ligands was observed by 1H NMR 








Figure 1.35 Photo-induced release of en from [(bpy)2Ru(pytp)Co(en)2]5+, as seen in 
aliphatic region of 1H NMR spectra (pytp = 3-(pyridine-2-yl)-[1,2,4]triazino[5,5-
f][1,10]phenanthroline); the peak associated with the free en molecule is marked(*). 
Spectra shown were taken after (from top to bottom) 0, 10, 30, 60, 120 and 180 minutes 
irradiation. 
 
The reaction scheme for the synthesis of [Ru(bpy)2(pytp)]2+ complex and the 
complexation of the cobalt(III) complex is shown in  
Scheme 1.1. One of the important facts about the synthesis of the ruthenium(II) 
complex is the stepwise synthesis of the bridging ligand on ruthenium(II) metal centre. 
The pytp: (3-pyridine-2-yl)-[1,2,4]triazino[5,6-f][1,10]phenanthroline) ligand is 
asymmetric in nature and the stepwise synthesis facilitates the selectivity of the 
bridging end for the cobalt(III) metal centre, as well as easy purification and increased 
yields are another important aspects of this synthesis. 
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[Co(en)2(NO2)2]+ was synthesised as a starting cobalt(III) complex and both the nitrito 
ligands were substituted by highly labile OTf ligands by reacting with neat 
trifluoromethanesulfonic acid (HOTf) to facilitate the mild reaction conditions. During 
the synthesis of the heterodinuclear complex, the reaction mixture should be protected 
from heat and light as they could lead to the decomposition of the complex, possibly due 
to the thermal electron transfer or the light induced electron transfer. These OTf ligands 
are crucial when employing extremely mild conditions during the synthesis of the 
heterodinuclear complex. 
 
Scheme 1.1. Reaction pathway for the synthesis of complex 1.66. 
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1.7  Thesis coverage 
 
During this research we investigated the possible modifications on both the 
ruthenium(II) and cobalt(III) centres. Modifications on ruthenium(II) centre to 
manipulate the higher total complex charge and modifications on cobalt(III) including 
the replacement of ethane-1,2-diamine (en) with nitrogen mustard ligands. 
N-(2-chloroethyl)ethane-1,2-diamine, L3 will replace the ethane-1,2-diamine (en) 
ligands shown in complex 1.66. N-(2-chloroethyl)ethane-1,2-diamine (L3) was chosen 
as the cytotoxic nitrogen mustard to be synthesised on the cobalt(III) metal centre due 
to the easily obtained precursor [Co(L1)2(NO2)2]+ (L1: 2-((2-aminoethyl) amino)-             
-ethanol) and we explore the possibility of increasing the number of chloroethyl arms 
on the nitrogen mustard.  
Chapter 02 describes the coordination chemistry of the simplest 2-((2-amino-
ethyl)amino)ethanol, L1, precursor ligand. L1 ligand was of interest to us as a precursor 
ligand in the one step synthesis of nitrogen mustard compounds on cobalt(III) centre. 
The subsequent functional group chemistry required to produce mustard species was 
investigated and the functional group chemistry was found to both depend on and 
change the coordination chemistry of the cobalt(III) centre. This reaction chemistry is 
described in chapter 02. 
Chapter 03 reports the coordination chemistry of amino alcohol ligands with cobalt(III) 
metal centre. Amino alcohols are an important class of ligands for the project as they act 
as precursors for the nitrogen mustards. The coordinated amino alcohols were 
converted to nitrogen mustard ligands by chlorinating the alcohol group. But these 
alcohol oxygen atoms can also coordinate to the cobalt(III) metal centre, which provides 
some synthetic challenges, but also some opportunities. We therefore report the 
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coordination behaviour of several different amino alcohol ligands with the cobalt(III) 
metal centre. 
The model dinuclear complex 1.66 carried a 5+ positive charge; one of the aims of the 
research project is to modify the bipyridine ligands coordinated with the ruthenium 
metal centre in a way to lower the total complex charge. In that aspect some ligands like 
4,4’-dicarboxy-2,2’-bipyridine and 4,4’-diethoxycarbonyl-2,2’-bipyridine were 
suggested. 
Chapter 04 discusses the synthetic strategy for preparation of Ru(II)-Co(III) 
heterodinuclear metal complexes and describes its implementation, including the 
preparation of a suitable nitrogen mustard containing cobalt(III) precursor complex. 
Chapter 05 summarises the current state of the project and outlines the prospects and 
directions of future work. 
Chapter 06 provides the experimental details for synthetic work and molecular 
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2. Synthesis of a nitrogen mustard ligand on a cobalt(III) metal 
centre and related reaction chemistry 
2.1  Introduction 
 
One of the key aims of this research project is to synthesise a nitrogen mustard on an 
inert cobalt(III) metal centre. This synthetic route would allow us to avoid the handling 
of free toxic nitrogen mustard compounds during the preparation of such complexes. 
The proposed methodology involves the complexation of amino alcohol compounds, 
such as 2-((2-aminoethyl)amino)ethanol, L1, 2,2’-(ethane-1,2-diylbis(azanediyl))-
diethanol, L2, with a cobalt(III) inert metal centre, followed by the chlorination of the 
alcohol groups. For example, on chlorination L1 will be converted to, L3, Figure 2.1. 
 
Figure 2.1. Chemical structures of L1, L2 amino alcohol ligands and L3 nitrogen mustard. 
 
One of the key requirements to achieve the proposed synthetic route is the availability 
of a non-coordinated hydroxyethyl group. That will allow conventional functional group 
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chemistry to be utilised for the synthesis of a nitrogen mustard on the cobalt(III) metal 
centre.[115], [116] 
Until now, such complexes have been prepared by the complexation of a free mustard 
compound onto the cobalt(III) metal centre.[66], [73], [76], [117] Detailed information on these 
complexes can be found in chapter 01, Section 1.4.1.2. Most of the nitrogen mustard 
compounds used in those studies were prepared by direct chlorination of the 
corresponding alcohol group of the free amino alcohol compounds.[118]  
Boens et al.[119] recently reported a new synthetic method to synthesise eight different 
nitrogen mustard compounds using the reaction conditions shown in Figure 2.2. The 
chlorination of the alcohol group was performed under very mild conditions, utilising a 
thionyl chloride/pyridine system, in chloroform, at room temperature. 
 
 
Figure 2.2. Reaction scheme for the synthesis of nitrogen mustard ligands. 
 
Handling of these nitrogen mustard compounds is problematic due to their instability, 
their susceptibility to hydrolysis or solvolysis in their free base form, and their high 
toxicity.[73]  
As a safer synthetic approach, Downward et al.[120] investigated the synthesis of a 
nitrogen mustard on the inert cobalt(III) metal centre. 
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2.2  Previous work 
 
The aim of synthesising the nitrogen mustard on the cobalt(III) metal centre is to 
investigate a better and safer synthesis approach for these cytotoxic nitrogen mustard 
molecules and also later in the project these cobalt(III) nitrogen mustard complexes will 
take part in the Ru(II)-Co(III) pro-drug system (Refer chapter 04). 
L1 was chosen as a potential ligand to synthesise a nitrogen mustard on a cobalt(III) 
metal centre. This synthesis was previously studied in Hartshorn group by Alan 
Downward.[121], [120] 
After complexing L1 ligand with the cobalt(III) metal centre according to Downward et 
al.[120] synthesis, the chlorination method reported by Truce et al.[116] was employed to 
chlorinate the pendant alcohol group. SOCl2/ DMF were used to achieve chlorination, 
where SOCl2 is a chlorinating agent and DMF acts as a catalyst for the reaction, Scheme 
2.1. 
 
Scheme 2.1. The reaction mechanism for chlorination of alcohol using SOCl2 / DMF. 
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Luca et al.[115] proposed a mechanism for the chlorination of alcohol groups using 2,4,6-
trichloro[1,3,5]triazine (TCT) and DMF. TCT is the chlorinating agent, and DMF is a 
catalyst. 
Downward et al.[120] used SOCl2/DMF as a chlorinating agent for the conversion of 
alcohol functionality to chloro-functionality. The reaction mechanism for the 
chlorination of alcohol is shown in Scheme 2.1. 
Downward et al. synthesised [Co(L1)2(NO2)2]+, 2.06, and in this complex the L1 ligand 
coordinated as a bidentate ligand, through the amine nitrogen atoms. The hydroxyethyl 
group was planned to be chlorinated using SOCl2 / DMF later in the synthetic route to 
convert the L1 to L3. 
It’s worth noticing at this stage, that the L1 ligand has the potential to coordinate in a 
variety of ways. It can be coordinated in a bidentate binding fashion through the 
nitrogen atoms only, or it can coordinate as a tridentate ligand utilising both nitrogen 
atoms as well as the oxygen atom. The hydroxyl group of the L1 ligand can stay 
protonated or be deprotonated, depending on the reaction conditions. Sarma et al.[122] 
and Drinkard et al.[123] previously reported tridentate coordination behaviour for the L1 
ligand. From now onward the protonated ligand will be referred to as L1 and the 
deprotonated L1 ligand, 2-(2-aminoethyl)amino]ethanoate, will be referred to as (L1-
H),Figure 2.3. 
 
Figure 2.3. Protonated L1 and the deprotonated L1-H ligand presenting their binding 
modes. 
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Figure 2.4. Possible isomers of [Co(L1)2(X)2]+ complex formed during complexation of L1 







Primary amines trans/trans, trans/cis, and cis/cis to X group in cis bis(L1) complexes 
 
The L1 linkage isomerism. 
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secondary amine group. 
 




Ʌ and Δ configurations around Co in cis 
bis(L1) complexes. 
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Under the reaction conditions used by Downward et al.[120], the L1 ligand coordinated in 
bidentate fashion, leaving the hydroxyethyl arm free. Therefore, the reaction conditions 
shown in Figure 2.5 allowed the pendant hydroxyethyl groups to be converted to 
chloroethyl groups, thereby synthesising the nitrogen mustard on a cobalt(III) metal 
centre. Since the nitrogen lone pair is coordinated with the cobalt(III) metal centre, the 
nitrogen mustard is much less reactive than the free ligand. The reaction mechanism of 
free nitrogen mustard is discussed in the section 1.2.3.1. 
 
Figure 2.5. Synthesis of a nitrogen mustard on the cobalt(III) metal centre. 
 
2.2.1  Synthesis of precursor complex [Co(L1)2(NO2)2]+, 2.06, 
 
The synthesis of complex 2.06 was achieved under classic Wernerian conditions,[124] in 
which a rapid ligand exchange equilibria involving labile cobalt(II) ions led to formation 
of a distribution of complex ions that presumably reflects the relative stability of those 
complexes. This distribution is largely fixed by oxidation to inert cobalt(III) 
complexes.[120] 
The 2.06 complex was synthesised according to the reported literature procedure by  
Downward et al.[120]  
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The X-ray crystal structure of complex [Co(L1)2(NO2)2]+ 2.06 reported in literature, 
Figure 2.6, revealed the presence of a single isomer in the solid phase; formation of the 
particular isomer of this complex may be due to its higher stability or lower solubility. 
The thermodynamic stability of the complex may be due to the arrangement of 
hydroxyethyl arms on opposite sides of the complex, minimising steric hindrance, and 
making hydrogen bonding interactions between the amine hydrogen atoms and nitrite 
oxygen atoms. 
 
Figure 2.6. The asymmetric unit of [Co(L1)2(NO2)2]+complex, 2.06 with atom-labelling. 
The R, R isomer is shown, but the S, S isomer is also present in the unit cell. The anion, 
solvent molecules and the hydrogen atoms, except amine hydrogens, have been omitted for 
clarity.[120] 
 
The X-ray crystal structure of the compound confirmed that two L1 ligands were 
coordinated to the cobalt(III) centre through the amines, in a mutually trans 
bis(bidentate) manner. The other two binding sites on the octahedral metal centre, 
were trans to each other, and were occupied by N-bound nitrite ligands. Both the nitrite 
ligands were involved in hydrogen bonding interactions with amine hydrogen atoms, 
2.06 
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which made them inequivalent as one nitrite ligand bridges the secondary amine 
hydrogen atoms and the other nitrite ligand bridges with the primary amine hydrogen 
atoms. These interactions are shown in dotted lines in Figure 2.6. The asymmetric unit 
in the structure shown in Figure 2.6 is chiral, due to the stereogenic secondary amine 
ligating group (the R,R isomer is shown in Figure 2.6) however the space group of the 
crystal structure requires the presence of the other isomer, making the crystal 
racemic.[120] 
2.3  Results and Discussion  
 
The precursor complex [Co(L1)2(NO2)2]+, 2.06 shown in Figure 2.6 was synthesised 
according to the procedure described by Downward et al.[120] The chlorination of 
alcohol groups using SOCl2/DMF pair was carried out to synthesise the nitrogen 
mustard on the cobalt(III) metal centre. 
 
2.3.1  Chlorination of alcohol groups in the complex 2.06 for the synthesis of 
the related nitrogen mustard 
 
In order to use the synthetic route suggested, depending on the results reported by 
Downward et al.[113], for the preparation of ruthenium(II)cobalt(III) heterodinuclear 
complexes, the mustard-containing complex should have highly labile ligands to satisfy 
the low energy reaction conditions during the synthesis of heterodinuclear complexes.  
In brief, the alcohol groups in the 2.06 complex were chlorinated aiming to synthesise 
the 2.08 complex shown in Figure 2.5. The N-bound nitrite ligands found on the 
complex 2.08 can be easily substituted with the highly labile trifluoromethanesulfonate 
ligands (OTf)[125] Another advantage of having OTf anions coordinate is to make the 
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cobalt(III) nitrogen mustard complex soluble in acetonitrile. This solubility was 
achieved through the formation of the corresponding OTf salt. This process generally 
involves treating either the nitrite or chloride complex with trifluoromethanesulfonic 
acid (HOTf) under a vacuum at a temperature between 60 and 100 °C.[125], [126] 
At the initial stage of this research project various chlorinating reagents, such as HCl, 
PCl3, POCl3, SOCl2, and SO2Cl2 were tested and SOCl2 has been identified as the best 
reagent for the substitution of the hydroxyl groups with the chlorine atoms.  
The precursor complex [Co(L1)2(NO2)2]+ 2.06 was reacted with SOCl2 in the presence of 
catalytic amount of DMF at room temperature. After evaporating excess SOCl2 under a 
vacuum, the resulting pink solid material was recrystallized from 1:1 ethanol/water 
mixture to yield pink crystals. These crystals were characterised using mass 
spectrometric analysis; m/z = 384.0166, 1H NMR, 13C NMR analysis, as well as X-ray 
crystallography, to confirm the formation of the complex [Co(Cl)(L3)2(NO2)]+, 2.07. 
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     2.07 
Figure 2.7. The X-ray crystal structure of [Co(Cl)(L3)2(NO2)]+ 2.07 with atom-labelling 
The hydrogen atoms, except stereogenic hydrogen atoms and anion, have been omitted for 
clarity. The X-ray crystal structure shows the hydrogen bonding between N-bound nitrite 
ligand and primary amine hydrogens atoms. 
 
The 2.07 complex shows distorted octahedral geometry. The amine ligands were 
coordinated in mutually trans bis(bidentate) manner. Also, one of the N-bound nitrite 
ligands seen in the precursor complex 2.06 had been replaced by a chloride ligand. The 
crystallographic studies revealed the replaced N-bound nitrite ligand was hydrogen-
bonded to secondary amine hydrogens of the starting material; Figure 2.6. The 
remaining nitrite ligand retained the hydrogen bonding to the primary amine 
hydrogens as shown in Figure 2.7. 
The complex 2.07 differs from the precursor complex 2.06 by having coordinated 
nitrogen mustard ligands and also an axial chloride ligand as shown in the Scheme 2.2. 
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Scheme 2.2. Synthesis of nitrogen mustard coordinated with the cobalt(III) metal centre. 
This reaction scheme shows the conversion of alcohol function to chloro function as well as 
the substitution of one of the N-bound axial nitrite ligands with chloride. 
 
During the chlorination of the alcohol groups, formation of the 2.07 complex was 
observed instead of the expected 2.08 complex, Figure 2.5. 
According to the X-ray crystal structure shown in Figure 2.6, two of the trans N-bound 
nitrite ligands show differences in their hydrogen bonding with the amine hydrogen 
atoms. This difference may cause one of the N-bound nitrite ligands to be substituted by 
the chloride ligands. 
Primary amine hydrogens are more acidic, and hence are stronger hydrogen bond 
donors than those on the secondary amines which led to the lower reactivity of the N-
bound nitrite ligand. 
However, the remaining Co-NO2 bond length after chlorination seemed to be consistent 
with that of the Co-NO2 bond length of the precursor complex. Accordingly, it is possible 
that the hydrogen-bonding interaction from the most acidic hydrogen of the primary 
amines stabilise the remaining N-bound axial nitrite ligands during the chlorination 
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relative to the N-bound nitrite ligand hydrogen bonding to secondary amine ligands, but 
not the trans influence type process. However, there was not enough evidence to 
confirm the chemistry behind this process. 
However, this unexpected ligand exchange was challenging. Attempts to use the 2.07 
for the HOTf reaction were unsuccessful and decomposition of the 2.07 complex was 
observed. 
Therefore, a series of reactions were carried out using 2.06 as starting material, as 
shown in Figure 2.8, to get a better understanding about the chemistry related to ligand 
exchange, stability and coordination chemistry of the complex 2.06 and related 
complexes. 
During the process of investigating the ligand exchange behaviour of the complexes 
presented in this chapter, we found that one product complex can act as a starting 
material to another complex. Using this information the reaction web diagram was 
developed shown in Figure 2.8. Those reaction routes will also be discussed under the 
different starting materials in each section respectively. 
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Figure 2.8. The chemistry detailed in this chapter. 
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2.3.2  Synthesis of complex [Co(Cl)2(L3)2]+, 2.09, 
 
After separating the crystals of 2.07 from the chlorination reaction, the remaining hot 
filtrate changed colour from pink to bluish-green and, after few days; the solution 
yielded bluish-green block shaped crystals. The obtained crystals were filtered and 
washed with cold ethanol and characterised by mass spectrometric analysis and X-ray 
crystallography. 
The mass spectrometric analysis of the crystals showed the presence of both the 2.07 
and 2.09 complexes confirming the non-homogeneous nature of the crystalline 
material. The ion appearing at m/z: 374.9897 confirmed the presence of 2.09/2.10 and 
the m/z relevant to 384.0167 confirmed the presence of 2.07 in the crystalline material 
sample. 
 
Figure 2.9. The mass spectrum of the crystalline material showing presence of both the 
complexes, [Co(Cl)2(L3)2]+, 2.09/2.10 and [(Co(Cl)(L3)2(NO2)]+, 2.07. Experimental m/z 
signals and simulated isotope patterns are shown for both the complexes.  
Chapter 02  58 
 
The X-ray crystallographic studies of the selected crystal showed the presence of the cis 
amine trans chloride isomer, complex 2.10, one of the axial chloride ligands showed 
mixing with nitrite ligands. This must be due to the presence of the cis amine isomer of 
2.07 in the crystalline material and both the complexes crystallised together. 
 
Figure 2.10 X-ray crystal structure of [Co(Cl)2(L3)2][CoCl4 ], 2.10 with atom-labelling. A 
solvent molecule and the attached hydrogen atoms, except hydrogen bonding amine 
hydrogen atoms, were omitted for the clarity. 
 
The complex 2.10 shows distorted octahedral geometry having coordinated two L3 
ligands and two chloride ligands around the cobalt(III) metal centre. Only one axial 
chloride ligand, Cl18 shows mixing / disorder with nitrite ligand. The presence of nitrite 
ligand in mixing with chloride is indicated by the two prominent electron densities 
beside the Cl8 chloride axial ligand and better refinement value was obtained after 
2.10 
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modelling the nitrite ligand on the crystal structure. This is most likely due to the 
presence of both the 2.10 and the cis amine isomer of 2.07 in the reaction mixture and 
crystallising together. This finding suggests the non-homogeneous nature of the 
crystalline material.  
The crystal structure of 2.10 shows different ligand arrangement compared to the 
starting material 2.06. 
The complex 2.10 shows a cis amine substituent configuration. But the starting material 
2.06 is a trans amine complex. The isomerisation of the L3 ligand could be facilitated by 
the generation of cobalt(II) ions in the medium. Even the small amount of cobalt(II) 
present in the medium could reduce more cobalt(III) species in the medium. Due to the 
labile nature of cobalt(II), the ligands on the cobalt(II) centre can rapidly exchange, and 
cobalt complexes can isomerise under these circumstances. The above crystal structure, 
Figure 2.10, is one of the examples of an isomerisation followed by the re-oxidation of 
the cobalt(II) complex. This complex does not represent the bulk sample as confirmed 
by the complicated 13C NMR spectroscopy and the broadening of the 13C NMR could also 
be due to the presence of a trace amount of cobalt(II) contaminant in the sample. 
During the recrystallization process, ethanol acts as a solvent; the reducing nature of the 
ethanol may have cause the production of the cobalt(II) ions in the medium.  
The findings about 2.10 guided us to develop a new synthetic route for the complex [Co 
(Cl)2(L3)2]+, 2.09.  
Chlorides are much weaker ligands compared to the nitrite ligands. By having 
dichloride ligands coordinated with the cobalt(III) nitrogen mustard complex, there is a 
possibility of using it, without any modifications, to coordinate with the Ru(II) second 
Chapter 02  60 
 
metal centre to synthesise the heterodinuclear complex. Therefore 2.09 could be a 
potential candidate during the prodrug synthesis. 
There is some evidence from the previous literature about the use of dichloride 
complexes during the synthesis of dinuclear complexes. Liang et al.[127] used cis-
[Co(Cl)2(phen)2]Cl·3H2O to coordinate to the [(phen)2Ru(bpibH2)]2+ complex to 
synthesise the dinuclear [(phen)2Ru(bpibH2)Co(phen)2](ClO4)5·2H2O; {bpibH2 = 1,4-
bis([1,10]phenanthroline-[5,6-d]imidazole-1-yl)-benzene}. 
 
Figure 2.11. Chemical structure of [(phen)2Ru(bpibH2)Co(phen)2]5+, 2.18. 
 
Another possibility of having dichloride ligands is to replace them with even more labile 
OTf ligands[72], hence employing the mild reaction conditions during the complexation. 
However Downward et al. explored the possibility of reacting [Co(Cl)2(en)2]+ complex 
with [Ru(bpy)2(pytp)]2+ to form dinuclear complex, however the reaction failed and the 
synthesis of dinuclear complex was successfully completed with the [Co(en)2(OTf)2]+ 
complex. 
The first synthesis attempt for the complex 2.09 involved the heating of the precursor 
complex 2.06 at 70 °C in the presence of conc. HCl, using ethanol as a solvent and also 
adding LiCl to increase the chloride ion concentration in the medium. This experiment 
was unsuccessful as the reaction led to the decomposition of the precursor complex, the 
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appearance of blush-green reaction mixture confirmed the formation of cobalt(II) ions 
in the medium.  
For the second attempt the complex 2.07 was chosen as the starting material and was 
heated at 70 °C with conc. HCl and EtOH in the presence of LiCl; the resulting dark green 
colour solution suggested the presence of trans dichloride ligands on the cobalt(III) 
metal centre.[128] After evaporating the solvent, ethanol was added to the sticky solid 
material to yield a light green powdered material of the complex 2.09.  
The complex 2.09 is highly sensitive to temperature; and therefore it was necessary to 
maintain the reaction temperature at ~70 °C. The reaction was slow and needed a 
longer reaction time to achieve completion. The yield of the reaction was lower due to 
the generation of cobalt(II) ions. The cobalt(II) propagate the reduction of cobalt(III) 
ions to cobalt(II) and the decomposition of the complex.  
The complex was characterised using mass spectrometry (m/z = 374.9896), NMR 
spectroscopy, microanalysis and X-ray crystallography. 
The 1H NMR spectrum of the complex 2.09 is shown in Figure 2.12. The four different 
multiplets in the spectrum are relevant to eight different hydrogen atoms from each half 
of the complex. The three amine hydrogen (N3 and N6) peaks are placed in three 
different positions of the spectrum. The two primary amine hydrogens on N6 were 
chemically different due to the arrangement in space. The hydrogen atoms on the C1 
carbon appear down field in the spectrum at around 4.0 ppm compared to other 
hydrogen atoms. The two multiplets observed up field in the spectrum are relevant to 
the chemically different H4 and H5 hydrogens. 
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Figure 2.12. 1H NMR spectrum of [Co(Cl)2(L3)2], 2.09 in deuterated DMSO. The yellow 
coloured peaks are due to H2O and DMSO respectively. 
 
Figure 2.13. gCOSY NMR spectra of [Co(Cl)2(L3)2]+, 2.09. 
H4’ 
H2, H2’ 
H5, H5’, H4 
 
N6 N6’ N3 
H1, H1’ 
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COrrelation SpectroscopY (gCOSY) is a 2D NMR technique that gives correlation 
between J-coupled signals by incrementing the delay between two 90° proton pulses. 
This can be used to identify the spins which are coupled to each other. The information 
obtained from this spectrum helps to find the proton-proton coupling within three bond 
distance and also helps to confirm the proton assignment in the 1H NMR spectrum. 
 
Figure 2.14. gHSQC spectrum of [Co(Cl)2(L3)2]+, 2.09. 
 
The gHSQC spectrum Heretonuclear Single Quantum Correlation provides chemical 
shift correlation between 1H and 13C having one-bond J-coupling of ~110 to 170Hz. 
According to the above spectrum, C1 carbon appears more up field compared to the C5 
and C4 which are closer to primary or secondary amine nitrogen atoms. Also it was 
observed that the carbon atoms directly attached onto secondary nitrogen atoms (C5) 
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appears more up field compared to the carbon atoms directly attached onto primary 
amine nitrogen atoms (C4). 
The information obtained from HSQC spectra along with the 1H NMR spectra supported 
the assigning of 13C NMR peaks. 
 
Figure 2.15. 13C NMR spectra of [Co(Cl)2(L3)2]+, 2.09. 
 
Slow evaporation of the very dilute solution of the complex in ethanol yielded green 
crystals suitable for X-ray crystallography studies. Mass spectrometric analysis and the 
NMR studies confirmed the presence of cobalt(III) complex in the crystalline material. 
The X ray crystal structure of the complex showed the presence of a chloride anion 
confirming (+1) total complex charge and cobalt(III) metal in the complex cation. 
 
C4  C2 
C5 
C1 




Figure 2.16. X-ray crystal structure of [Co(Cl)2(L3)2]+, 2.09. Chloride anion and ethanol 
solvent molecules, as well as hydrogen atoms on the complex, except the hydrogen atoms 
on secondary amine nitrogen atoms, were omitted for the clarity.  
The asymmetric unit of the compound [Co(Cl)2(L3)2]+;Selected bond lengths (Å) and 
bond angles (°); Co1-N4 1.9994(8), Co1-N3 1.9666(9), Co1-N2 1.9933(8), Co1-N5 
1.9478(8), Co1-Cl6 2.2494(3), Co1-Cl7 2.2293(3), N2-C18 1.4805(1), C18-C19 
1.5174(2), C19-Cl8 1.7950(1), N4-Cl4 1.4794(1), C14-C15 1.5124(2), C15-Cl9 
1.7901(1), N2-Co1-N5 86.15(4), N3-Co1-N4 85.48(4), N2-Co1-N3 95.05(4), N5-Co1-N4 
93.33(4), Cl6-Co1-N2 89.57(2), Cl6-Co1-N3 90.13(3), Cl6-Co1-N5 89.69(3), Cl6-Co1-N4 
88.45(3), Cl6-Co1-Cl7 179.436(1), Cl7-Co1-N2 90.95(3), Cl7-Co1-N3 90.03(3), Cl7-Co1-
N4 91.03(2), Cl7-Co1-N5 90.14(3). 
 
The cobalt(III) complex, shown in  
Figure 2.16, was crystallised in the orthorhombic space group Pbcn. The asymmetric 
unit consisted of the complete cationic complex, two ethanol molecules and one 
chloride ion. The chloride ion was found in two different positions having half 
occupancies. The cobalt(III) complex possessed a distorted octahedral geometry. The 
two chloride ligands were trans to each other. The secondary amine nitrogen atoms 
were arranged trans to each other. Both the chiral nitrogen atoms, N2 and N4 have the S 
configuration. The chloride anion was hydrogen-bonded with one of the hydrogen 
2.09 
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atoms on the stereogenic centre with the distance of 2.7553(8) Ǻ, and the ethanol 
oxygen atom was hydrogen bonded with one of the primary amine hydrogen atoms 
with the distance of 2.3866(1) Ǻ. Another hydrogen bonding interaction between a 
chloride anion and the ethanol hydroxyl hydrogen atom was observed with a distance of 
2.2205(2) Ǻ.  
 
2.3.3  Synthesis of [CoCl(L1)2(NO2)]+, 2.11, 
 
The complex 2.11 is different from the precursor 2.06 by having substituted one of the 
nitrite ligands with chloride ligand only, as shown in Figure 2.8. The colour of the 2.11 
is close to the appearance of starting material 2.06. 
The complex 2.11 was synthesised by reacting a methanolic (50 mL) solution of the 
precursor complex 2.06, with 10 mL of SOCl2 at room temperature and the stirring was 
continued overnight. The methanol solution became light pink in colour, still containing 
some unreacted precursor complex 2.06 suspended in the flask. The methanol solution 
was filtered and concentrated. Addition of ether to the solution yielded a light pink 
powder. 
The pink powder was purified by using SP-C25 cation exchange column 
chromatography. The first eluted orange band was relevant to the m/z = 312.108 as 
shown in the Figure 2.17. The target complex 2.11 was eluted as a third orange colour 
band with 0.02M NaCl solution. The eluted band of complex 2.11 was desalted with 
numerous methanol extractions followed by G10 size exclusion chromatography to 
obtain the pure powdered material, after evaporating the solvent. 
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The mass spectrometric analysis of the powdered material showed the presence of 2.11 
complex; m/z = 348.0839, 1H NMR, and 13C NMR analyses were used to characterise the 
2.11 compound. The analysis results obtained suggested that 2.11 complex possessed 
one chloride and one nitrite ligand in the axial positions. One of the axial nitrite groups 
in 2.06 was replaced by a chloride ligand and the 1H NMR spectrum is similar to that of 
the precursor complex 2.06. 
During the synthesis, the SOCl2 react with methanol to form dimethoxy sulfoxide in the 
reaction mixture and it is an exothermic reaction. The heat produced during the 
reaction may have facilitated the substitution of one of the N-bound nitrite ligands with 
a chloride ligand.  
The crystals suitable for X-ray crystallographic analysis were obtained by slow 
evaporation of concentrated methanolic solution of the compound 2.11. The crystal 
structures that were obtained were highly disordered among the N-bound axial nitrite 
and a chloride ligand.  
This reaction supported the findings of non-equality of axial nitrite ligands and also 
confirmed that one of the nitrite ligands is loosely bound to the cobalt(III) centre 
compared to the other nitrite ligand and under very mild reaction conditions the loosely 
bound nitrite ligand can be easily substituted with chloride ligands. The methanol 
alcohol medium contributed to stabilising the alcohol functional groups against 
chlorination. 
If the reaction of 2.06 with SOCl2 in methanol medium continued for a longer reaction 
time, or if there was a mild increase in temperature, the formation of [Co(Cl)2(L1)2]+, 
2.12 was observed, Figure 2.8, and also possible cobalt(III) complexes with L1-H 
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ligands were observed by mass spectrometric analysis, Figure 2.17. But the formation of 
nitrogen mustard complexes were not observed under any of these reaction conditions. 
 
 
Figure 2.17. Mass spectrum of complex 2.11, showing other minor compounds formed 
during the synthesis. 
 
2.3.4  Synthesis of [Co(Cl)2(L1)2]+, 2.12, 
 
Complex 2.12 in Figure 2.8 is different from its starting material as it has two trans 
chloride ligands coordinated to the cobalt(III) centre due to the substitution of nitrite 
ligands on 2.06 complex. 
The complex 2.12 is obtained by dissolving the precursor 2.06 in ethanol in the 
presence of conc. HCl, followed by continuous stirring of the mixture for 48 hours at 
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~70°C. After completion of the reaction the solvent was evaporated under vacuum and, 
the solid was dissolved into methanol. The product 2.12 was precipitated by addition of 
diethyl ether into the methanolic solution of the complex to yield a very sticky solid.  
This residue was recrystallized from ethanol to give the complex as a bluish-green 
powdered material. The product was characterised by mass spectrometric analysis 
(m/z = 337.06), 1H NMR, 13C NMR spectroscopy, and X-ray crystallography. The bluish 
colour is unusual for trans dichloride cobalt(III) complexes, and may indicate the 
presence of a small amount of cobalt(II) contaminants, although not sufficient to affect 
the NMR analysis. 
The NMR studies of the powdered material showed two fold symmetry of the complex 
in deuterated DMSO. 
The slow evaporation of a 1:1 ethanol:water solution of 2.12 resulted the bottle green 
block shaped crystals (Yield: 20%) suitable for X-ray crystallographic studies.  
 
 
Figure 2.18. X-ray crystal structure of [Co(Cl)2(L1)2]+, 2.12, with atom labelling. The 
diagram shows the trans L1 ligands in trans dichloride complex. The chloride anion, 
ethanol solvent molecule and hydrogen atoms, except secondary amine hydrogens, were 
omitted for clarity.  
2.12 
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The asymmetric unit of the complex [Co(Cl)2(L1)2]+; Selected bond lengths (Å) and bond 
angles (°); Co1-N2 1.955(3), Co1-N3 1.993(3), Co1-N4 1.998(3), Co1-N5 1.957(3), Co1-
Cl6 2.2661(1), Co1-Cl7 2.2355(1), N3-C18 1.490(5), N4-C14 1.489(5), C18-C19 
1.517(6), C14-C15 1.514(6), C19-O9 1.425(5), C15-O8 1.426(6), N2-Co1-N3 85.93(1), 
N4-Co1-N5 86.02(1), N2-Co1-N4 93.06(1), N3-Co1-N5 94.95(1), Cl6-Co1-Cl7 178.98(1), 
Cl6-Co1-N2 89.72(1), Cl6-Co1-N3 88.16(1), Cl6-Co1-N4 89.08(1), Cl6-Co1-N5 89.49(1). 
 
The cobalt(III) complex crystallised in the triclinic space group Pī The asymmetric unit 
of the molecule contains a complete cobalt(III) cationic complex, with a chloride as an 
anion, and an ethanol molecule. The chloride ligands are trans to each other. Primary 
amine groups are trans to each other as well as the secondary amine are also arranged 
in a trans configuration. 
Both the hydrogen atoms on the stereogenic nitrogen centres have S configuration.  
When the bulk sample of 2.12 was dissolved in water, the solution changed from a 
bluish-green tint to purple. This may be due to the rapid ligand exchange of the axial 
chloride ligands with water molecules in the aqueous medium.  
Another crystallisation experiment was set up by using the same bulk sample. The 
feather-like bluish crystals were obtained (yield: 5%) by slow diffusion of diethyl ether 
into a methanolic solution. 
X-ray crystallographic analysis of these crystals confirmed the presence of 2.13, Figure 
2.8, a different isomer of the complex 2.12. 
 
 




Figure 2.19. X-ray crystal structure of [Co(Cl)2(L1)2]+, 2.13, with atom labelling. Chloride 
anion and the hydrogen atoms except the hydrogen atoms, on secondary amine hydrogens, 
were omitted for the clarity.  
The asymmetric unit of the complex [Co(Cl)2(L1)2]+; Selected bond lengths (Å) and bond 
angles (°); Co1-N2 L16(3), Co1-N3 1.943(3), Co1-N4 1.955(4), Co1-N5 L16(3), Co1-Cl6 
2.2524(1), Co1-Cl7 2.2483(1), N2-C12 1.487(5), N5-C16 1.495(5), C12-C13 1.514(6), 
C16-C17 1.518(5), C13-O8 1.427(5), C17-O9 1.422(5), Cl16-Co1-Cl17 178.21(4), N2-
Co1-N3 86.32(1), N4-Co1-N5 86.48(1), N2-Co1-N5 97.07(1), N3-Co1-N4 90.18(1),  Cl6-
Co1-N2 89.57(1), Cl6-Co1-N3 88.32(1), Cl6-Co1-N4 87.95(1), Cl6-Co1-N5 92.72(1), Cl7-
Co1-N2 90.99(1), Cl7-Co1-N3 90.02(1), Cl7-Co1-N4 91.31(1), Cl7-Co1-N5 88.9(1). 
 
The X-ray crystal structure of the complex 2.13 was solved in P21/n monoclinic space 
group. The asymmetric unit contains the complete cation with one chloride anion. The 
cobalt atom possesses a distorted octahedral geometry. Two chloride ligands were trans 
to each other. Primary amine groups are cis to each other leaving secondary amine 
nitrogen atoms cis to each other. Both the N5 and N2 stereogenic centres show S 
configuration. 
2.13 
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The chloride anions in the coordination sphere are hydrogen bonded with the primary 
amine hydrogens having distances of 2.317(1) Ǻ and 2.411(1) Ǻ, respectively. 
The comparison of calculated and experimental powder diffraction patterns were not in 
agreement. Many peaks observed in the calculated pattern were found in the 
experimental powder distribution; however, many extra peaks also appeared in the 
experimental powder pattern. That must be most likely due to the presence of other 
isomers, cobalt(II) impurities or contaminants.  
Also the 1H NMR and 13C NMR spectra obtained for the crystalline material of complex 
2.13 was highly complicated and noisy. This suggests the presence of different isomers 
of this complex and the broadening of the spectra suggest the presence of cobalt(II) ions 
in the medium. 
The relative arrangement of the diamine ligands showed a different arrangement to the 
starting material 2.06. This isomerisation is not surprising as we observed the presence 
of cobalt(II) impurity in the bulk material. 
The synthesis of complex 2.13 demonstrated the suitable reaction conditions for the 
substitution of monodentate nitrite ligands with chloride ligands, without affecting 
(chlorinating) the hydroxyl groups. The stability of hydroxyl groups may be due to the 
solvent ethanol used during the reaction. 
 
2.3.4.1  Synthesis of complex 2.09 using complex 2.12 as starting material 
 
Reaction of the complex 2.12 with SOCl2/DMF led to the formation of complex 2.11. 
After the reaction, excess SOCl2 was removed under vacuum, and the solid material was 
precipitated by adding ethanol. The powdered green material was characterised using 
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mass spectrometric analysis, 1H NMR and 13C NMR analysis, and the results were 
consistent with the compound 2.09 obtained from reaction route explained under the 
heading 2.3.2. 
 
2.3.5  Tridentate binding of the L1 ligand, 2.15 to 2.17, 
 
The uneven ligand substitution of axial nitrite ligands during the chlorination of alcohol 
groups in 2.06 led us to explore the possibility of changing the order of reactions to 
obtain 2.08, Figure 2.8. 
Therefore, the complex 2.06 was first reacted with HOTf aiming to synthesise the 
complex [Co(L1)2(OTf)2]+, 2.18. Then coordinate 2.18 with the ruthenium(II) centre to 
form the heterodinuclear complex. The chlorination of alcohol groups of L1 ligands on 
cobalt(III) to be done later in the synthesis as shown in the Scheme 2.3. 
The precursor 2.06 was reacted with neat HOTf under a nitrogen atmosphere, and the 
purple solid material was isolated by adding ether. The mass spectrometric analysis of 
the powdered material showed the presence of both 2.15 (m/z = 265.1069) and 2.14 
(m/z = 415.30) complexes in the mixture, Figure 2.8. By increasing the amount of HOTf 
and increased reaction times, complex 2.14 can be completely converted to 2.15. 
In the presence of HOTf the nitrite ligands on 2.06 may have first been substituted by 
the OTf ligands. Due to the labile nature of the OTf ligand the alcohol oxygen become a 
strong electron donor to the central metal centre. 
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Scheme 2.3. Proposed reaction scheme (II) for the synthesis of heterodinuclear complex. 
 
These complexes demonstrated the possible tridentate coordination of the L1-H ligand. 
Unfortunately, we were not able to separate 2.14 and 2.15 to characterise them 
separately at this stage. Similar tridentate binding behaviour of L1-H ligand was 
observed in the presence of moderately weaker chloride ligands too, Figure 2.17. 
The complex 2.14 was identified from the mass spectrometric analysis, and could be an 
intermediate leading to the formation of complex 2.15. Disappearance of m/z = 415.30 
peak relevant to 2.14 in the spectrum with longer reaction times, confirmed that the 
complex favours tridentate binding of the ligand.  
The tridentate binding of L1-H ligand with cobalt(III) was reported by Sarma et al.[129]. 
In their report, pH, solvent, the coordinated groups, and the relative metal to ligand 
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concentration were identified as the most important factors affecting the polydentate 
nature of the ligand. 
According to Sarma et al the deprotonation of the acidic hydroxyl hydrogen is facilitated 
by the pH of the medium. Also after coordinating to the metal centre, the proton 
attached to hydroxyl oxygen becomes highly acidic and is easily lost under higher pH 
conditions.[122] 
 
2.3.4.2  Synthesis of complex [Co(L1-H)2]+ under high pH conditions 
 
The precursor 2.06 was stirred in an aqueous solution of NaOH (pH = 13) overnight, 
and the resulting brownish red material was collected after removing the solvent under 
reduced pressure. The residue was dissolved into a minimal amount of methanol and 
filtered and dried under the reduced pressure to obtain the pink powdered material. 
The residue was characterised by mass spectrometric analysis, (m/z = 265.1069), as 
2.15/ 2.16 /2.17. The most acidic proton on the coordinated hydroxyl group was 
removed under high pH conditions. According to Bailar et al.[124] vacating of the sites 
occupied by nitrite ligands must be facilitated by high pH conditions.[129] Therefore, the 
total system can achieve high thermodynamic stability having tridentate ligands around 
the central metal.  
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Figure 2.20.13C NMR spectrum of the bulk sample of 2.15, 2.16. and 2.17 recorded in D2O. 
 
The 13C NMR analysis of the above complex seemed complicated, as 13C NMR spectrum 
showed fourteen different peaks. The 13C NMR peaks were distributed into three 
different groups in the spectrum. The results were not very surprising, as there are 




































Figure 2.21. Possible facial isomers of the complex [Co(L1-H)2]+. 
 
The 2.16 complex was crystallised by adding aqueous PF6¯ ions to the medium. The 
crystals suitable for the X-ray crystallography were grown after exchanging the chloride 
anion with a PF6¯anion. Diffusion of diethylether into a methanolic solution of the 
complex yields bright red crystals suitable for X-ray crystallography. 
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Figure 2.22. X-ray crystal structure of [Co(L1-H)2]+, 2.16, complex with atom-labelling 
showing cis amine trans oxygen conformation. Hydrogen atoms on the cationic complex, 
except chiral hydrogen atoms, were omitted for clarity. 
The molecular structure of the complex [Co(L1-H)2]+; Selected bond lengths (Å) and 
bond angles (°); Co1-O2 1,9082(2), Co1-N3 1.967(2), Co1-N4 1.932(2), O2-C8 1.406(3), 
N4-C5 1.484(4), N3-C6 1.482(3), 1.486(4), C7-C8 1.525(3), C5-C6 1.517(4); O2-Co1-N3 
86.20(6), O2-Co1-N4 91.32(8), N3-Co1-N4 86.7(1)  
 
X-ray crystal structure of the complex 2.16 was solved in orthorhombic Pbcn space 
group. The asymmetric unit of the complex consists of half of the cationic complex and 
half of the hexafluoridophosphate anion. The complex shows distorted octahedral 
geometry. The two oxygen atoms from the alcohol groups coordinate in trans manner. 
The cis primary amine nitrogen atoms and cis secondary amine nitrogen atoms 
completed the octahedral configuration around the metal centre. The hydroxyl groups 
were deprotonated. The fluoride atoms of the PF6
¯ anion were hydrogen bonding with 
the secondary amine hydrogens, with the distance of 2.43(3) Å and also with the 
hydrogen atoms on C8 with the distance of 2.47(2) Å. Also another hydrogen bond was 
2.16 
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observed between primary amine (N4) hydrogens and oxygen (O2) atoms with the 
distance of 2.03(2) Ǻ. 
There are a few incomplete literature reports about different alkoxide complexes [123], 
[130] and further studies were carried out to understand the chemistry of [Co(L1-H)2]+ 







Figure 2.23. Other possible reaction pathways for the synthesis of complex [Co(L1-H)2]+. 
Only one isomer of the complex [Co(L1-H)2]+ is shown in the figure. 
 
Reaction path (a), Figure 2.23 was described by Kotovaya et al.[130] during the synthesis 
of tris(2-aminoethanolato)cobalt (III) complexes having sulphate as an anion. 
During the synthesis, L1 was added dropwise with stirring to CoSO4·7H2O dissolved in 
2:1, aq. ethanol mixture. The obtained red coloured solution was left for slow 
evaporation.  
The complex [Co(L1-H)2]+ was also synthesised by reaction of the precursor complex, 
2.06 , with either aq. NaOH or neat HOTf, as discussed in previous sections. 
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Reaction path (d), Figure 2.23 was discussed by Sarma et al.[129] in literature for the 
synthesis of the complex [Co(L1-H)2]+. The synthesis was done by reacting 
[Co(NH3)6]Cl3 with L1 in the presence of activated charcoal and ammonium hydroxide.  
The complex 2.19 is shown in the Figure 2.24 is isolated as its iodide salt. The plate-like 
red crystals suitable for X-ray diffraction analysis were obtained by the slow 
evaporation of the aqueous solution of the complex. The total complex charge of 2.19 is 
(+2) due to only one of the de-protonated L1-H ligands. 
 
 
Figure 2.24. X-ray crystal structure of [Co((L1)L1-H)]2+, 2.19, complex with atom 
labelling. The hydrogen atoms except the N7 and O3 hydrogen atoms were omitted for 
clarity. 
The molecular structure of [Co(L1)(L1-H)]2+: Selected bond lengths (Å) and bond angles 
(°); Co1-O2 1.8921(2), Co1-O3 1.9170(2), Co1-N4 1.9513(2), Co1-N5 1.9619(2), Co1-N6 
1.9482(2), Co1-N7 1.9551(2), O3-Co1-O2 179.73(7), O3-Co1-N4 87.11(8), O3-Co1-N5 
85.31(7), O3-Co1-N6 90.46(7), O3-Co1-N7 94.13(7), O2-Co1-N4 92.69(8), O2-Co1-N5 
2.19 
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94.88(7), O2-Co1-N6 89.75(7), O2-Co1-N7 85.69(7), C8-O2-Co1 108.60(1), Co1-O3-C12 
113.85(1). 
 
The crystal structure of the complex was solved in monoclinic space group P21/c. Two 
of the ligands were arranged in distorted octahedral geometry around the cobalt(III) 
metal centre showing a tridentate binding fashion for the each ligand. The two ligands 
were different with respect to the protonation state. This structure represents the trans 
amine, trans oxygen isomer of the complex. In the coordination sphere, two fully 
occupied iodide atoms confirms the (2+) charge of the complex cation; one of the (+) 
charge generated from the cobalt(III) metal centre, while the other (+) charge added 
from the protonated O3 oxygen atom. The prominent electron density close to O3 
confirms the attached hydrogen during structure solution.  
The experimental powder diffraction pattern of the bulk material of the 2.19 had extra 
peaks that didn’t appear in the calculated powder diffraction pattern of the single 
crystal. This data clearly represent the presence of some contaminant or possibly a 
different isomer of the 2.19 present in the bulk material, and confirmed that the bulk 
sample is different from the single crystals.  
Due to insufficient sample size, NMR spectrometry or elemental analysis were not 
possible. In solution state both the ligands will be chemically similar due to the fast 
exchange of O3 hydrogen atoms. 
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2.3.4.3  Complexes of [Co(L1-H)2]+ with ZnCl2 or MnCl2, 2.20 to 2.22, 
 
Previously discussed 13C NMR analysis of the bulk sample of [Co(L1-H)2]+.and the X-ray 
crystallographic studies of the 2.16 and 2.19 complexes suggested the presence of 
possible isomers. 
The attempts to separate the different isomers of [Co(L1-H)2]+ complex using cation 
exchange SP-C25 column chromatography were unsuccessful. Two different isomers 
2.16 and 2.19 were already presented in section 2.3.4. 
During this research a new synthetic route was developed to identify different isomers 
of complex [Co(L1-H)2]+ by reacting them with ZnCl2 /MnCl2 salts. 
However, apart from identifying different isomers of the complex [Co(L1-H)2]+ a new 
coordination chemistry of the [Co(L1-H)2]+ complex was also discovered.  
These complexes showed that the oxygen atom on alkoxide complexes is capable of 
coordinating with metal centres like zinc(II) or manganese(II) to form 
heteropolynuclear complexes and here we report some of the heteropolynuclear 
complexes of 2.15 and 2.17 with ZnCl2 or MnCl2 metal salts. 
The solid material obtained from the reaction path (d), Figure 2.23 was dissolved in 
methanol to obtained reddish purple solution and mixed with a methanolic solution of 
ZnCl2. The mixture was heated, resulting in a pink solution. The pink reaction mixture 
was analysed by mass spectrometry. The mass spectrum shows the peaks that can be 
assigned to the following complexes: 
[C8H22N4O2Co1]+ [Co(L1-H)2]+ = m/z =265.1050 
[C8H22N4O2Cl2Zn1Co1]+ =m/z=398.9721 
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[C8H22N4O2Cl4Zn2Co1]+ = m/z =532.8406 
The identified peaks relevant to above complex cations suggested the possible 
complexation of ZnCl2 with complex [Co(L1-H)2]+ 
The obtained pink solution was filtered, and left for slow evaporation. The pink plate 
like crystals appeared in the solution were analysed by 13C NMR spectroscopy and gave 
a highly complicated noisy spectrum.  
The plate-like pink crystals that appeared in the solution (Yield: 22%) were suitable for 
X-ray crystallography. Randomly selected crystals from the bulk material were analysed 
by X-ray crystallography. 
 
 
                                                                                       2.20 
Figure 2.25. Asymmetric unit of the complex 2.20 with atom-labelling. The picture 
showed the cis amine trans oxygen isomer of the complex forming trinuclear complex with 
ZnCl2. Three of these inter connected units were present in the molecular structure. 
Molecular structure of [Co(Cl5)(L1-H)2Zn2]; Selected bond lengths (Å) and bond angles 
Co1-O2 1.9177(2), Co1-O3 1.9192(2), Co1-N4 1.963(1), Co1-N5 1.9764(1), Co1-N6 
1.969(4), Co1-N7 1.958(1), O2-Zn16 1.9807(1), O3-Zn19 1.9765(1), Zn19-Cl17 
2.2387(2), Zn16-Cl18 2.2027(2), Zn19-Cl20 2.2640(1), Zn19-Cl21 2.2872(1), Zn19-Cl22 
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2.2393(2). O2-Co1-N6 85.26(4), O2-Co1-N5 1.915(1), O2-Co1-N4 90.838(6), O2-Co1-N7 
91.327(6), O3-Co1-N4 1.919(1), O3-Co1-N5 84.644(6), O3-Co1-N6 93.852(6), O3-Co1-
N7 90.969(6), Zn16-O2-Co1 133.894(5), Zn16-O2-C13 1.8206(1), Cl17-Zn16-Cl18 
122.326(1), Cl18-Zn16-O2 109.683(5), Cl17-Zn16-O2 108.22(6), Zn19-O3-C11 
120.236(5), Zn19-O3-Co1 130.43(5), Cl20-Zn19-O3 106.370(6), Cl21-Zn19-O3 
110.440(5), Cl22-Zn19-O3 108.274(6). 
 
The complex crystallises in Pī space group. The asymmetric unit of the complex consist 
of one cobalt(III) alkoxide complex with coordinated two ZnCl2 molecules with trans 
oxygen atoms making a trinuclear metal complex. The positive charge of the complex is 
balanced by the presence of extra chloride atom on one of the zinc(II) metal centres. 
There is no significant change to be noticed in Co-O bond lengths between the 2.20 and 
2.16 structures. 
The alkoxide complex, found within the 2.20 trinuclear complex is another possible 
isomer of [Co(L1-H)2]+ and identified as 2.15.  
 
Figure 2.26. The molecular structure of complex 2.20 showing connection of three units 
via chloride bridging. 
 
The molecular structure of the trinuclear complex shows the presence of three 
asymmetric units. Each of these units is bridging through chlorine atoms. 
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Figure 2.27. Packing structure of the complex 2.20 through 011 planes showing the 
cavities present in the packing structure. 
 
The view of the packing structure through 011 planes shows the large empty cavities 
along the plane. Intermolecular hydrogen bonds are observed between primary amine 
hydrogen atoms and chloride atoms in the distance of 2.385Å. Intramolecular hydrogen 
bonds were observed between the secondary amine hydrogen atoms and the adjacent 
chloride atoms in the distance of 2.401 Å. 
All the crystals in the bulk sample were similar in appearance. However, the X-ray 
crystallographic analysis of another crystal obtained from the same batch happened to 
be structurally different to the previously obtained crystal structure, Figure 2.28. 




Figure 2.28. Molecular structure of 2.21 with atom-labelling. The structure shows the 
presence of cis oxygen cis amine isomer complexing with ZnCl2 making a trinuclear 
complex. The solvent water molecules and all the hydrogen atoms except the hydrogen on 
N4 were omitted for the clarity. 
The molecular structure of [Co(Cl)5(L1-H)Zn2]; Selected bond lengths (Å) and bond 
angles(°); Co1-N4 1.966(5), Co1-N5 1.955(4), Co1-N6 1.949(5), Co1-N7 1.956(5) , Co1-
O2 1.957(4), Co1-O3 1.911(4),  O2-Zn16 1.975(4), O3-Zn17 1.983(4), Zn16-Cl20 
1.956(4), Zn17-Cl20 1.938(4), Zn16-Cl22 2.266(2), Zn16-Cl21 2.269(2), Zn17-Cl18 
2.268(2), Zn17-Cl19 2.229(2). N5-Co1-O3 90.6(2), N7-Co1-N5 85.2(2), N5-Co1-O3 
90.6(2), N6-Co1-N5 93.7(2), N6-Co1-O2 86.11(2), O2-Co1-O3 89.7(2), O2-Co1-N4 
90.53(2), N4-Co1-N5 93.4(2), O2-Zn16-Cl20 104.26(2), O3-Zn17-Cl20 92.74(2), Zn16-
Cl20-Zn17 114.92(2). 
 
The complex 2.21 is crystallised in the Aea 2 space group. The molecular structure of 
the alkoxide complex shows the cis amine cis oxygen isomer co-ordinating with ZnCl2, 
via polydentate oxygen atoms forming trinuclear metal complex. Each of the cis oxygen 
atoms of the alkoxide complex is coordinated with zinc(II) metal centres. Each zinc(II) 
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atom shows tetrahedral geometry having three chlorine atoms and one oxygen atom 
coordinated. The two zinc(II) metal centres are bridged through a chlorine atom. There 
are three water molecules located in the sphere of the asymmetric unit of the molecule. 
Intramolecular hydrogen bonding is observed between one of the primary amine 
hydrogens and the bridging chlorine atom with the distance of 2.143 Å and 
intermolecular hydrogen bonding is observed between one of the primary amine 
hydrogens and one of the water molecules in the sphere with the distance of 2.098Å. 
The total complex is neutral in charge. 
Reaction of the methanolic solution the complex [Co(L1-H)2]+ with the methanolic 
solution of MnCl2.4H2O resulted a pink colour solution, The reaction mixture was 
filtered and left for slow evaporation, the small red crystals formed (yield: 13%) were 
analyse by mass spectrometry and X-ray crystallography. The mass spectrometric 
analysis of the sample shows the presence of cobalt(III) alkoxide complex. However 
none of the fragments represent the complexation of alkoxide complex with the MnCl2. 
The X-ray crystallographic analysis of the crystals represents the cis amine cis oxygen 
isomer complexing with MnCl3 molecules to form a dinuclear complex. 
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Figure 2.29. X-ray crystal structure of 2.22 with atom-labelling. The two structures 
present in the asymmetric unit are related to each other from their molecular symmetry. 
The hydrogen atoms in the structure, except the primary amine hydrogens, were omitted 
for the clarity. 
Molecular structures of [Co(Cl)3(L1-H)2Mn2]; Selected bond lengths (Å) and bond 
angles(°); Co1-N4 1.953(5), Co1-N5 1.9785(6), Co1-N6 1.973(5), Co1-N7 1.968(7), Co1-
O2 1.906(4), Co1-O3 1.888(5), Mn16-O2 2.209(5), Mn16-O3 2.124(5), Mn16-Cl17 
2.474(7), Mn16-Cl18 2.426(7), Mn16-Cl19 2.413(8), Co20-N23 1.9642(5), Co20-N24 
1.96644(6), Co20-N26 1.98(5), Co20-O21 1.8825(5), Co20-O22 1.8855(4), Mn35-O21 
2.1294(5), Mn35-O22 2.2008(5), Mn35-Cl36 2.4281(7), Mn35-Cl37 2.4636(7), Mn35-
Cl38 2.4147(8), N4-Co1-N5 97.80(2), N5-Co1-N6 85.13(2), N5-Co1-O2 87.71(2), N5-
Co1-O3 89.02(2), N7-Co1-O2 1.968(7), N7-Co1-O3 93039(2), N7-Co1-N4 1.962(6), N7-
Co1-N6 1.965(7), O2-Mn16-O3 71.55(3), O2-Mn16-Cl18 110.168(2), O2-Mn16-Cl17 
87.73(3), O2-Mn16-Cl19 131.857(2), O3-Mn16-Cl18 2.1147(5), O3-Mn16-Cl17 
158.569(3), O3-Mn16-Cl19 94.123(2), N24-Co20-O21 88.813(4), N24-Co20-O22 
87.455(2), N24-Co20-N23 97.568(2), N24-Co20-N26 86.093(2), N25-Co20-O22 
90.1078(2), N21-Co20-O 21 92.253(2), N25-Co20-N23 85.168(2), N25-Co20-N26 
92.116(2), O21-Mn35-O22 71.181(3), O22-Mn35-Cl36 108.044(2), O22-Mn35-Cl37 
2.22 
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89.157(3), O22-Mn35-Cl38 135.979(1), O21-Mn35-Cl36 95.1214(2), O21-Mn35-Cl37 
159.546(2), O21-Mn35-Cl38 93.937(2). 
 
The X-ray crystal structure of the complex 2.22 was solved in P21/n monoclinic space 
group. The asymmetric unit consists of two dinuclear complexes which are similar in 
molecular symmetry. The total complex charge is neutralised by the chlorine atoms on 
the manganese(II) metal centre. The two cis oxygen atoms of the alkoxide complex were 
directly coordinating to the manganese metal centre. The manganese(II) centre showed 
the trigonal pyramidal geometry. 
There is intramolecular hydrogen bonding between one of the primary amine 
hydrogens and one of the chlorine atoms. Also intermolecular hydrogen bonding is 
observed between primary amine hydrogens with chlorine atoms on the adjacent 
molecule. 
X-ray crystallographic analysis of the complex bulk sample confirmed the formation of 
three different isomers, Figure 2.30 in the reaction mixture. The fourth possible isomer 
with the two oxygens cis and the two amine groups trans was not observed. 
 
 
Figure 2.30. Three different isomers of the [Co(L1-H)2]+ complex. 
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Each of the isomer shown in the Figure 2.30 will give rise to four signals in 13C NMR 
spectroscopy. In combination we are expecting twelve different carbon peaks. 13C NMR 
spectrum of the bulk sample shown in Figure 2.20 consists of fourteen different peaks 
and these three isomers most likely represent the twelve of those peaks. 
 
2.3.4.4 Use of [Co(L1-H)2]+ for the synthesis of 2.09 
 
The isomeric mixture of the bulk sample was reacted with SOCl2/DMF reagent to 
investigate the possibility of opening the Co-O bond while introducing chloride ligands 
to satisfy the coordination sphere. At higher temperatures formation of 2.09 was 
observed. The reaction needs a longer reaction time compared to a normal alcohol 
chlorination reaction. The reaction was monitored by mass spectrometry to confirm the 
complete conversion of complex 2.15 to 2.09. The disappearance of m/z: 265.1080 
peak was monitored with the complete conversion and reaction mixture turned to a 
green colour. Once the reaction was completed, excess SOCl2 was removed under 
reduced pressure. Cold ethanol was added to the obtained green coloured slurry. First 
ethanol washing of the complex was discarded and the green powdered material was 
obtained by further trituration of thick green slurry was filtered and washed with cold 
ethanol. The green powdered material was analysed by mass spectrometry and NMR 
spectroscopy. 
Mass spectrometric analysis of the green powdered material shows the presence of 
[Co(Cl)2(L3)2]+ complex at m/z: 374.9903. However we identified three possible 
isomers in the starting material, Figure 2.30. These three different isomers can result in 
three different isomers of the chlorinated products as shown in Figure 2.31. 
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Figure 2.31. Possible isomers of [Co(Cl)2(L3)2]+ complex. 
 
However we only managed to isolate the 2.09 complex in the bulk sample and the 
presence of 2.09 was confirmed by NMR studies.  
 
 2.3.6  Synthesis of [Co(L3)2(NO2)2]+, 2.08,  
 
The complex 2.08, Figure 2.8, is interesting to us as it contains trans dinitrite ligands 
and two nitrogen mustard molecules coordinated with the cobalt(III) metal centre. As 
our final goal is to connect this nitrogen mustard cobalt(III) complex on to the 
[Ru(bpy)2(pytp)]2+ complex, the nitrite ligands can be easily converted to highly labile 
triflate (OTf) ligands by reacting with trifluoromethanesulfonic acid (HOTf). 
When the chlorination of the alcohol was done using 2.06 at room temperature we 
observed the formation of complex 2.07. The complex 2.07 showed the substitution of 
one of the axial nitrite ligands with chloride ligand as discussed in the section 2.3.1.  
Hence we explored different reaction conditions to avoid this ligand substitution of 
nitrite by chloride as we were interested in having nitrite ligands in both axial positions. 
Chapter 02  92 
 
A variety of modifications were introduced to the synthesis procedure, such as lowering 
reaction temperature. When the reaction temperature was lowered, the formation of 
complex 2.08 was observed along with the complex 2.07. 
The 2.08 was synthesised by reacting 2.06 with SOCl2/DMF pair below 0°C. The 
reaction mixture was kept in the ice/salt bath throughout the reaction. The reaction was 
continued for eight hours to complete the reaction and the excess SOCl2 was removed 
under vacuum. The crude product was further purified using SP-C25 cation exchange 
column, the yellow coloured band eluted with 0.01M NaCl was collected and desalted to 
obtaine (Yield:64% ) the complex 2.08. The complex was characterised using mass 
spectrometric analysis (m/z = 395.0407), NMR spectrometric techniques and elemental 
analysis. 
1H NMR spectrum of the complex 2.08 showed the presence of seven different 
multiplets relevant to eight different hydrogen atoms. 




















Figure 2.32. 1H NMR spectrum of complex 2.08 in D2O with reference to TMPS. 
 
2.3.5.1 Synthesis of 2.08 using 2.07 as a starting material 
 
As discussed in previous section the difficult synthetic conditions for the preparation of 
the complex 2.08 drove us to investigate other possible synthetic procedures for the 
complex 2.08. We investigated the possibility of substituting the chloride ligand on the 
complex 2.07 to nitrite ligand. Similar conversions were reported in literature.[131] 
The complex 2.07 was reacted with NaNO2 under cold conditions in the presence of 
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form large yellow crystals. The crystals formed were exactly similar in appearance to 
the crystals of the complex 2.06. 
One of the crystals formed during the very first attempt was analysed by X-ray 
crystallography and found to be [Co(L3)2(NH3)(NO2)]2+, 2.25. 
 
Figure 2.33. X ray crystal structure of complex 2.25 with atom-labelling. The chloride 
anions, solvent water molecule and the hydrogen atoms, except N5 and N2 amine 
hydrogen atoms, were omitted for clarity. 
The molecular structure of [Co(L3)2(NH3)(NO2)]2+; Selected bond lengths (Å) and bond 
angles(°);Co1-N3 1.929(5), Co1-N2 1.987(5), Co1-N4 1.946(6), Co1-N5 1.990(6), N3-
Co1-N4 90.69(2), N4-Co1-N2 1.946(6), N3-Co1-N5 90.2(3), N5-Co1-N2 89.8(3), N4-Co1-
N5 85.9(3). 
 
X-ray crystal structure of the complex 2.25 was solved in R3c trigonal space group. The 
asymmetric unit of the complex contained half the molecule, one chloride anion and a 
water molecule. The presence of chloride anion in the coordination sphere confirmed 
the (+2) total complex charge. The complex shows the distorted octahedral geometry 
with two L3 ligands, nitrite ligand and an amine ligand coordinated on to the cobalt(III) 
2.25 
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centre. In this molecule, axial chloride ligand is replaced with ammonia. The axial 
chloride ligand on 2.07 may have been replaced by an ammonia ligand to produce 2.25 
in the reaction mixture.  
The complex possesses a C2 symmetry axis through the axial nitrite and amine ligands. 
The chiral secondary nitrogen atoms show R configuration. The chloride anion in the co-
ordination sphere is hydrogen bonded to the secondary amine hydrogen with the 
distance of 2.425(2) Å. 
The analysis of the bulk sample using mass spectrometry and 1H NMR spectrometry 
reveals the bulk material (blue) is different to the calculated powder pattern of the 
crystal structure 2.25 (black). The comparison of powder pattern from bulk material 
(blue) represents relatively similar pattern to the powder diffraction pattern calculated 
for 2.08 crystals.  
 
Figure 2.34. The calculated powder patterns for the complex 2.25 (black) and 2.08 (red) 
in comparison with the experimental powder pattern obtained for the bulk sample of 2.25 
(blue). 
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The powder diffraction analysis of the bulk sample is different to both the calculated 
powder pattern of complex 2.25 and 2.08 crystals. However some of the peaks in the 
experimental pattern follow the similar pattern to the calculated results of 2.08 crystals. 
This is most likely due to the mixture of 2.08 and 2.25 in the bulk sample with 2.08 in 
the higher percentage. 
The conversion of chloride ligand to nitrite ligand reaction of 2.07 was repeated and the 
large block shape orange coloured crystals that appeared in the reaction mixture were 
analysed by mass spectrometry, NMR spectrometry and X-ray crystallography.  
The yellow crystals were analysed by X-ray crystallography and solution to the 
structure is shown in Figure 2.35. 
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Figure 2.35. X-ray crystal structure of [Co(L3)2(NO2)2]+, 2.08, complex with atom 
labelling. Chloride anion and the solvent water molecules were omitted for the clarity. 
Hydrogen atoms, except amine hydrogen atom, have been omitted. 
Molecular structures of [Co(L3)(NO2)2]+; Selected bond lengths (Å) and bond angles(°); 
Co1-N2 1790(5), Co1-N2 1,979(5), Co1-N3 2.039(5), Co1-N4 1.94(5), Co1-N5 1.948(5), 
Co1-N6 1.997(5), Co1-N7 1.936(5), Co22-N23 2.040(5), Co22-N24 1.979(5), Co22-N25 
1.984(5), Co22-N26 1.943(5), Co22-N27 1.997(5), Co22-N28 1.949(5); N7-Co1-N3 
91.1(2), N7-Co1-N4 93.6(2), N7-Co1-N5 177.6(2), N7-Co1-N6 86.0(2), N2-Co1-N3 
179.9(2), N2-Co1-N4 89.4(2), N2-Co1-N6 89.0(2), N4-Co1-N3 90.7(2), N4-Co1-N6 
178.3(2), N24-Co22-N23 179.7(2), N24-Co22-N25 89.5(2), N24-Co22-N23 90.5(2), 
N24-Co22-N27 89.4(2), N25-Co22-N27 178.8(2),  N26-Co22-N23 91.5(2), N26-Co22-
N23 91.5(2), N26-Co22-N24 88.8(2), N26-Co22-N25 86.5(2), N26-Co22-N28 177.6(2), 
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N27-Co22-N23 90.6(2), N28-Co22-N23 90.9(2), N28-Co22-N25 93.3(2), N28-Co22-N27 
86.2(2). 
 
The 2.08 complex is crystallised in Pī space group. The asymmetric unit of the complex 
consist of three complete molecules along with five water molecules and six half 
occupancy chloride anions. All three molecules are crystallised in distorted octahedral 
geometry. The two axial nitrite ligands are arranged perpendicular to each other. The 
nitrite ligands were hydrogen bonded to primary amine hydrogens and secondary 
amine hydrogens. Both the secondary chiral amine centres in each complex shows S 
configuration Figure 2.35. 
The nitrite ligand, that was hydrogen bonded with secondary amine hydrogens, has a 
shorter bond length 1.98 (4) Å with the cobalt(III) metal compared to the nitrite ligand, 
that was hydrogen bonded to primary amine hydrogens and the cobalt(III) metal centre 
2.041(3) Å. Both the N-bound nitrite oxygens have hydrogen-bonding distance with the 
amine hydrogens around ~2Å. There were intramolecular hydrogen bonds observed 
between chloride ligands and water molecules. 
 
2.4  Electronic absorption spectroscopy 
 
Ultraviolet-visible (UV/vis) spectroscopy is the study of the transitions involved in the 
rearrangements of valence electrons. In the field of inorganic chemistry, UV/vis is 
usually associated with d–d transitions and coloured transition metal complexes. The 
colour of the transition metal complexes in solution is dependent on several factors: the 
metal, the metal oxidation state, and the number of metal d electrons. For example; 











Figure 2.36. The vibrant colours of various cobalt(III) complexes in methanolic solution.  
 
Similarly some of the cobalt(III) complexes discussed in this chapter showed vibrant 
colours with different ligands in the coordination sphere, Figure 2.36. The different 
colours of cobalt(III) complexes presented here are due to the different energies of d-d 
transitions. The different ligands coordinated to the cobalt(III) centre are responsible 
for changing the energy gap associated with the d-d transitions therefore, leading to 




2.06 2.08 2.07 2.09 2.11 2.12 2.16 PF6¯ 
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Figure 2.37. Visible region of the spectrum showing the absorption patterns of the 
cobalt(III) complexes of 2.06, 2.07, 2.08, 2.09, 2.12 and 2.16. 
 
2.5.  Summary 
In this chapter we reported the synthesis and characterisation of a series of cobalt(III) 
complexes. This study helps to understand the coordination chemistry, ligand exchange 
behaviour and the stability of these complexes under different reaction conditions.  
Twelve different new cobalt(III) complexes, Figure 2.8, were synthesised and the 
sequential understanding of these complexes allowed us to successfully synthesise the 
desired nitrogen mustard cobalt(III) complex, 2.08. 
There is more than one new synthetic route developed for some of the complexes. All 
the complexes were characterised using X-ray crystallography. There are ten different 
new crystal structures discussed in this chapter. This chapter also included the 
chemistry about tridentate binding L1 ligand and alkoxide complexes. Three different 
isomers of the complex [Co(L1-H)2]+ are reported in this chapter. 
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The oxygen atoms in alkoxide complexes can bind with other metal centres to form 
polynuclear complexes. Three polynuclear complexes of [Co(L1-H)2]+ with MnCl2 or 
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3. Coordination chemistry of amino alcohols and synthesis of nitrogen 
mustards on a cobalt(III) metal centre 
 
 3.1  Introduction 
 
The work reported in this chapter describes the coordination chemistry of a series of 
amino alcohol ligands, (L1-L9), with cobalt(III) centres. Here we report the successful 
synthesis of twelve different new cobalt-amino alcohol complexes and their X-ray 
crystallographic analysis. 
A new safe synthetic route for the [Co(bceen)2Cl2]+ (bceen = N,N’-bis(2-
chloroethyl)ethane-1,2-diamine) complex was developed using the [Co(L2-H)2]+ (L2- 
2,2'-(ethane-1,2-diylbis(azanediyl))diethanol) amino alcohol complex. A detailed 
description of the synthesis and characterisation is included in this chapter. 
The coordination chemistry of 2-((2-aminoethyl)amino)ethanol, L1 with the cobalt(III) 
metal centre was discussed in chapter 02. We were fortunate enough to obtain the 
single isomer of the complex [Co(L1)2(NO2)2]+, 2.06, chapter 02, by reacting the L1 
ligand with Co(NO3)2·6H2O under oxidising conditions. 
 
Figure 3.1. Chemical structure of [Co(L1)2(NO2)2]+, 2.06, complex. 
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The potential for tridentate binding of the L1 ligand with the cobalt(III) metal centre is 
also discussed in chapter 02. The reaction of complex 2.06 with aqueous sodium 
hydroxide exhibited the tridentate binding nature of deprotonated L1 ligand 2-((2-
aminoethyl)amino)ethanolate (L1-H) in the complex [Co(L1-H)2]+. Also, the reaction of 
2.06 complex with trifluoromethanesulfonic acid (HOTf) leads to the tridentate binding 
of L1 ligand with cobalt(III) centre. But due to the low pH conditions the protonated 
state of L1 could be different. 
 
Figure 3.2. Chemical structure of [Co(L1-H)2]+ complex. 
 
Similar tridentate coordination chemistry for the L1 ligand and its deprotonated form 
was discussed earlier by Bailar et al.[122], [129] and Drinkard et al.[123] and the complex, 
[Co(L1-H)(L1)]2+, was synthesised by displacement of ammonia from [Co(NH3)6]Cl3 by 
L1 ligands. According to their findings, the reaction occurs extremely slowly in an 
aqueous solution at steam bath temperature (~90°C), however a faster reaction could 
be obtained by adding activated carbon to the hot reaction mixture.[123] 
Although the tridentate binding nature of L1 ligand was suggested, there are not 
sufficient characterisations of those complexes to conclude the protonation state of L1, 
information about different isomers or the reactivity of these complexes. 
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Therefore, to obtain a better understanding about coordination behaviour of amino 
alcohols, different amino alcohol ligands shown in Figure 3.3, were reacted with 
cobalt(III) metal centres, using [Co(NH3)6]Cl3 as the starting material, in the presence of 














Figure 3.3. Ligands used to synthesise range of cobalt(III) complexes. 
 
The complexes discussed in this chapter showed deprotonation of the alcohol groups of 
the ligands shown in Figure 3.3 during coordination. For example ligand L1, was found 
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to coordinate as the 2-((2-aminoethyl)amino)ethanolate anion, due to the loss of a 
proton, and this anionic form of the ligand will be represented as (L1-H). Likewise, each 
proton that is removed during the coordination will be denoted as (-H) having the 
relevant ligand number in front.  
The ligands L1, L4, L5, and L6 were used from commercially available sources, L2, L7 
and L9 were synthesised according to the literature procedures, and the ligand L8 was 
obtained as a by-product during the synthesis of L2. 
Also, we investigated the possibility of using these alkoxide complexes to synthesise 
nitrogen mustards on a cobalt(III) metal centre by opening the bond between cobalt(III) 
and the ethanolate group. This is an extension of the studies reported for the L1 derived 
compounds that were reported in chapter 2. 
Nitrogen mustards with more than one alkylating sites are of interest because of their 
higher toxicity compared to mono-alkylating nitrogen mustard ligands, and their ability 
to form inter / intra strand crosslinks with DNA strands.[33] The synthetic attempts to 
prepare cobalt(III) nitrogen mustard complexes with the L2 ligand proved unsuccessful 
by Alan Downward.[121] According to his results, L2 formed a highly insoluble red 
powdered material reacting with Co(NO3)2·6H2O. In this chapter, we describe a new 
synthetic route for the bis alkylating nitrogen mustard cobalt(III) complexes such as 
[Co(bceen)2Cl2]+ (bceen=N,N’-bis(2-chloroethyl)ethane-1,2-diamine) and 
[Co(bceen)2(NO2)2)]+. The synthesis involves the [Co(L2-H)2]+ type alkoxide complex as 
a starting material. Further information about this synthesis can be read in section 3.3. 
During this research we also uncovered some interesting coordination behaviour of the 
alkoxide complexes with other metal salts such as ZnCl2 and MnCl2. The polyvalent 
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oxygen atoms that are already involved in Co-O bonding are also able to coordinate with 
other metal centres such as zinc(II) and manganese(II). Here, we report new 
polynuclear complexes of cobalt(III) with manganese(II) or zinc(II) metal centres and 
their X-ray crystallographic investigations. The complexes of [Co(L1-H)2]+ with ZnCl2 
and MnCl2 were already reported in chapter 02.  
The complexes reported in this chapter were characterised using a range of different 
techniques, including mass spectrometry, NMR spectroscopy, elemental analysis, UV/vis 
spectrometry, IR spectroscopy, and X-ray crystallography. 
 
3.2  Results and Discussion 
 
3.2.1  Synthesis of cobalt(III) complexes of 2-aminoethanol, L4, 
 
2-Aminoethanol, L4, is an bidentate ligand, which forms [Co(L4-H)3]-type chelate 
complexes.[132], [130] These complexes can exist as either the fac or mer isomeric 
forms.[132]   
                                                               
                            fac isomer                                             mer isomer                                                              
The first synthesis of [Co(L4-H)3] was reported by Yoneda and Kida.[133] The complex 
was synthesised by heating [Co(NH3)5Cl]Cl3 or [Co(NH4)4Cl2)Cl with L4, and on the basis 
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of molar conductivity measurements they claimed the formation of three different 
compounds depending on the protonation state of the ligand such as [Co(L4-H)3], 
[Co(L4)2(L4-H)]2+ and [Co(L4)(L4-H)2]+. 
Stepanenko et al.[132] synthesised the fac isomer of the [Co(L4-H)3] by reacting L4 with 
CoCl2.6H2O in the presence of KOH and the product was characterised by X-ray 
crystallography. 
Extensive studies of the coordination behaviour of L4 with cobalt(III) under different 
reaction conditions were reported by Kotovaya et al.[130] 
Kotovaya analysed the pink crystals obtained by reacting L4 with CoSO4·7H2O and 
confirmed the complex as the fac isomer. The X-ray crystallographic studies of the pink 
crystals confirmed the formation of [Co(L4-H)3].3H2O complex.  
Further reaction of [Co(L4-H)3].3H2O with sulfuric acid affords three other compounds 
depending on the protonation state of L4 and those compounds are [Co(L4-
H)3]2(SO4)3.4H2O, [Co(L4)3](SO4)(HSO4)·H2O and {[Co(L4)3][Co(L4-H)3](SO4)3}·7.75H2O.  
X-ray crystallographic studies of {[Co(L4)3][Co(L4-H)3]}(SO4)3·7.75H2O indicate the 
presence of two independent complexes, [Co(L4)3]3+ and [Co(L4-H)3], which are linked 
by O−H···O hydrogen bonding. 
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Figure 3.4. X-ray crystal structure reported in literature of the complex {[Co(L4)3][Co(L4-
H)3]}(SO4)3·7.75H2O showing the binuclear structure. The SO42-anions and the hydrogen 
atoms in the 3.01 complex, except hydroxyl hydrogen atoms, were omitted for the clarity. 
 
This research work began by repeating the Kotavaya et al.[130]procedure for the 
synthesis of [Co(L4-H)3]·3H2O. The pink rectangular shaped crystals that formed in the 
bulk solution were analysed using 1H NMR spectroscopy and 13C NMR spectroscopy, 
UV/vis, IR, microanalysis and X-ray crystallography and the results were consistent 
with the reported data in the literature.[130] 
During this research we investigated the stability of the fac isomer under different 
reaction conditions. L4 was reacted with [Co(NH3)6]Cl3 according to the method 
described by Drinkard et al.[123], for the complexation of L1 with cobalt(III) centres. The 
1H NMR spectra and 13C NMR confirms the presence of two types of chemically different 
hydrogen atoms and chemically different carbon atoms, respectively. The two carbon 
shifts appeared at 60.50 ppm and 44.10 ppm confirmed the formation of highly 
symmetric fac isomer in comparison to the mer isomer with four chemically different 
peaks with two different intensities in the carbon spectrum. 
3.01 
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Hayami et al.[133] also explored the reaction of L4 with cobalt(III) metal centre. Hayami 
suggested two kinds of complex salt to be present, depending on elemental analysis 
results, in a 1:1 ratio, in the reaction mixture depending on the protonation state of the 
L4; [Co(L4)2(L4-H)]2+ and [Co(L4)(L4-H)2]+. Hayami also suggested the face-to-face 
bonding (Figure 3.5) of the complex. The face to face binding pattern is also in 
agreement with the X-ray structure reported in Figure 3.4 apart from the suggested 
chemical formulas are different in two individual complexes present in the 
dimer;[Co(L4)3][Co(L4-H)3]3+, 3.01, and [Co(L4)2(L4-H)][Co(L4)(L4-H)2]3+ (Hayami). 
 
Figure 3.5. Face-to-face bonding of {[Co(L4)2(L4-H)][Co(L4)(L4-H)2]}3+ complex. 
 
3.2.2  Synthesis of cobalt(III) complexes of azanediyldiethanol, L5, 
 
The complexes of L5 with cobalt(III) complexes are not reported in the literature. 
Therefore the coordination chemistry of L5 with cobalt(III) was studied during this 
research under two different reaction conditions. 
Initially, the cobalt(III) complex of L5 was synthesised according to the procedure 
described by Kotovaya et al.[130] for the synthesis of [Co(L4-H)3]. 
Red plate-like crystals of the iodide salt formed from a methanol solution after about a 
month (yield = 68%), and were analysed by mass spectrometry, NMR spectroscopy, UV/ 
vis and IR spectroscopy. Analysis of the bulk crystals using NMR spectrometry and mass 
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spectrometric results supported the two-fold symmetry of the complex, and confirmed 
that the bulk material is composed of a single diastereoisomer. The structure deduced 
by X-ray crystallography is fully supported by all the other analytical results. 
A crystal suitable for X-ray crystallographic study was selected from the bulk sample 
and analysed, and the refined solution of the crystal structure is shown in Figure 3.6. 
 
 
Figure 3.6. X-ray crystal structure of [Co(L5-H)2]+, 3.02, complex showing cis amine-trans 
oxygen configuration. The iodide anion and the hydrogen atoms on the complex, except the 
hydrogens on amine nitrogen atoms and hydroxyl oxygen atoms, were omitted for the 
clarity. 
The asymmetric unit of the compound [Co(L5-H)2]+; Selected bond lengths (Å) and bond 
angles(°) Co1-O4 1.905(8), Co1-O2 1.921(9), Co1-O3 1.938(9), Co1-O5 1.937(1), Co1-N6 
1.956(1), Co1-N7 1.947(1), O2-C8 1.407(2), O4-C12 1.415(1), O3-C10 1.492(2), O5-C14 
1.506(2), N6-C15 1.497(2), N6-C13 1.507(1), N7-C11 1.483(1), N7-C9 1.506(1), O4-
Co1_O2 178.8(4), O4-Co1-O5 92.2(4), O2-Co1-O3 92.5(4), O5-Co1-O3 91.0(4), O4-Co1-
N6 86.8(4), O4-Co1-N7 93.1(4), O4-Co1-O3 87.7(4), O2-Co1-N6 93.1(4), O2-Co1-N7 
85.7(4), O2-Co1-O5 89.1(4), N7-Co1-N6 95.9(4), O3-Co1-N6 173.9(4), O3-Co1-N7 
86.9(4), O5-Co1-N6 86.7(4), O5-Co1-N7 174.2(4). 
3.02 
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The crystal structure of the complex 3.02 was solved in monoclinic space group P21/c 
(R-factor of 8.07%) The asymmetric unit of the complex consists of a complete complex 
cation and an iodide anion. The presence of a single anion confirms the (+1) charge of 
the complex. The additional electron density around O3 and O5 was consistent with 
assignment of hydrogen atoms being bonded to these oxygen atoms, and the 
protonation state of the (L5-H) also explained the (+1) complex charge. The relatively 
longer bond lengths of Co1-O3 1.938(9) Å and Co1-O5 1.937(1) Å compared to Co1-O2 
1.921(9) Å and Co1-O4 1.905(8) Å also supports the modelled protonation state of O3 
and O5 oxygen atoms, satisfying Clarfield et al.’s[134] reports about the increase in Co-O 
bond distances with protonation. 
The complex has distorted octahedral geometry. The two amine groups are arranged cis 
to each other. The amine nitrogen atoms are arranged in the trans configuration to the 
protonated oxygen atoms. The non-protonated oxygen atoms are arranged in the trans 
configuration relative to each other. 
 
Chapter 03  113 
 
    
Figure 3.7. 1H NMR spectrum of the [Co(L5-H)2]+, 3.02,  complex.  
 
The key portion of 1H NMR spectrum of 3.02 is shown in Figure 3.7. The assignments 
were made by using spin-spin coupling information from gCOSY and HSQC experiments. 
The HSQC spectrum shows significantly different chemical shifts for C4, C’4 carbon 
atoms and C1, C’1 carbon atoms 55.44 ppm and 67.10 ppm, respectively. This 
assignment was made as protonated oxygen atoms carry a relatively higher positive 
charge, causing the signals, due to the adjacent carbon atoms, to be shifted up field in 
the 13C NMR spectrum.[135]  
In a second synthetic method, L5 was reacted with [Co(NH3)6]Cl3 under basic conditions 
to investigate the influence of the reaction conditions for the complexation. 
 
2H, 2’H, 4H, 4’H,1H, 1’H  
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The bluish crystalline material obtained from slow evaporation of the reaction mixture 
was highly unstable outside the solution and not suitable for X-ray crystallographic 
analysis.  
The mass spectrometric analysis of the crystalline material showed the presence of a 
prominent peak at m/z = 533.1496 and the one unit separation of the isotope peaks 
reveals the ion to have a (+1) charge. The mass of 3.02, Figure 3.6 discussed in the 
previous synthesis, was observed in the mass spectrum at m/z = 267.07. The mass 
533.1496 is nearly a double the mass of 3.02 and could be evidence for the presence of 
a dimeric species made up of two 3.02 type complexes. The 1H NMR and 13C NMR 
results were complicated and didn’t provide sufficient information to allow a structural 
proposal to be made. 
Numerous experimental techniques, such as changing anion, diffusion, complexing with 
other metal salts etc, were investigated to crystallise these alkoxide complexes in order 
to study their coordination chemistry throughout this work. Among them reacting with 
other metal salts seems to be proven as cobalt(III) alkoxide complexes tend to 
crystallised very easily as polynuclear complexes with manganese(II) / zinc(II), 
compared to the pure cobalt(III) alkoxide complexes. This is a new technique 
discovered during this research and there is not any precedent literature found in 
relation to this technique. This technique was extensively used to isolate different 
isomers of [Co(L1-H)2]+ complex and to perform X-ray crystallographic studies on those 
complexes. The detailed discussion about this technique and the coordination chemistry 
of [Co(L1-H)2]+ with MnCl2 and ZnCl2 can be read in chapter 02. 
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The present work reported in this chapter also used this strategy in some situations to 
obtain crystals suitable for X-ray crystallographic studies to explore the coordination 
chemistry of these complexes. 
Therefore the bluish crystalline material obtained by reacting L5 with cobalt(III) under 
the Drinkard reaction conditions was further reacted with MnCl2.4H2O. 
The pink crystals, suitable for X-ray crystallographic analysis, appeared in the solution 
were analysed by X-ray crystallography and the solution to the structure is shown in 
Figure 3.8. 
 
Figure 3.8. The tetranuclear complex [{Co(L5-2H)(L5-H)}(MnCl2)2], 3.03, with atom-
labelling. The methanol solvent molecules, hydrogen atoms on the complex, except the 
hydrogen atoms on amine nitrogen atoms and hydroxyl oxygen atoms were omitted for 
the clarity.  
The molecular structure of [{Co(L5-2H)(L5-H)}(MnCl2)2]: Selected bond lengths (Å) and 
bond angles(°) Co-O4 1.902(3), Co1-O5 1.926(3), Co1-O6 1.887(3), Co1-N2 1.935(4), 
3.03 
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Co1-N3 1.972(4), Mn1-O5 2.469(3), Mn1-O6 1.946(3), Mn1-Cl2 2.2956(3), Mn1-Cl1 2 
2.3652(1), O15-C14 1.415(6); O4-Co1-O5 96,98(2), O4-Co1-N2 84.79, O4-Co1-N3 
93.62(2), O5-Co1-N2 88.04(2), O5-Co1-N3 169.35(2), O6-Co1-O5 84.47(1), O6-Co1-N2 
93.99, O6-Co1-N3 84.97(2), N2-Co1-N3 94.04(2), Cl2-Mn16-Cl1, 100.66(6), Cl2-Mn16-
O5 93.00(8), Cl1-Mn16-O5 165.91(9), O6-Mn16-Cl2 127.97(1), O6-Mn16-CL48 
98.68(1), Cl2-O4-Co1 115.8(3), Co1-O5-Mn16 92.2(1), C8-O5-Mn16 121.0(3), Co1-O6-
Mn16 112.64(2), C10-O6-Co1 115.1(3), C10-O6-Mn16 130.9(3) 
The molecular structure of 3.03 showed the tetranuclear complex composed of two 
manganese(II) and two cobalt(II) atoms held together by (L5-2H) and (L5-H). The 
distorted octahedral geometry and neutral total complex charge is consistent with the 
(+3) oxidation state of the cobalt centre. 
Five coordinating sites of each octahedral cobalt(III) centre are satisfied by the (L5-2H) 
and (L5-H) ligands. The (L5-2H) is coordinated in tridentate binding manner, while the 
(L5-H) showed the bidentate coordination through one of the deprotonated oxygen 
atoms and the amine nitrogen atom. The hydroxyethyl arm of (L5-H) is not coordinated.  
The sixth coordination site of each cobalt(III) metal centre is completed by the 
coordination of one oxygen donor from the (L5-2H) from adjacent octahedral centre. 
 
Figure 3.9. The structural diagram of the complex 3.03. 
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The crystal structure was solved in the monoclinic space group P21/c with an R-factor 
of 5.82%. The ligands around the cobalt(III) metal centre were arranged in a distorted 
octahedral geometry, while the ligands around the manganese(II) metal centre showed 
trigonal bipyramidal geometry. The asymmetric unit consists of half of the molecule, 
and the total complex is neutral in charge, Figure 3.8. There are two disordered 
methanol molecules present in the asymmetric unit. 
There are three different oxygen atoms from the (L5-2H) and (L5-H) coordinated to 
each cobalt(III) centre, two oxygens are donated from (L5-2H) and the third from (L5-
H). The two oxygens coordinated in trans configuration, around the cobalt(III), are from 
(L5-2H) and (L5-H) ligands respectively. The third oxygen atom coordinated trans to 
the amine nitrogen atoms is from (L5-H), and is involved in bridging with the second 
metal centre as shown in Figure 3.9. 
The two MnCl2 molecules are coordinated to the dimer [Co(L5-2H)(L5-H)]2 through 
oxygen bridging. Each MnCl2 is bonded to two oxygen atoms, and each of the oxygen 
atoms is from the separate cobalt (III) centres. Likewise the two trans oxygens in each 
complex form bonds to separate MnCl2 molecules. The fifth coordination of 
manganese(II) is satisfied by the cobalt(III)-cobalt(III) bridging oxygen; from the (L5-
2H).  
The distance between Mn1-O5 is 2.470(3) Å. The other Mn-O bond lengths in the 
complex are 1.946(2)-1.955(3) Å, however, in literature reported by Kondaveeti et 
al.[136], the Mn-O bond lengths are between 2.069-2.230Å. Therefore, Mn1-O5 could be 
considered as a weak bonding interaction. 
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One of the special features of this complex is that the complex itself is composed of five 
tetra atomic squares Figure 3.9.  
In the sphere, half of the methanol molecule is disordered over many sites, two of which 
are modelled. There was insufficient electron density associated with the hydrogen 
atoms on solvent methanol oxygen. Therefore those hydrogens were not modelled. 
 
Figure 3.10. The view through 001 plane, showing the channels filled with methanol 
solvent molecules, of the packed 3.03 complex. 
 
The packing structure, Figure 3.10, of the complex 3.03 shows that the complexes are 
arranged along the 001 plane. The spaces in between the complexes are filled with 
methanol solvent molecules. The hydrogen bonding interactions between the chlorine 
ligands and amine hydrogens hold the crystal packing. 
Chapter 03  119 
 
The complex was also characterised in solution using mass spectrometric analysis. A 
molecular ion peak was observed with a matching isotopic pattern at (M+H)+ = m/z = 
783.0065, and fragments relevant to the complex, with matching experimental and 
calculated isotope patterns were also observed at [(M-2(Cl2))+H]+= m/z = 711.949, [(M-
2(Cl2))]2+= m/z = 355.974 and [(M-2(MnCl2))+H]+=533.1427]. NMR studies of complex 
3.03 could not be performed as it contains paramagnetic manganese(II) centres. 
To establish whether the single crystal study is representative of the bulk sample, 
powder diffraction analysis was performed for the powder obtained for the complex 
3.03 and compared with the calculated powder pattern obtained from the single crystal 
structure of 3.03. 
 
 
Figure 3.11. Comparison of experimental and calculated powder diffraction patterns of 
the complex 3.03. 
The powder diffraction patterns, Figure 3.11, obtained from the experimental data and 
calculated data from single crystal are not in agreement. The calculated powder pattern 
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experimental pattern are similar in appearance to the calculated data, however slightly 
different 2ɵ value for two powder patterns were observed. This could be due to the non-
crystalline nature of the powder sample.  
The mass spectrometric results obtained from the reaction of ligand L5 with 
[Co(NH3)]Cl3, (m/z = 533.1496) at the start of the synthesis and one of the fragments 
observed in the mass spectrum of the complex 3.03, [(M-2MnCl2)+H+] = 533.1427, 
represent a similar m/z ratio. Therefore in support with those mass spectrometric 
numbers and the X-ray crystallographic information of compound 3.03, the chemical 
structure shown in Figure 3.12 is most likely to be present in the bluish powdered 
material obtained from the first reaction mixture. 
 
 
Figure 3.12. Proposed structure of a dinuclear cobalt(III) complex, [Co(L5-2H)(L5-H)]2, 
3.04, based on mass spectrometry data.  
 
Considering the bluish colour of the resulting powder and the difficulty of recording the 
NMR spectrum it suggests the presence of a cobalt(II) species in the mixture. This 
cobalt(II) species can either be present as a contaminant or can be in complexation with 
complex 3.04 as shown in the Figure 3.13. 
3.04 
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Figure 3.13. Proposed chemical structure for the tetranuclear complex 3.05. 
 
Nesterove et al.[137] reported metal clusters consisting of cobalt(III), copper(II) and 
nickel(II) metal centres coordinated through (L5-2H) and (L5-H). The synthesis 
method reported by Nesterov et al.[137] is different to the synthesis procedure we report 
in this work. The literature procedure involved a one-pot reaction of mixture of metal 
ions with the L5. But the tetranuclear 3.03 complex reported in this chapter was 
obtained by separate reaction processes which involved first, isolation of the cobalt(III) 
complex after reaction with L5 ligand and then reaction of the complex with manganese 
chloride in methanolic solution. 
 
3.2.3  Synthesis of cobalt(III) complexes of 2,2’-(ethane-1,2-
diylbis(azanediyl))diethanol, L6, 
 
A number of cobalt(III) complexes prepared using L6 have been reported in 
literature.[138], [139], [140], [141] L6 ligand shows different protonation states and the 
different coordination chemistry with cobalt(III) centres. The reported complexes are of 
cobalt(II), nickel(II), or copper(II). 
3.05 
Chapter 03  122 
 
The tetradentate binding behaviour of L6 was reported by Reiter et al[138] with the 
en:L6 ligands in a 1:1 ratio is coordinated to the cobalt(III) metal centre.  
Another cobalt(III) complex with (L6-2H) and glycine was also reported by Stepanenko 
et al[139] as shown in, Figure 3.14. The (L6-2H) shows a tridentate binding nature 
leaving one of the hydroxyethyl arms uncoordinated while glycinate filled two 
coordination sites through the amine group and one of the carboxylate oxygen atoms. 
 
Figure 3.14. Various coordination patterns of the ligand (L6-2H) and different ways of 
satisfying the octahedral geometry of cobalt(III) complexes. 
 
We decided to further investigate the possible coordination chemistry of L6 with a 
cobalt(III) centre as part of our study of this class of ligands. 
Therefore the L6 was reacted with [Co(NH3)6]Cl3 according to the Drinkard method. 
The pink aqueous solution obtained from the reaction was filtered and left for slow 
evaporation. Block-shaped large pink crystals appeared in the solution overnight. 
Attempts to characterise these crystals using mass spectrometric and NMR 
spectrometric analyses were unsuccessful.  
The pink crystals were analysed by X-ray diffraction analysis and the solution to the 
crystal structure is shown below. 
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Figure 3.15. The X-ray crystal structure of [Co(L6-H)(Cl)] , 3.08, complex with atom 
labelling for the asymmetric unit. Hydrogen atoms, except the hydroxyl hydrogens were 
omitted for the clarity. The complex demonstrates the tetradentate binding of (L6-H). 
The molecular structure of [Co(L6-H)(Cl)]; Selected bond lengths (Å) and bond angles 
(°); Co1-O2 2.3262(4), Co1-O3 1.9111(2), Co1-Cl5 2.335(3), Co1-N4 2.2031(5), N4-C7 
1.6814(3), N4-C10 1.2870(2); C10-N4-Co1 46.39(1), Co1-N4-C7 107.316(3), N4-Co1-O2 
78.845(5), O3-Co1-N4 81.305(5), O3-Co1-Cl5 97.8971(5), O2-Co1-CL45 2.2714(4). 
 
The X-ray crystallographic analysis results of the crystals confirmed the oxidation state 
of the metal as cobalt(II) and further explained the impossibility of achieving NMR 
spectroscopy for the complex 3.08 due to the paramagnetic nature of cobalt(II) metal 
centre. The trigonal bipyramidal geometry of cobalt metal is unusual for cobalt(III)[142] 
hence further confirmed the oxidation state of the metal as (+2) and also the prominent 
electron density found close to two coordinated oxygen atoms were used to model the 
cobalt(II) cationic complex. 
 
3.08 
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Figure 3.16. Packing structure of [Co(L6-H)(Cl)], 3.08, complex through 101 plane, 
showing intramolecular hydrogen bonding network stabilising the packing structure. 
 
The crystal structure for the complex [Co(L6-H)(Cl)] was solved in orthorhombic Pnma 
space group (R-factor of 4.39%). The asymmetric unit of the complex consisted of half of 
the molecule. There were no anions present in the structure. Given that cobalt(I) is a 
rare oxidation state, the neutral charge of the complex must result from one or more of 
the hydroxyl groups being deprotonated. The trigonal bipyramidal geometry of the 
metal centre makes the cobalt(II) oxidation state the most likely one. C8 and C10 atoms 
are disordered in two positions. C7 is the symmetry equivalence position. Powder 
diffraction pattern obtained for the bulk crystalline material is in agreement with the 
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calculated powder pattern of the 3.08 crystal. This result confirms that the single 
crystal structure obtained for the 3.08 structure represent the bulk sample. 
After separating the 3.08 crystals from the solution, the liquid portion was dried under 
vacuum and the solid residue was dissolved back into methanol and reacted with 
methanolic MnCl2 and ZnCl2. The pink reaction mixture was filtered and left for slow 
evaporation.  
The reaction mixture with added MnCl2 did not produce any crystals, but the ZnCl2 
mixture yielded pink crystals suitable for X-ray crystallographic studies. 
 
Figure 3.17. X-ray crystal structure of 3.09 with atom-labelling for asymmetric unit 
showing the tetranuclear complex. Solvent molecules and hydrogen atoms were omitted 
for the clarity. 
The molecular structure of the complex [Co(L6-3H)(MeOH)(ZnCl2)]2; Selected bond 
lengths (Å) and bond angles(°); Co1-O2 1.905(4), Co1-O3 1.947(4), Co1-O6 1.951(4), 
Co1-N5 1.918(4), Co1 O4 1.899(4), O2-Zn14 1.987(4), Zn14-Cl15 2.244(2), Zn14-Cl16 
2.249(2); O4-Co1-O6 90.23(2), O4-Co1-N5 85.14(2), O6-Co1-O2 86.7(2), O6-Co1-O3 
3.09 
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174.11(2), O2-Co1-O3 89.29(2), O2-Co1-N5 87.06(2), O4-Zn14-Cl15 109.42(1), O4-
Zn14-Cl16 110.87(1), Cl15-Zn14-Cl16 113.8(7). 
 
The crystal structure was solved in the C2/c monoclinic space group with the R factor of 
5.67%, Figure 3.17. The ligand (L6-3H) was bound in a tetradentate binding fashion 
using all three oxygen atoms and a single quaternary nitrogen atom for coordination. No 
electron densities were found close to the coordinated oxygen atoms which confirmed 
the deprotonation of oxygen atoms during coordination.  
The structure of the complex 3.09, Figure 3.17, shows the formation of a tetranuclear 
complex with the involvement of ZnCl2 molecules. There are no anions present in the 
crystal structure. This suggests the total complex to be neutral in charge. Each 
cobalt(III) centre shows distorted octahedral geometry, characteristic for the (+3) 
oxidation state of the metal centre. 
As shown in the Figure 3.17 ligands around cobalt(III) centre were arranged in a 
distorted octahedral geometry The four coordinates around the cobalt(III) centre are 
satisfied by a ligand (L6-3H) and the fifth coordination is satisfied by a solvent 
methanol molecule. The two cobalt(III) centres of [Co(L6−3H)MeOH]+ configuration 
associated forming a dimer, which also satisfied the sixth coordination for each the 
complexes through mutual single oxygen bridging.  
The four oxygen atoms around each cobalt(III) centre were arranged trans to each 
other. One set of trans oxygens were from (L6-3H) ligand and the second set is from 
(L6-3H) oxygen atom and methanol oxygen coordinated with the cobalt(III) centre. 
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The oxygens from (L6-3H) that are trans to each other are coordinated with the zinc(II) 
metal centres. The two methanol molecules coordinated to cobalt(III) metal centres are 
arranged on opposite sides of the dimeric structure. The oxygen atoms of coordinated 
methanol is in the same plane with the oxygen atoms bridging the cobalt(III)centres. 
The methanol solvent molecule and the water molecule in the surrounding are 
hydrogen bonded to the coordinated methanol hydrogen atom.  
 
Figure 3.18. Packing structure of the complex 3.09. A view through a 101 plane. The 
channels between the crystal packing are occupied by the solvent methanol and water. 
 
The packing structure of the complex 3.09 through the 101 plane showed the channels 
between the complex molecules formed during the packing. The channels are filled with 
solvent waters and methanol molecules. The hydrogen bonding interactions with the 
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distance of 2.56(1) Å were observed between the solvent molecule oxygens and the 
hydroxyl hydrogen of the coordinated methanol. 
Another analogue of the 3.09 obtained from a different crystallising vial was studied 
using X-ray crystallography. The crystal structure of the complex 3.10, Table 3.1 is 
solved in P21/n monoclinic space group, with an R factor of 2.66%.  
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Space group C2/c P21/n 










Co1-O6 1.951(4) 1.933(2) 
Co1-O4 1.899(4) 1.9021(2) 
Co1-O3 1.867(4) 1.8643(2) 




O6-Co1-O4 90.25(2) 87.92(9) 
O6-Co1-O2 86.7(2) 88.64(9) 
O6-Co1-O3 174.08(2) 176.08(8) 
O6-Co1-N5 95.1(2) 93.99(9) 
 
The cationic component of complex 3.10, is similar in coordinating pattern to the 
complex 3.09 shown in Figure 3.17, only the position of the water molecule has changed 
during crystallisation  
The reason for changing the position of water molecule is unknown but the new 
position of water molecule facilitates some hydrogen bonding interactions. The 
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hydrogen bonding interactions with the water hydrogen and Cl15 chloride ligands on 
the zinc(II) metal centre have a distance of 2.354(1) Å, which can be considered as a 
weak hydrogen bonding due to the longer distance. Another hydrogen bonding 
interaction between the water oxygen and the coordinated methanol hydrogen with the 
distance of 1.844(2) Å makes this structure different from the complex 3.09.  
 
 
Figure 3.19. Packing structure of complex 3.10 through 101 plane. The strong hydrogen 
bonding network due to the displacement of water is prominent in packing structure. 
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3.2.4  Synthesis of cobalt(III) complexes of 2-((pyridine-2-ylmethyl) amino)-    
-ethanol, L7, 
 
The ligand L7 was synthesised according to the procedure reported by Chmielewski et 
al.[143] Chmielewski synthesised L7 as precursor compound to the thermo-labile 
protecting groups. The ligand was characterised by mass spectrometric analysis, 1H 
NMR and 13C NMR analysis, and the data obtained was found to agree the reported 
literature values, confirming the synthesis of the L7. 
There is no literature reported about the coordination chemistry of this ligand. 
Therefore to explore the coordination behaviour of L7, the complex 3.11 was 
synthesised by reacting the L7 with [Co(NH3)6]Cl3 according to the Drinkard et al.[123] 
method. The resulting purple reaction mixture was filtered and concentrated under 
reduced pressure. Addition of few drops of concentrated aqueous ammonium 
hexafluoridophosphate yielded a pink powder.  
The obtained powdered material was characterised using mass spectrometry m/z= 
(M+) = 361.1062, 1H NMR, 13C NMR, gCOSY, and HSQC NMR, UV/vis, IR, elemental 
analysis and X-ray crystallography.  
Crystals suitable for X-ray crystallographic studies were grown by slow evaporation of 
methanolic solution of the complex. The pink block shape crystals obtained were 
analysed by X-ray crystallography and solution to the structure is shown below. 
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                                  3.11 
 
Figure 3.20. Structure of [CoL7-H)L7]2+ , 3.11. The solvent water molecule, two 
hexafluorophosphate anions and hydrogen atoms, except the amine and hydroxyl 
hydrogen atoms, were omitted for the clarity. The hydroxyl hydrogens are half occupancy. 
Molecular structure of [CoL7-H)L7]2+; Selected bond lengths (Å) and bond angles(°); 
Co1-O4 1.920(3), Co1-N2 1.961(4), Co1-N3 1.954(5); O4-Co1-N2 85.89(2), O4-Co1-N3 
90.75(2), N3-Co1-N2 83.91(2), Co1-N2-C5 106.8(3), Co1-O4-C6 111.5(3), C7-N2-Co1 
109.3(3). 
 
Compound 3.11 crystallised in the C2/m monoclinic space group. The asymmetric unit 
of the molecule consists of half of the complex 3.11. The octahedral geometry and the 
bond lengths values around the metal centre was characteristics to cobalt(III) metal 
centres. The asymmetric unit consist of two halves of PF6̄ ions and one L7 coordinated 
to cobalt(III). 
The two PF6 ions found in the structure confirms the (+2) charge of the complex. The 
prominent electron density close to the O4 atom confirms the protonated state of the 
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oxygen. The hydroxyl hydrogens are half occupied due to their fast exchange and 
confirmed the (2+) charge of the complex. 
The cobalt(III) metal centre shows octahedral geometry having two of the L7 ligands 
coordinated with the central metal centre, Figure 3.20, L7 coordinated with the 
cobalt(III) metal centre are arranged in a cis, trans coordination pattern; the pyridine 
ligands are arranged trans to each other, while the secondary amine ligands are trans to 
hydroxyl oxygens. The chiral amine nitrogen atoms show S configuration. 
The complete structure consists of only one cationic complex. The packing structure 
shows the hydrogen bonding between adjacent two cationic complexes. The hydrogen 
bonding interactions between hydroxyl hydrogen and the oxygen as shown in the 
Figure 3.22 hold the two structures together. 
  
Figure 3.21. The packing structure of complex 3.11 through 001 plane. The 
intramolecular hydrogen bonding interactions are prominent. The two complexes are 
arranged in face to face arrangement and a water molecule is found in the centre of the 
two complexes. 





Figure 3.22. Dimeric structure of [Co(L7-H)L7](PF6)2 , 3.11, complex 
 
The packing of the crystal is stabilised by the hydrogen bonding network between the 
chiral amine hydrogen and fluorine atoms of the hexafluoridophosphate anion. As 
shown Figure 3.21 two 3.11 molecules arranged facing to each other and a disordered 
water molecule is sitting in between the dimer. The symmetry axis runs through the 
water molecule which relates the two complexes by symmetry. The disordered 
hexafluoridophosphate anions formed hydrogen bonds with amine hydrogens while 
filling the spaces in the crystal packing. 
1H NMR studies of the complex 3.11 show nine different peaks associated with the 11 
different protons. The assignment of the proton peaks was supported by gCOSY and 
HSQC spectral data. The data are consistent with the isomer and symmetry elements 
revealed by the X-ray data analysis. 
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Figure 3.23. 1H NMR spectrum of complex [Co(L7-H)L7]2+, 3.11 recorded in DMSO 
solvent. 
 
The NMR studies confirmed the twofold symmetry of the complex contradicting the 
solid state results of coordination of two different L7 and (L7-H) with the cobalt(III) 
centre. 
The two fold symmetry of the complex is achieved by the fast proton exchange between 
two oxygen atoms in solution state. 
The mass spectrometry data confirmed that there were two L7 ligands coordinated to 









H6’, H7, H7’ 
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The identical 1H NMR spectra obtained for the extracted powdered material and the 
pink crystals were useful in confirming that the single crystal represent the bulk sample. 
 
3.2.5  Synthesis of cobalt(III) complexes of 2,2’-(ethane-1,2-
diylbis(azanediyl))diethanol, L2, 
 
The 2,2’-(ethane-1,2-diylbis(azanediyl))diethanol L7, was synthesised and 
characterised according to the procedure described by Kira et al.[144] The obtained 
powdered material was dissolved in methanol to make a concentrated solution and, 
after leaving the solution for slow evaporation, transparent crystals grew into flowered 
shape lumps. The X-ray crystal structure of this compound is shown in Figure 3.24 
below. 
 
                                                                         3.12 
Figure 3.24. X-ray crystal structure of ligand L2 with atom labelling. The hydrogen atoms 
on carbon atoms were omitted for the clarity. 
Molecular structure of (C6H18N2O2); selected bond lengths (Å) and bond angles (°); O1-
C1 1.4112(4), N4-O3 1.4676(5), 1.4670(3), N4-C3 1.4676(5); O1-C2-C3 112.5742(1), 
C2-C3-N4 11.0902(1), C3-N4-N5 110.503(1). 
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The ligand crystallised in a P21/n monoclinic space group. The asymmetric unit contains 
half of the ligand. The packing structure shows that each ligand is hydrogen bonded 
with two adjacent molecules. The hydroxyl oxygen atom of each ligand is hydrogen 
bonded with the primary amine hydrogen atom of the next ligand with the distance of 
2.2842(6) Å. 
The X-ray crystal structure of the L2 has been reported previously in literature as its 
nitrate salt.[145]  
The literature reported hydrogen bonding distance of 1.869(15) Å is smaller than the 
hydrogen bonding distance observed in the packing structure of 3.12. This result is not 
surprising as the literature compound is in its protonated state and the electro-positive 
nature of the ligand influence the strong interactions.  
There is no literature precedent for the complexation of L2 with cobalt(III). Therefore 
L2 was reacted with a cobalt(III) metal centre according to the Drinkard et al. 
method.[123] The resulting purple reaction mixture was filtered and concentrated under 
the reduced pressure. A few drops of concentrated aqueous lithium iodide solution was 
added to the reaction mixture and left for slow evaporation.  
The yellow crystals started to grow from the neck of the vial as the solution started to 
evaporate slowly over a period of one week. 
The yellow crystals were collected and analysed by mass spectrometry, NMR 
spectrometric techniques, UV/vis, IR microanalysis, as well as X-ray crystallography. 
Mass spectrometric analysis of the complex indicated the presence of [Co(L2-H)2]+ 
complex with m/z = 353.1594. There are many coordination possibilities for the (L2-H) 
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Figure 3.25. Different possible isomers of the complex formula [Co(L2-H)2]+. 
 
Crystals obtained (yield 65%) by slow evaporation of an aqueous solution of the 
reaction mixture were suitable for X-ray crystallographic analysis. 
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Figure 3.26. X-ray crystal structure of [Co(L2-H)2]+, 3.13, present as its trans/trans/trans 
isomer with atom-labelling. The tri iodide anion in back ground and the hydrogen atoms 
on the complex, except amine and hydroxyl hydrogens, are omitted for the clarity. 
Molecular structure of [Co(L2-H)2]+; Selected bond lengths (Å) and bond angles(°); Co1-
O2 1.892(2), Co1-N3 1.946(2), Co1-N4 2.00(2); O2-Co1-N3 87.63(9), N3-Co1-N4 
86.71(9), O2-Co1-N4 95.03(8). 
 
The crystal structure is solved in P21/c monoclinic space group with the R value of 2.57. 
The asymmetric unit consists of half of the complex cation and half of the triiodide 
anion. The complex itself shows a distorted octahedral geometry. One of the hydroxyl 
groups from each ligand was deprotonated during coordination in trans manner with 
the cobalt(III) centre. The absence of electron density around the coordinated oxygen 
also supported the idea of deprotonation during coordination. The amine nitrogen 
atoms bonded to the coordinated oxygens are coordinated with the cobalt(III) in trans 
3.13 
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manner, also the amine nitrogen atoms bonded to the free hydroxyethyl arms show 
trans coordination with the metal centre. The hydrogen atom of the hydroxyl group 
forms an intramolecular hydrogen bond with the deprotonated oxygen atom from the 
same ligand.  
 
 
Figure 3.27. The packing structure of complex 3.13 through 111 plane shows the 
arrangement of triiodide anions in space between cationic complexes. 
 
Intermolecular hydrogen bonding between the secondary amine hydrogen atoms and 
hydroxyl hydrogen from the adjacent molecule may help to stabilise the packing 
structure. Iodide was added as part of an exploration of whether other anions would 
improve the crystallisation conditions.[123] The iodide ions added need to follow the 
reaction process below to form rod like I3¯ anions. 
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The iodide ions added to the reaction mixture need to undergo an oxidation process to 
produce iodine in the reaction mixture to react with iodide anion. This oxidation 
process could be facilitated by the reduction of cobalt(III) to cobalt(II) in the reaction 
mixture. The cobalt(II) contaminant observed in the product material could be 
produced from the above reduction process.  
Also the reaction mixture was open to the atmosphere during crystallisation and the 
iodide anion in the reaction mixture could be oxidised by atmospheric oxygen to 
produce iodine molecules. 
These anions arranged into two different directions and filled the spaces between 
crystalline complexes. These I3
¯ carry the highest percentage of electron density from 
the electron density map generated during the X-ray crystallographic studies. 
An X-ray powder diffraction analysis of the bulk crystalline material was carried out to 
confirm that the single crystal represents the bulk material.  
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Figure 3.28. The powder diffraction patterns of complex 3.13 showed the experimental 
(green) and the calculated (red) patterns are in agreement. 
 
The powder diffraction pattern was found to match the calculated and experimental 
values and unambiguously confirmed that the single crystal for 3.13 is a representative 
of the bulk material. 
The 1H NMR spectrum and 13C NMR spectrum of 3.13 crystals were unexpectedly 
complicated as shown in Figure 3.29 and Figure 3.30. 
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Figure 3.29. 1H NMR of complex 3.13 in D2O with reference to TMPS, showing a range of 
peaks due to different types of protons. 
 
 
Figure 3.30. 13C NMR of complex 3.13 in D2O with reference to TMPS, showing a range of 
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The NMR spectra, Figure 3.29, Figure 3.30, confirmed that the compound 3.13 has 
different behaviour in solution compared to the solid state. This complexity may be due 
to the isomerisation of the complex in solution, but the information obtained so far is 
not sufficient enough to draw a solid conclusion. 
After extracting the crystals, the supernatant solution gave rise to a very small amount 
of X- ray quality crystals. The crystals were similar in appearance to the crystal of 
complex 3.13. The unit cell of the new crystals had different dimensions to the crystals 
of 3.13 complex crystals. 3.13: a=9.35502(1), b=(10.36870(1), c=11.02739(2); 3.14: 
a=9.7243(6), b=(22.1877(7), c=(23.8537(1)). 




Figure 3.31. X-ray crystal structure of isomer 3.14 of the [Co(L2-H)2]2+ complex. The 
triiodide anion, the iodine molecule and the hydrogen atoms, except the hydrogen atoms 
on amine groups, were omitted for the clarity. 
3.14 
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The molecular structure of [Co(L2-H)2]+; Selected bond lengths (Å) and bond angles(°); 
Co1-O2 1.876(1), Co1-O3 1.875(1), Co1-N4 1.964(2), Co1-N5 1.956(2), Co1-N6 
1.958(2), Co1-N7 1.958(2); O2-Co1-O3 176.0(6), O2-Co1-N4 91.1(6), O2-Co1-N5 91(6), 
O2-Co1-N6 85.2(6), O2-Co1-N7 91.0(7), O3-Co1-N4 91.8(7), O3-Co1-N5 91.6(7), O3-
Co1-N6 92(7), O3-Co1-N7 86.3(7), N5-Co1-N4 93.7(6), N6-Co1-N5 84.8(6), N7-Co1-N4 
86.9(8), N7-Co1-N5 177.9(8), N7-Co1-N6 94.7(7). 
 
The complex crystallised in a Pbca orthorhombic space group which is different to the 
P21/c space group of 3.13.The asymmetric unit consists of a complete complex cation 
with a triiodide anion  
The 3.14 complex shows a distorted octahedral geometry with two (L2-H) ligands 
coordinated around the metal centre. The coordinated oxygen atoms are trans to each 
other and similar to the arrangement of complex 3.13 the main difference observed to 
the complex 3.13 is the cis coordination pattern of amine groups and the arrangement 
of hydroxyethyl arms. In the 3.13 hydroxyethyl arms arranged into the opposite side of 
the complex while the hydroxyethyl arms of 3.14 arranged into the same side of the 
complex. 
In the packing structure, intermolecular hydrogen bonding interactions are observed 
between the hydroxyl hydrogens and coordinated oxygen atoms of the adjacent 
molecule. Also another hydrogen bond was found between hydroxyl group oxygen with 
secondary amine hydrogen atom. The complex 3.14 does not show the presence of 
intramolecular hydrogen bonding which is seen in the 3.13 crystal structure. This may 
be due to the longer distance between coordinated oxygen atom and the uncoordinated 
hydroxyl hydrogen atoms. 
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Unfortunately, other characterisation could not be performed due to the low yield of 
3.14 crystals. A random selection of 10-12 crystals from this small sample were 
analysed by X-ray crystallography and the cell dimensions compared with the obtained 
cell dimensions for 3.13 and 3.14 crystal structures. While some crystal showed 
matching dimensions, others did not match with the 3.13 or 3.14 structure dimensions. 
This could be due to the formation of other isomers during the reaction in a very small 
yield. But the diffraction patterns of these crystals were not enough to collect data for 
the analysis. 
 
3.2.6  Synthesis of cobalt(III) complexes of 2,2’-((2-((2-hydroxyethyl)amino) - 
-ethyl)azandiyl)diethanol, L8, 
 
The attempts to synthesise L8 and purify the desired ligand were unsuccessful. But 
during the synthesis of L2 the formation of L8 and L9 as by-products was observed. 
After crystallising L9 from hot THF, the yellow oil obtained was mainly composed of L8 
and L9. The ligand mixture was reacted with [Co(NH3)6Cl3] under the Drinkard et al[123] 
reaction conditions. 
The purple aqueous reaction mixture was filtered and few drops of concentrated LiI 
solution were added. The aqueous solution of the reaction mixture yielded bright red 
plate-like crystals (yield 40%).  
These crystals were analysed by NMR techniques, mass spectrometric analysis, UV/vis, 
IR, microanalysis, and X-ray crystallography. 
Mass spectrometric analysis of the crystals showed the presence of a possibly dimeric 
species giving m/z = [M]2+ = 498.12 and half of the dimer as m/z = [M/2]+=248.0548. 
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1H NMR analysis of the complex and assignment of peaks is supported by 13C MNR 
spectroscopy, HSQC and gCOSY NMR spectroscopy. 
The analysis of the red crystals from above techniques confirmed the presence of the 
3.15 complex Figure 3.33. The structure shows the presence of cobalt(III) complex in 
coordination with( L8-2H) ligand. The results confirmed that this reaction technique 








Figure 3.32. 1H NMR spectrum of complex [Co(L8-2H)]2]2+, 3.15 in D2O with reference to 
TMPS. 
Red crystals obtained from the reaction mixture were analysed by X-ray crystallography 
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Figure 3.33. Dimeric structure of complex 3.15. The triiodide anion and the hydrogen 
atoms, except protonated amine and oxygen, were omitted for the clarity. 
The asymmetric unit of the complex [Co2(L8-2H)2]2+; Selected bond lengths (Å) and 
bond angles(°); Co1-O4 1.918(5), Co1-O5 1.910(5), Co1-O6 1.893(5), Co1-N2 1.933(6), 
Co1-N3 1.915(7), O6-Co1’ 1.925(5); O4-Co1-Co1’ 134.46(2), O4-Co1-N2 85.4(2), O5-
Co1-O4 87.3(2), O5-Co1-N2 169.7(2), O5-Co1-N3 85.7(3), O6-Co1-O4 174.9(2), O6-Co1-
O5 95.1(2), O6-Co1-N2 92.8(2), O6-Co1-N3 87.4(3), N3-Co1-N2 88.1(3). 
 
The crystal structure of complex 3.15 was solved in the C2/c monoclinic space group. 
The asymmetric unit of the complex consists of half of the complex and a triiodide 
anion. 
Each cobalt(III) metal centre has a distorted octahedral geometry with coordinated (L8-
2H) filling five coordination sites. The sixth coordination site is filled by O6 oxygen 
atom on the ligand bound to the other cobalt(III) ion. The two cobalt(III) metal centres 
were found in the proximity of 2.866(2) Å. 
3.15 
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The monomers are held together by the formation of a Co2-O2 ring across an inversion 
centre. The complex utilizes the hydroxylate oxygen to form two Co-O-Co bridges 
between the cobalt(III) centres. The Co1-O6 has a shorter bond length (1.893Å) 
compared to other Co-O bond lengths (1.910-1.983) Å. 
Each half of the molecule present in the asymmetric unit of the complex 3.15 is 
associated with a triiodide anion which confirmed the (+1) charge for the each half of 
the molecule and (+2) charge for the complete dimer. The (+1) charge is due to one 
protonated oxygen atom on the (L8-2H). The longer bond length of Co1-O4 1.918(5) 
compared to Co1-O5 1.910(3) suggested the possible protonation of the O4 oxygen 
atom and also the lowest refinement value obtained was with an added proton on the 
O4 oxygen compare to the O5 confirmed the protonation of O4 atom. 
The complex 3.15 is reacted with ZnCl2 in a methanolic solution and the resulting pink 
solution was filtered and left for slow evaporation. The resulting orangish-pink plate 
like crystals were analysed by X-ray crystallography. 
 
Chapter 03  150 
 
 
Figure 3.34. Tetranuclear complex, 3.16 with atom-labelling for the asymmetric unit. 
Hydrogen atoms present on the complex were omitted for the clarity. 
The asymmetric unit of the complex [Co(L8-3H)ZnCl2]2; Selected bond lengths (Å) and 
bond angles(°); Zn15-Cl16 2.259(2), Zn15-Cl17 2.253(2), Zn15-O2 1.921(6), Co1-O4 
1.892(5), Zn15,O4’ 1.948(6), Co1-O2 1.906(6), Co1-O3 1.902(5), Co1-O3’ 1.944(5), Co1-
N5 1.939(6), Co1-N6 1.898(6); Cl17-Zn15-Cl16 110.36(9), O2-Zn15-Cl16 108.48(2), O2-
Zn15-Cl17 111.14(2), O2-Co1-N5 84.2(2), O3-Co1-O2 91.0(2), O3-Co1-N5 172.4(2), O4-
Co1-O2 171.2(2), O4-Co1-O3 97.6(2), O4-Co1-N5 87.5(2), O4-Co1-N6 88.3(3), N6-Co1-
O2 93.9(3), Co1-O2-Zn15 120.4(3), Co1-O3-Co1’ 100.7(2). 
 
The tetranuclear complex 3.16 shows the complexation of a dinuclear 3.15 complex 
with two zinc chloride molecules. Each zinc chloride is coordinated to two of the non-
bridging oxygen atoms of the 3.15 complex, respectively, from opposite directions. 
The compound crystallised in the Pbca orthorhombic space group. The asymmetric unit 
of the complex consists of half of the complex and two water molecules. The two water 
3.16 
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molecules connect with inter molecular hydrogen bonding and also hydrogen bond to 
the amine hydrogen of the complex. 
The zinc(II) ions are bonded to oxygen atoms that are already coordinated to the 
cobalt(III) metal centre. 
The cobalt(III) metal centre shows the distorted octahedral geometry and the zinc metal 
centre shows distorted tetrahedral geometry. There are no significant changes observed 
between the bond lengths and bond angles between 3.15 and 3.16.The tetranuclear 
complex 3.16 is neutral in charge and during coordination of ZnCl2 the complex 3.15 
showed the deprotonation of O4 oxygens. 
 
3.2.7  Synthesis strategy of cobalt(III) complexes of 2,2’,2’’,2’’’-(ethane-1,2-
diylbis(azanetriyl))tetraethanol, L9, 
 
L9 was synthesised and characterised according to Herrag et al.[146] Attempts to isolate 
complexes of L9 with cobalt(III), according to the method of Drinkard et al[123] were 
unsuccessful. The change of colour of the reaction mixture from yellow to purple 
indicates some complexation, presumably due to the coordination of oxygen atoms with 
the cobalt(III) metal centre. 
The formed complex seems to be highly unstable at higher temperatures. The bluish 
coloured material obtained during the purification is a sign of cobalt(II), which suggests 
the decomposition of the complex.  
The information obtained for the analysis of crude product is insufficient to understand 
the complexation of L9 with cobalt(III) metal centre. Attempts made to crystallise any 
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possible cobalt(III) complex formed with L9 ligand using ZnCl2/MnCl2 were not 
successful.  
Oxygen atoms in the Cu2O2 ring have shortened bond lengths of 1.940Å and 1.959Å 
between oxygen and copper(II) ions in comparison to the axial protonated oxygen and 
copper(II) ions. This longer bond length is the characteristics of Jahn–Teller distortion 
observed for copper coordinated compounds.  
 
3.3  Utilising 3.13 alkoxide complex to synthesise DNA cross-linking 
nitrogen mustard on cobalt(III) metal centre 
 
Bis-alkylating nitrogen mustard compounds are highly effective as cytotoxic compounds 
compared to mono-alkylating counterparts.[147] While mono-alkylating nitrogen 
mustard compounds only alkylate a single base of a DNA molecule, bis-alkylating 
nitrogen mustard compounds have the capability to form inter- or intra-strand cross-
links by alkylating the two nitrogen bases on the DNA molecule and this strategy was 
discussed in chapter 01.[148] The cross-links are strong covalent bonds highly resistant 
to DNA repair enzymes.[147] 
L2 possesses two hydroxyethyl groups, which have the potential to be converted to 
chloroethyl functionalities, to give a cross-linking type of nitrogen mustard compound. 
Due to the high toxicity of nitrogen mustard compounds, new synthetic procedures 
were investigated to append a cross-linking nitrogen mustard on cobalt(III) metal 
centre in its hydroxyethyl precursor form and hence avoid the free handling of toxic 
nitrogen mustard compounds.  
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Previous attempts to complex L2 with cobalt(III), with the focus of synthesising 
nitrogen mustard cobalt(III) complexes, proved unsuccessful as reported by Alan 
Downward in his thesis.[121]  
The study of the coordination chemistry of amino alcohol ligands, lead us to synthesise 
desired cobalt(III) precursor complexes necessary for the synthesis of cobalt(III) 
complexes with coordinated bis-alkylating nitrogen mustard ligands. Here we describe 
the chemistry required to achieve the functional group chemistry that is required to 
prepare the bis-alkylating nitrogen mustards. 
Two different complexes of this category, [Co(bceen)2Cl2]+, 3.17 and 
[Co(bceen)2(NO2)2]+, 3.18, were synthesised by strictly following the safe synthesis 
concept during this work.  
Reaction of 3.13 complex with SOCl2 / DMF reaction mixture showed the formation of 
[Co(bceen)2Cl2]Cl, 3.17, complex. Heating of the reaction mixture was necessary to 
achieve the complete conversion of 3.13 to 3.17 complex, Figure 3.36. This may be due 
to the strong bonding interaction between cobat(III) metal centre with coordinated 
hydroxyl oxygen. 
Mass spectrometric analysis of the reaction mixture shows possible complex 
intermediates during conversion of the complex 3.13 to 3.17. The recognised mass 
spectrometric cationic components are, [C12H30N4O4Co1]+ = m/z = 353.1599; 
[C12H28N4O2Cl2Co1]+ = m/z = 389.0921; [C12H29N4O2Cl3Co1]+ = m/z = 425.0688; 
[C12H30N4Cl4O2Co1]+ = m/z = 463.04; [C12H28N4Cl6Co1]+ = m/z=496.978, with possible 
structures being shown in the Figure 3.36. This analysis helps us to develop a stepwise 
reaction pathway for the synthesis of complex 3.17. 
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Figure 3.35. ESI-MS(+ve mode) of reaction mixture with possible structural components. 
 
 
Figure 3.36. Suggested reaction pathway for the conversion of 3.13 into 3.17 complex. 
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The information obtained supported the suggested reaction route for the conversion of 
complex 3.13 to 3.17, Figure 3.36. The reaction was repeated numerous times and the 
reaction mixtures were analysed in different intervals during the reaction. The results 
obtained by mass spectrometric analysis shows the presence of 3.19 throughout the 
reaction and suggest that the 3.19 is as a stable cationic fragment in the reaction 
mixture. The increased reaction temperature and the long reaction time were necessary 
to eliminate 3.19 from the mixture. The Co-O bond opens up as free hydroxyl ethyl 
groups while replacing axial coordinates with chloride ligands. The completion of the 
reaction, to obtain the complex 3.17, is satisfied by the chlorination of hydroxyl groups. 
Reaction mixture was heated at 70 °C overnight to obtain the complete conversion of 
3.13 to 3.17.  
The green reaction mixture obtained suggested the coordination of trans chloride 
ligands with the cobalt(III) metal centre.[149] The excess thionyl chloride was removed 
under vacuum and the obtained green thick material was re-dissolved in ethanol.  
After reacting 3.13 with SOCl2 / DMF, the SOCl2 was removed under the vacuum. The 
obtained powdered green material, after mixing the green slurry with ethanol, was 
filtered and washed with cold ethanol solution to obtain a pure material.  
One of the disadvantages of this reaction is the formation of cobalt(II) ions in the 
reaction mixture. Formation of cobalt(II) ions was inferred from the bluish coloured 
ethanol washings. A few ethanol washings were necessary to remove cobalt(II) ions 
from the product material. The formation of cobalt(II) could be influenced by the heat 
applied during the reaction as these complexes are not very stable and also the electron 
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rich sulfur from DMF was most likely to facilitate the reduction of cobalt(III). The 
formation of cobalt(II) could lead to the reduced yield of the product.  
The obtained product was analysed by mass spectrometry, 1H NMR spectroscopy, 13C 
NMR spectroscopy, gCOSY, and HSQC NMR techniques. Also UV/vis, IR and X-ray 
crystallographic analysis supported the structure assignment of complex 3.17. 
 
Figure 3.37. ESI-MS analysis of complex 3.17 showing matching isotopic pattern; 
experimental (top) and calculated (bottom) 
 
The mass spectra shown in Figure 3.37 of the complex 3.17 indicate the (+1) charge of 
the complex. The mass spectrum of 3.17 shows a very complex isotopic pattern which 
clearly points to the presence of six chlorine atoms and its 35Cl and 37Cl isotopes in their 
respective natural abundances. 
The 1H NMR spectrum of complex 3.17 seems simple. The protons on the carbon atom 
directly attached to chlorine appear as two multiplets, more down field at around 4 
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ppm. The other twelve protons appear in four different multiplets. The assignment of 
the protons was supported by gCOSY and HSQC spectra.  
The powdered material obtained was dissolved into a warm ethanol solution and left 
for slow evaporation. The plate like green crystals were analysed by X-ray 
crystallography.  
The crystal structure for the complex 3.17 was solved in the P21/c monoclinic space 
group,Figure 3.38. The asymmetric unit consist of two half complex molecules, a 
chloride anion and three water molecules. The two half complexes are part of two 
slightly different complexes that are present in the structure due to the arrangement of 
chloroethyl arms in space. One of the complexes show pointing of chloroethyl arms of 
each ligand to the same side while the other molecule shows the arrangement of  
chloroethyl arms of each ligand to opposite side of the molecule. 
 
Figure 3.38. Complete [Co(bceen)2Cl2]+, 3.17 with atom-labelling. Complexes generated 
by the asymmetric units showing the different arrangement of chloroethyl arms in space. 
The chloride anion and hydrogen atoms were omitted for the clarity. 
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Molecular structure of [Co(bceen)2Cl2]+; Selected bond lengths (Å) and bond angles(°); 
Co12-Cl24 2.2398(9), Co12-N14 2.028(3), Co12-N15 2.008(3), C22-Cl23 1.798(5), Cl20-
C19 1.793(5), Co1-Cl23 2.255(9), Co1-N2 2.014(3), Co1-N3 2.013(3), Cl9-C7 1.798(4), 
Cl11-C10 1.802(5); Cl24-Co12-Cl24’ 180 N14-Co12-Cl24’ 90.84(1), N14’Co12-Cl24’ 
89.16(1), N14’-Co12-Cl24 90.84(1), N14-Co12-N14’ 180.0, N15’-Co12-Cl24 85.61(1), 
N15-Co12-Cl24’ 94.39(1), N15-Co12-Cl24 94.39(1), N15-Co12-Cl24’ 85.61(1), N15-
Co12-Cl24’ 85.61(1), N15-Co12-N14 85.09(1), N15’-Co12-N14 94.91(1), N15’-Co12-
N15’ 180.0, N2-Co1-Cl232 90.2(9), N22-Co1-Cl13 90.2(9), N22-Co1-Cl132 89.8(9), N22-
Co1-N2 180.0, N3-Co1-Cl13 86.81(9), N3-Co1-Cl132 93.19(9), N32-Co1-N22 86.14(1), 
N32-Co1-N2 93.86 (1). 
 
The complex crystallised in a distorted octahedral geometry. The two complexes show 
different arrangement of chloroethyl arms in space. Chloroethyl arms in one of the 
complexes were pointing to the same side of the complex and the chloroethyl arms in 
other complex shows the arrangement in opposite side of the complex.  
Water molecules in the space form hydrogen bonds with amine hydrogens and oxygen 
atom of the water molecule. The second water molecule is hydrogen bonded to the 
chloride anion. Likewise water molecule makes an intermolecular hydrogen bonding 
network which stabilised the crystal packing. 
The complex 3.17 also crystallised as its [ZnCl4]2- salt. The block-shaped green crystals 
were analysed by X-ray crystallography. 
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Figure 3.39. The [Co(bceen)2Cl2]2[ZnCl4], 3.22 complexes generated by different 
molecular segments in asymmetric unit  showing their arrangement in space. The [ZnCl4]2- 
anion is omitted for the clarity. 
 
The complex crystallises in Pī triclinic space group. The asymmetric unit consists of four 
half molecules and one [ZnCl4]2- anion. Three of the half molecules have chloroethyl 
arms pointing to opposite directions and the fourth has chloroethyl arms pointing to the 
same direction. 
A range of cobalt(III) nitrogen mustard complexes with two other labile ligands were 
investigated to complete the synthesis of heterodinuclear complexes. According to 
Downward et al’s Findings, OTf was chosen as the suitable labile ligands. One of the 
ways of introducing the OTf ligands on to the cobalt(III) centre is by reacting a 
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cobalt(III) complex with a coordinated nitrite ligand with trifloromethanesulfonic acid. 
Therefore, reaction of complex 3.17 with NH4OH and NaNO2 facilitated the exchange of 
the chloride with the nitrite ligand. The yellow coloured reaction mixture was left in the 
fridge to obtain yellow powder. Mass spectrometric analysis of the yellow powder 
obtained under the cold conditions shows the presence of complex 3.18.  
 
 
Figure 3.40. Reaction pathway for the synthesis of complex 3.23. 
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Figure 3.41. ESI-MS analysis of the complex 3.18.The complex isotope pattern is 
prominent in the spectra. Experimental (top) and calculated (below). 
 
The matching isotopic pattern confirms the presence of complex 3.18. The increased 
complexity of the isotopic pattern is mainly due to 35Cl and 37Cl isotopes. As the number 
of chlorine atoms in the complex increases higher complexity can be expected.  
3.4  Summary 
 
This chapter describes the coordination pattern of the range of a similar class of ligands 
(L1-L9) with cobalt(III) metal centres. The focus of this project was to append a 
nitrogen mustard compound on a cobalt(III) metal centre, and investigating the 
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behaviour of hydroxyethyl groups during coordination is the main focus from these 
results.  
This study also demonstrated the use of alkoxide complexes to synthesise bisalkylating 
nitrogen mustard cobalt(III) complexes.  
The alkoxide complexes also exhibit interesting polynuclear coordination ability and the 
polunuclear complexes with zinc(II) chloride and manganese(II) chloride are reported 
in this chapter. This opens up wider research possibilities to investigate the 
coordination behaviour of these alkoxide complexes with other metal salts and also to 
investigate electrochemical and magnetic properties of these complexes. 
Also, more complex amino alcohol ligands can be employed or changing reaction 








































Synthetic approaches to ruthenium(II) 
cobalt(III) heterodinuclear complexes 
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4. Synthetic approaches to ruthenium(II) cobalt(III) heterodinuclear 
complexes  
 
4.1  Introduction 
 
The key goal of this project is to design a ruthenium(II)-cobalt(III) heterodinuclear 
system as a potential prodrug system. There are dinuclear ruthenium(II)-cobalt(III) 
complexes reported in the literature.[107], [109], [110], [127] However, there are few reports 
about the use of these metal systems in medicinal applications.[110] 
Models of possible photoactivated ruthenium(II)-cobat(III) systems were previously 
studied by Alan Downward in the Hartshorn group.[113], [114], [121] He synthesised a 
heterodinuclear metal system composed of a ruthenium(II) and cobalt(III) metal pair 
and demonstrated that the photoinduced ligand release of such systems is possible, as 
discussed in chapter 01. 
 
Figure 4.1. Ruthenium(II)-cobalt(III) heterodinuclear system synthesised by Alan 
Downward.  
 
In this project, we sought to improve the system to achieve an effective prodrug in the 
following ways; 
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 4,4’-Dicarboxylic-2,2’-bipyridine is one of the best ligands for lowering the total 
complex charge. Each carboxylic ligand on both the bipyridine ligands can be 
deprotonated over a range of pH values to lower the total complex charge down 
to (+1). 
 Long alkyl chains on the bipyridine ligand are also another approach to 
introduce hydrophobicity. The hydrophobic ligands were introduced onto the 
fourth position of bipyridine ligands through esterification reactions. 
 The cobalt(III) metal centre was modified by replacement of the ethane-1,2-
diamine ligands with cytotoxic nitrogen mustard ligands. 
The efficient electronic communication between the two metal centres was satisfied by 
the pytp (where, pytp = 3-(pyridine-2-yl)-[1,2,4]triazino[5,6f] 
[1,10]phenanthroline) bridging ligand. The desired heterodinuclear complexes were 
synthesised with the pytp bridging ligand. 
 
Figure.4.2. Ruthenium(II) cobalt(III) heterodinuclear complex with suggested 
modifications. The nitrogen mustard on the cobalt(III) centre can be replaced by other 
mustard ligands. 
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Chapter 2 and chapter 3 broadly discussed the synthetic strategy of preparing the 
cobalt(III) nitrogen mustard complexes without needing to handle the free mustard 
ligands. We have described some coordination chemistry of amino alcohol ligands with 
more than one hydroxyethyl arm, and the use of the resulting alkoxide complexes to 
synthesise possible DNA cross linking nitrogen mustards on cobalt(III) centres. 
Here firstly, we investigate the possible use of [Co(L3)2(NO2)2]+, 2.08, and related 
complexes for coordination to the ruthenium(II) metal centre through the pytp bridging 
ligand. The NO2 axial ligands on the cobalt(III) metal centre need to be substituted with 
highly labile ligands such as trifluoromethanesulfonate (OTf) to allow the linking 
reaction to be carried out in very mild conditions. The synthesis and characterisation of 
[Co(L3)2(OTf)2]+, 4.02, will be discussed in this chapter. 
The synthetic strategy for preparation of other ruthenium(II) cobalt(III) 
heterodinuclear complexes from the related ruthenium(II) complexes and 
[Co(tren)(OTf)2]+, 4.03 will also be included in this chapter. Proposed reaction scheme 
for the synthesis of 4.10(a, b, c, d) complexes is shown in Scheme 4.1. 
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Scheme 4.1. Synthetic route for the ruthenium(II) cobalt(III) heterodinuclear metal 
complexes, 4.10. From now onwards, the compounds relevant to different substituents will 
be represented by the compound number written with relevant letter (a, b, c, or d) as 
shown in the table. 
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Synthesis of ruthenium (II) pytp complexes 4.09a-4.09d will be discussed in this 
chapter. The [Co(tren)(NO2)2]+, 4.03, was synthesised according to the procedure 
reported by Bernal et al.[150]  
 
4.2  Results and Discussion 
 
4.2.1. Synthesis of [Ru(bpy)2(pytp)]2+, 4.09a, 
 
[Ru(bpy)2(pytp)]2+, 4.10a, was synthesised according to the synthetic procedure 
developed by Downward et al.[113] The aromatic region of the 1H NMR spectrum of 




Figure 4.3.  The aromatic region of the 1H NMR spectrum of [Ru(bpy)2(pytp)]2+,4.09a, 
complex in CD3CN, showing peak assignments. 
 
H4C H4C’ H6E H3E 
H3A, H3A’ 
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4.2.2  Synthesis of [Ru(4,4’-dmbpy)2(pytp)]2+, 4.09b, 
 
Commercially available 4,4’-dimethyl-2,2’- bipyridine, 4.04b, was reacted with 
commercially available RuCl3·nH2O according to the procedure described by Sullivan et 
al.[151] Formation of the complex, 4.05b was observed by mass spectrometric analysis as 
a (+1) charged complex, [M-Cl]+ = 505.0728. 
The crude black residue of the dichloride ruthenium complex, 4.05b, was carried onto 
the next step of the reaction without further purification, Figure 4.1, as is standard for 
these synthetic sequences.[152], [153] 
1,10-Phenanthroline-5,6-dione, 4.06 was synthesised according to the reported 
procedure[154] and complexed with 4.05b according to the procedure described by 
Reddy et al.[155] The complex 4.07b was precipitated by the addition of a concentrated 
aqueous solution of ammonium hexafluoridophosphate, Figure 4.1.  
Complex 4.07b was then purified by silica gel column chromatography using 
acetonitrile as the mobile phase and dried under vacuum. The obtained red powdered 
material was dissolved into a minimum amount of methanol, and precipitated by 
addition of a concentrated aqueous solution of ammonium hexafluoridophosphate. The 
resulting orange powder was characterised by mass spectrometric analysis [M]2+ = m/z 
= 340.07, 1H NMR, and gCOSY spectroscopy. 
4.09b was synthesised by the procedure described by Downward et al.[113] 
Condensation reaction between the complex 4.07b with pyridine-2-
carbohydrazonamide, 4.08, was carried out in ethanol. The resulting complex was 
purified by column chromatography (silica gel, acetonitrile/saturated aqueous KNO3, 
7:1), and the product, 4.09b, was isolated as its hexafluoridophosphate salt. 
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The product was then characterised by mass spectrometric analysis, NMR spectroscopic 
techniques as well as UV/vis, IR, and fluorescence techniques. A key signal from the 
mass spectrum of complex 4.09b, with a matching calculated isotope pattern, is shown 
in Figure 4.4. 
m/z 
Figure 4.4. A key signal from the mass spectrum of [Ru(4,4’-dmbpy)2(pytp)]2+, 4.09b, 











Figure 4.5. The aromatic region of 1H NMR spectrum of the complex Ru(dmbpy)2(pytp)]2+, 
4.09b, in CD3CN. 
 
The 1H NMR spectrum of complex 4.09b shows fifteen non-equivalent proton signals. 
Some of them are overlapping, as shown in Figure 4.5. Six different pyridine systems 
exist within the complex. The complex becomes unsymmetrical after the addition of 
4.08 to complete pytp bridging. The peaks assigned to the C4 and C4’ protons appear 
further downfield on the spectrum compared to the E3 and E6 protons, due to the 
anisotropic ring current effect. Assigning of the peaks in the spectrum was substantially 
supported by the gCOSY NMR spectroscopy. The H3A, H3B from the bipyridine ligands 
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H5A and H5A’ were highly shielded due the ring current arising from the C aromatic 
rings and the peaks relevant to H5A and H5A’ appeared upfield, with chemical shifts of 
7.09 ppm and 7.32 ppm, respectively.  
The twelve methyl protons appeared in two different sets in the alkyl region, each 
representing the integration of six protons. 
The two different 1H NMR spectra obtained for complexes 4.09a and 4.09b represent a 
similar distribution pattern for the 1H NMR peaks except the multiplets relevant to H4A, 
H4A’, H4B and H4B’ in 4.09a spectrum. 
The assignment of the sole singlet in the spectrum (8.41 ppm, H3A) of 4.09b was 
straightforward. It is also worth noticing the remarkable deshielding of H3 protons 
upon complexation with the ruthenium(II) centre. In the gCOSY spectrum, correlation 
among ortho, meta, and para protons are normally observable. Also the differences 
between J-coupling has greatly aided assignments, especially of H3 and H6 aromatic 
protons. 
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Figure 4.6. The aromatic region of gCOSY NMR spectrum of [Ru(dmbpy)2(pytp)]2+, 4.09b 
complex. The spectra shows coupling between adjacent protons. Each colour represents a 
different ring system in the 4.09b complex. 
 
The gCOSY NMR spectrum shown in Figure 4.6 is consistent with the assignment of 
peaks in the 1H NMR spin system. 
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4.2.3  Synthesis of [Ru(decbpy)2(pytp)]2+, 4.09d, 
 
(decbpy =4,4’-diethoxycarbonyl-2,2’-bipyridine), 4.04d, 
 
The ligand, decbpy, 4.05d, was synthesised according to the following reaction, Scheme 
4.2. 
 
Scheme 4.2. Reaction scheme for the synthesis of 4.04d.  
 
The compound 4.04c was synthesised by oxidising commercially available 4.04b 
according to the procedure described by Zhou et al.[156] After characterisation, 4.04c 
was used for the esterification reaction. 
4.04d was obtained by esterifying 4.04c according to the procedure described by 
Garelli et al.[157]. Similar analysis results with the reported literature values confirmed 
the formation of the product.[158] 
The complex 4.07d was synthesised according to the procedure described by Schmidt 
et al.[159] 
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Complex 4.07d was reacted with 4.08 by condensation to complete the pytp bridging 
ligand, Scheme 4.1. The condensation reaction was performed to produce 4.09d by 
refluxing complex 4.07d and 4.08 in a 1:1 molar ratio in ethanol. The completion of 
reaction was confirmed by TLC analysis. The product was precipitated as its 
hexafluoridophosphate salt by the addition of a concentrated aqueous solution of 
ammonium hexafluorophosphate into a concentrated reaction mixture.  
The resulting residue was chromatographed on a silica gel column using an 
ethanol:NaOH(aq) (1:1) solvent system. The orange second band was dried under 
vacuum and the solid material was dissolved into a minimum amount of water. The 
product was separated from NaCl by a few dichloromethane (DCM) extractions. The 
complex affinity for the dichloromethane layer was influenced by adding a few 
millilitres of concentrated aqueous solution of ammonium hexafluoridophosphate. After 
complete extraction, the DCM layer was dried with anhydrous magnesium sulfate and 
then the solvent was evaporated under vacuum to obtain the desired complex. 
The obtained product was characterised by mass spectrometric analysis, UV/vis, IR, 
NMR techniques. 
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m/z 
Figure 4.7. The key signal of the mass spectrum of 4.09d (top), experimental isotopic 
pattern (middle), simulated isotopic pattern (bottom). 
 
The mass spectrum shown in Figure 4.7, confirmed the formation of the complex 4.09d. 
After condensation of 4.07d with 4.08, the complex becomes asymmetric. Each of the 
peaks corresponding to the methyl and ethyl groups at 1.52 and 4.15 ppm were 
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Figure. 4.8. The aromatic region of the 1H NMR of the complex [Ru(decbpy)2(pytp)]2+ 
4.09d. The 1H NMR signals belonging to each ring system has the similar colour. For 
example all the 1H NMR peaks from E pyridine ring were coloured in green.  
 
The 1H NMR spectrum of the complex showed eighteen different peaks in relation to 
forty two different protons. 
The assigning of the peaks in 1H NMR spectrum was achieved using gCOSY NMR and 1D 
TOCSY experiments.  
The 8.02 ppm region of the gCOSY spectrum is complicated due to the overlap of peaks 
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accuracy of the assigned peaks from the gCOSY experiment and was mainly used for the 
assigning of proton peaks from the E ring system. 
The splitting pattern observed in the spectrum, Figure. 4.8 had similar features to the 
splitting pattern of the complex 4.09b. 
One of the differences observed in this spectrum compared to the spectrum shown in 
Figure 4.3 is the shifting of H3A and H3A’ proton signals to the down field in the 
spectrum.  
 
4.2.4  Synthesis of [Ru(dcbpy)2(pytp)]2+, 4.09c, 
 
4,4’-Dicarboxy-2,2’-bipyridine was selected as a potential ancillary ligand on the 
ruthenium(II) metal centre to manipulate the higher total complex charge of the Ru(II)-
Co(III) heterodinuclear complex.  
During this research we wanted to explore the hydrophobic and hydrophilic properties 
and a range of different charges of the ruthenium(II) complex , and the influence on the 
properties of the dinuclear complex due to the different charges of the ruthenium(II) 
centres. 
The carboxylic moieties on ancillary ligands can be deprotonated by varying the pH of 
the medium. The four carboxylic groups on the bipyridine ligands can be deprotonated 
to create four carboxylate groups lowering the net charge of the metal complex to (+1). 
The complex, 4.05c was synthesised by coordinating 2,2’-bipyridine-4,4’-dicarboxy 
acid, 4.04c with RuCl3.nH2O, Scheme 4.1, according the procedure reported by 
Nazeeruddine et al.[152] The formation of 4.05c was confirmed by UV/vis 
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spectrophotometric analysis, as well as mass spectrometric analysis [M-Cl]+= m/z = 
624.9698. The product was used for the next step of the synthesis without further 
purification. The condensation of 4.05c with 1,10-phenanthroline-5,6-dione, 4.06 was 
carried out under vigorous microwave reaction conditions. This procedure was adopted 
from reports by Freys et al.[160] and the reaction mixture turned yellow indicating the 
complexation of 4.06. The reaction was monitored by TLC. Formation of the product, 
4.07c was observed by mass spectrometric analysis [M]2+ = m/z = 400.022. Attempts to 
purify the product using silica gel column chromatography, as described in the 
literature procedure were unsuccessful. 
The complex 4.07c was used in the next step without further purification. As shown in 
Figure 4.9, the pytp bridging ligand was synthesised by reacting 4.07c with 4.08 in 
methanol. The progress of the reaction was monitored by TLC throughout the reaction 
to minimise time spent at reflux.  
 
  
Figure 4.9. Reaction path for the condensation between 4.07c with 4.08 for the stepwise 
synthesis of pytp bridging ligand to produce 4.09c. 
















Figure 4.10. The mass spectrum of 4.09c complex (top), including experimental (middle) 
and simulated (bottom) patterns. 
 
Attempts made to purify the complex using various numbers of chromatographic 
techniques were unsuccessful. The 4.09c complex behaves completely differently in 
solubility to 4.09a and 4.09b complexes. The hexafluoridophosphate salt of the 4.09c is 
insoluble in acetonitrile.  
One of the possible strategies to investigate the solubility of the complex 4.09C is 
deprotonation of the carboxylic acid moieties by changing the pH of the medium. 
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4.2.5  Fluorescence studies of 4.09a, 4.09b and 4.09d, 
 
 
Figure 4.11. Florescence spectrum for the complexes 4.09a (S1), 4.09b (S2) and 
4.09c(S3) reported in methanol as a solvent.  
 
The photochemistry of ruthenium polypyridyl complex was previously discussed in the 
chapter 01. The fluorescence spectrum is observed due to the electron transfer from an 
excited triplet state to singlet ground state. Due to the slight differences on the ligand 
substituents differences in the florescence spectrum is observed. 
 
4.2.6.  Synthesis of ruthenium(II)-cobalt(III) heterodinuclear metal complex, 
4.10b and 4.10d, 
 
The main purpose of synthesising complexes 4.09b, 4.09c and 4.09d was to 
incorporate them as part of a ruthenium(II)-cobalt(III) heterodinuclear metal complex. 
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Therefore, to investigate the possibility of utilising these complexes NMR scale reactions 
were carried out between 4.09b or 4.09d with 4.03, as shown in the Scheme 4.1. 
1HNMR experiments were used to monitor this reaction between ruthenium(II) pytp 
complex , 4.09b / 4.09d, with the complex 4.03.  
The dinitrite ligands on [Co(tren)(NO2)2]+, 4.12 are strong coordination ligands. It is 
important to replace these nitrite ligands with labile ligands to facilitate the formation 
of the heterodinuclear complex under very mild reaction conditions. Therefore, the 
nitrite ligands were replaced with the highly labile OTf ligands by reacting 4.12 with 
trifluoromethanesulfonic acid (HOTf), under the conditions reported by Chang et al.[71] 
The1H NMR experiment was carried out in 5mm NMR tube by mixing complexes 4.09b 
with 4.03 and 4.09d with 4.03 in separate 5mm NMR tubes in acetonitrile in a 1:1 
molar ratio. The NMR reaction mixture was kept in the dark throughout the reaction 
and only exposed to light during submitting the sample for analysis. The spectra were 
recorded in different time intervals and upon complexation, 4.09b with 4.03 or 4.09d 
with 4.03 showed the changing chemical shifts in the aromatic region of the 
ruthenium(II) complex shown in Figure 4.12 and Figure 4.13. The completion of the 
reaction was monitored by complete disappearance of some of the peaks in the 1H NMR 
spectrum of ruthenium(II)pytp complex, 4.09b and 4.09d and complete appearance of 
























Figure 4.12. The aromatic region of the 1H NMR spectrum of 4.09b showing changing 
chemical shifts of proton peak on complexation with [Co(tren)(OTf)2]+ 4.03. Each peak in 












Final dinuclear complex 


























Figure 4.13 The aromatic region of the 1H NMR spectrum of 4.09d showing changing 
chemical shifts of proton peak on complexation with [Co(tren)(OTf)2]+, 4.03 complex. Each 
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4.2.7  Preparation of [Co(L3)2(NO2)2]+, 2.08, to be complexed with 4.09b or 
4.09d 
 
[Co(L3)2(OTf)2]+, 4.02 complex was interesting to us because of highly labile 
trifluoromathanesulfonate (OTf) ligands. The highly labile OTf leaves easily during the 
coordination with the ruthenium(II)pytp complex, 4.09b or 4.09d. The synthesis of 
[Co(L3)2(OTf)2]+, 4.02 using 2.08 is as follows. 
 
Scheme 4.3. Reaction scheme for the preparation of 4.02. 
 
For the synthesis of the complex 4.02, initially complex 2.08 was reacted with neat 
HOTf under the nitrogen atmosphere. The gaseous nitrogen was passed through the 
reaction mixture to avoid moisture getting into the system. In the presence of moisture 
OTf ligands can get substituted by water. 
The reaction mixture was kept in the ice–salt bath (below 0 °C). After completion of the 
reaction, cold ether was added to precipitate the product from the reaction mixture. 
Analysis of the product shows it to be the protonated L3 ligand, presumably from the 
decomposition of the complex. The above results confirmed the requirements of 
employing mild reaction conditions. The complex 2.08 was kept under gaseous 
nitrogen; nitrogen was bubbled through the reaction mixture. The reaction flask was 
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kept in an acetone-dry ice bath while adding neat HOTf. The HOTf solidified on addition 
(mp: -40°C) but the slow increase of the temperature resulted in a melting of the HOTf 
which facilitated the mild reaction conditions for the complex. Later, the reaction 
mixture was transferred to an ice-salt bath, and reaction was continued for eight hours 
to achieve completion. The product was separated from the reaction mixture by the 
addition of cold ether to the reaction mixture. The resulting purple sticky material was 
analysed by mass spectrometry. 
  (m/z) 
Figure 4.14. Mass spectrometric analysis of the complex 4.02. 
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Figure 4.15. Possible cationic components identified in the mass spectrum shown in 
Figure 4.14. Relevant peak in the mass spectrum and the chemical structure are colour 
coded for easy identification. 
 
Mass spectrometric analysis of the extracted product material revealed the formation of 
the desired complex 4.02 and several other fragments produced from molecular ion. 
The m/z=395.04 peak present in the mass spectrum shows the presence of unreacted 
starting material, 2.08 in the reaction mixture. Also the presence of 4.13 cationic 
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complex appearing at m/z= 498.00 is due to the substitution of only one nitrite ligand 
with OTf ligand. The formation of the 4.13 cation is most likely due to the different 
chemical nature of two nitrite ligands in the starting material, 2.08. This different 
chemical nature of nitrite ligands in the precursor complex is previously discussed in 
the section 2.3.1. 
The complex 4.14 was also an interesting find, showing the replacement of an axial 
ligand (OTf or NO2) with a chloride ligand. The source of chloride ions could be the 
anionic chloride associated with the starting material or the hydrochloric acid 
generated during the HOTf acid reaction. Therefore bubbling nitrogen into the reaction 
mixture is important to efficiently remove HCl from the reaction mixture. As we know 
from the work in chapter 02, the affinity of the chloride ion for these axial positions is 
high; therefore the cationic 4.14 fragment is not surprising in the presence of even a 
trace amount of chloride ions in the medium. 
Scheme 4.4. Reaction scheme for the synthesis of [Co(L3)2(OTf)2]+, 4.02, complex. 
 
Therefore, to remove any chloride ions in the medium, an alternate approach was used. 
The starting material was reacted with equimolar amount of silver 
trifluoromethanesulfonate (AgOTf) in a methanolic medium to replace any sort of ionic 
chlorides in the medium with OTf ions. After stirring the AgOTf and the complex 2.08 in 
the methanolic solution for five hours, the white silver chloride precipitate was filtered. 
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The filtrate was dried under vacuum to obtain a yellow powdered material, and was 

















Figure 4.16. Mass spectra obtained under new reaction conditions shown in Scheme 4.4 
and the experimental (top) and calculated (below) isotope pattern for the complex 
[Co(L3)2(OTf)2]+, 4.02. 
After removing the chloride counter ions from the complex 2.08 using AgOTf, followed 
by the reaction with HOTf, the mass spectrum of the isolated light pink powdered 
material showed the disappearance of 4.13 and 4.14 from the mass spectrum, Figure 
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The results obtained also proved that the chlorine substituent on 4.14 is mainly due to 
the associated chloride anion, or the HCl produced due to the reaction of anionic 
chloride with HOTf rather than the HCl acid generated during the neat HOTf acid 
reaction. 
The inability to record the 1H NMR spectrum of the extracted material suggested the 
possible contamination with cobalt(II) ions. It could be due to the generation of 
cobalt(II) due to the decomposition of some material in the reaction mixture. Therefore 
the purity of the obtained product was insufficient to proceed to the next level of the 
synthesis. 
 
4.3  Summary 
 
The complexes [Ru(bpy)2(pytp)]2+, 4.09a, [Ru(dmbpy)2(pytp)]2+, 4.09b, and 
[Ru(decbpy)2(pytp)]2+, 4.09d, were successfully synthesised and characterised by NMR, 
UV/vis, IR, ESI-MS and fluorescence spectroscopic techniques. [Ru(dcbpy)2(pytp)]2+, 
4.09c, was synthesised and characterised by ESI-MS but purification of the product was 
unsuccessful due to the lower solubility of the complex. 
[Co(L3)2(OTf)2]OTf, 4.02, is an important complex to synthesis ruthenium(II)-
cobalt(III) heterodinucler complex. The highly labile OTf ligands on the 4.02 were 
important for employing mild reaction conditions during the synthesis of 
heterodinuclear complex. The proposed synthetic route for the synthesis of 
[Co(L3)2(OTf)2]OTf, 4.02, using [Co(L3)2(NO2)]+, 2.08 as starting material was also 
discussed in this chapter. 
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As an approach for the synthesis of Ru(II)-Co(III) heterodinuclear complex, the results 
obtained from the NMR studies, by complexation of Ru(dmbpy)2(pytp)]2+, 4.08b, with 
[Co(tren)(OTf)2]+, 4.03, and [Ru(decbpy)2(pytp)]2+, 4.09d, with [Co(tren)(OTf)2]+, 4.03, 
are also discussed in this chapter. 1H NMR studies presented in this chapter supported 
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5. Conclusions and Future Prospects 
 
5.1  Conclusions 
 
The work reported in this thesis has focused on the synthesis of a photoactivated 
prodrug system consisting of heterodinuclear metal centres; in particular Ru(II) and 
Co(III) centres.  
A key outcome of this research project is the safer synthetic approach to complexes of 
toxic nitrogen mustard compounds. The synthetic procedure focused on first the 
coordination of amino alcohol ligands onto the cobalt(III) inert metal centre, followed 
by the conversion of hydroxyethyl groups to chloroethyl groups. A detailed discussion 
of this chemistry is outlined in chapter 02. 
However, due to the proven complexity of coordination chemistry of amino alcohol 
ligands with cobalt(III) centres and lack of information about these complexes, a 
thorough investigation was included with regards to the cobalt(III) alkoxide complexes 
in chapter 02 and chapter 03. 
In chapter 02, the synthesis and crystallographic studies of twelve different cobalt(III) 
complexes derived from the precursor [Co(L1)2(NO2)2]NO3, 2.06, under different 
reaction conditions is reported. These complexes were discussed extensively in chapter 
02, in relation to their stability, coordination chemistry, reactivity, ligand exchange 
reactions, and isomerisation. Many of these complexes were synthesised multiple times 
via different synthetic routes. The results are presented in a reaction web that was 
developed and is shown in Figure 2.8, chapter 02. 
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More importantly, an understanding of the reaction web allowed for the synthesis and 
full characterisation of the complex, [Co(L3)2(NO2)2]Cl, 2.08, which was considered as 
one of the important complexes to reach the research goals and was unable to be 
synthesised by previous members of the Hartshorn group.  
The [Co(L1-H)2]+ alkoxide complex is one of those twelve complexes. The synthesis and 
isomerisation of this complex was discussed in chapter 02, and also reported the new 
technique by which these alkoxide complexes could be isolated in their neutral form by 
complexing them with ZnCl2 or MnCl2 metal salts. Using this technique three different 
isomers of complex [Co(L1-H)2]+ were isolated and X-ray crystallographic analysis of 
these were reported in chapter 02. 
The [Co(L1-H)2]+ complex could act as a starting material for the synthesis of a nitrogen 
mustard ligand on a cobalt(III) centre. This synthetic procedure is safer than established 
techniques that involve the handling of the free nitrogen mustard.  
Chapter 03 presents ten new cobalt(III) alkoxide complexes that were synthesised using 
seven different amino alcohol ligands. Many of the complexes were characterised by X-
ray crystallographic techniques.  
The new coordination chemistry of cobalt(II) alkoxide complexes demonstrated the 
dimerization of two cobalt(III) alkoxide complexes via hydrogen bonded oxygen 
bridging to form dinuclear complexes (3.03, 3.09, 3.10, 3.15, 3.16) and these 
complexes had not been reported in the literature. 
Four tetranuclear complexes (3.03, 3.09, 3.10, 3.16) with Co(III)/Zn(II) and 
Co(III)/Mn(II) were synthesised and reported in chapter 03. One of the special features 
of these tetranuclear complexes are they are uncharged and easily crystallised out from 
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a methanolic solution; hence we were able to investigate and report on the coordination 
chemistry of them. 
One of the reasons the coordination chemistry of amino alcohol ligands with cobalt(III) 
centres was investigated was to establish the potential use of such species in the 
synthesis of cobalt(III) nitrogen mustard complexes. In particular, amino alcohol 
ligands, with more than one alcohol group, are of interest as they are possible precursor 
ligands for the synthesis of poly-alkylating nitrogen mustard coordinated cobalt(III) 
complexes. 
The successful synthesis and characterisation of polyalkylating nitrogen mustard 
cobalt(III) complex 3.17 using a cobalt(III) alkoxide complex, 3.13 was discussed in 
chapter 03.  
Chapter 04 focuses on the synthesis of heterodinuclear complexes. Two different 
ruthenium(II)pytp complexes were successfully synthesised. The results obtained from 
1H NMR studies for the complexation of, [Ru(dmbpy)2(pytp)]2+, 4.09b and 
[Ru(decbpy)2(pytp)]2+, 4.09d with [Co(tren)(OTf)2]+, 4.03, are consistent with the 
formation of dinuclear Ru(II)-Co(III) heterodinuclear complexes. 
Unfortunately, due to the time restrictions, the isolation of these complexes from a large 
scale reaction could not be completed. The synthesis and isolation of 
[Co(L3)2(OTf)2]+,4.02, complex and Ru(II)-Co(III) heterodinuclear complex with a 
cytotoxic nitrogen mustard cobalt(III) complex appears challenging and so far we have 
been unsuccessful. The modifications suggested for the synthesis of such complexes will 
be discussed in future prospects section. 
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5.2  Future Prospects 
 
At the conclusion of our study, there were a number of avenues for future experiments 
which could still be pursued; here we outline some of these possibilities. In some cases, 
we have already done some preliminary experiments towards these studies and details 
will be given where appropriate. 
The following synthetic approach is suggested as an improvement to some of the work 
discussed in this thesis. 
 
5.2.1  Suitable precursor ligands for the synthesis of cobalt(III) nitrogen 
mustard complexes. 
 
In general, [Co(L3)2(NO2)2]+ , 2.08 and its derivatives were found to be unstable at high 
temperatures. The robust polydentate ligands stabilise the cobalt(III) complexes under 
the vigorous reaction conditions. For example, [Co(tren)Cl2]+ is stable compared to 
[Co(en)2Cl2]+. Therefore, the ligands shown in Figure 5.1 are proposed as potential 
precursor ligands to investigate the synthesis of nitrogen mustard on a cobalt(III) 
centre. The interconnected nitrogen atoms of these ligands will be able to form a robust 
coordination sphere on coordination with the cobalt(III) centre. The hydroxyethyl 
groups on the ligand can also be coordinated to the central metal or may stay un- 
coordinated and later can be easily converted to the chloroethyl functionality to 
synthesise nitrogen mustard cobalt(III) complexes. 
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Figure 5.1. Precursor ligands suggested for the complexation with cobalt(III) centres. 
 
The procedure published by Drinkard et al.[123] can be employed to synthesise 
cobalt(III)alkoxide complexes. The increased number of coordinating atoms present in 
the ligands, Figure 5.1, compared to the ligands discussed in chapter 03, may lead to the 
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formation of cobalt(III) clusters. This would be an interesting investigation to study the 
coordination chemistry of these ligands with cobalt(III) centres. 
 
5.2.2  Synthesis of [Ru(4,4’-dcbpy)2(pytp)]2+,4.09c,  
 
Method 01; 
A possible synthetic route for the preparation of [Ru(4,4’-dcbpy)2(pytp)]2+, 4.09c, was 
described in chapter 04. Due to the insolubility of 4.09c, obtaining purified material was 
unsuccessful.  
Changing the pH of the medium to deprotonate the carboxylic acid groups of 4.09c 
would improve the solubility of this complex. The complex needs to be examined over a 
range of pH values to understand the deprotonation stages of the four carboxylic acid 
ligands.  
Method 02; 
The hydrolysis of the (Ru(decbpy)2(pytp)]2+ complex can  also be attempted. 
 
Scheme 5.1.  Reaction scheme for the conversion of 4.09d to 4.09c via hydrolysis reaction. 
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5.2.3  Changing the bridging ligand 
 
During the course of this research program, pytp (pytp = 3-(pyridine-2-yl)-
[1,2,4]triazino[5,6-f][1,10]phenanthroline) was the only ligand we were interested in, 
as it has been proved successful by Alan Downward.[114] However, use of a symmetric 
bridging moiety would be of interest as the ligand can be synthesised separately and 
then complexed with the ruthenium(II) centres. 
 
Figure 5.2.  Proposed symmetric bridging ligands for the synthesis of heterodinuclear 
complexes. 
 
One of the disadvantages of synthesising the bridging ligand separately is that after 
complexation, the resulting mixture consists of mononuclear and dinuclear complexes. 
However, the two complexes will be significantly different in total complex charge, 
hence easily separable using cation exchange column (Sephadex SP C-25) 
chromatography.  
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Liang et al. reported the synthesis of 5.06 ligand,[127] and 5.07 and 5.08 were reported 
by Gholamkhass et al.[161] 
 
5.2.4  Synthesis of metal clusters and polynuclear complexes 
 
The dinuclear and polynuclear metal assemblies reported in chapter 03 opened up 
avenues for a number of research possibilities. The poly-coordinating ability of oxygen 
atoms in amino alcohol ligands and the heteropolynuclear complexes, Co(III)-Zn(II), 
Co(III)-Mn(II), showed interesting coordination chemistry.  
Instead of zinc(II) and manganese(II) it would be interesting to study the coordination 
chemistry of other metal salts such as Ni(II), Fe(II), Fe(III), Cu(II), Ag(I), etc with the 
alkoxide complexes. Some of the metal salts have already been tested (e.g. FeCl3, AgNO3, 
CuCl2, NiCl2), however we were unable to grow crystals from those compounds. There 
are large numbers of experimental techniques that remain untested, such as changing 
the crystallising solvent system, or use of different crystallisation techniques to obtain 
the desired material. Also, column chromatography would be helpful to separate these 
neutral compounds from charged by-products formed during the complexation. 
Amino alcohol ligands with a number of hydroxyl ethyl side arms, for example 5.03 and 
5.04 presented in Figure 5.1, could be reacted with desired metal salts to synthesise 
metal clusters or supramolecular assemblies. 
Especially by synthesising metal clusters using manganese(II) and cobalt(II) 
paramagnetic metal centres, we would be able to perform magnetic measurements on 
those complexes. There are some publications in the literature about the synthesis and 
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characterisation of metal clusters. Most of the ion clusters reported in the literature are 
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6. Experimental procedures 
 
6.1  General Information  
 
Unless otherwise stated, reagents were obtained from commercial sources and used as 
received. Water was purified by reverse osmosis in–house. HPLC–grade solvents were 
used for reactions and in case of moisture–sensitive reactions; solvents were dried by 
literature procedures, solvents stored under N2 in the solvent system and freshly 
distilled as required. Melting points were recorded on an Electrothermal melting point 
apparatus. Elemental analysis was done by the Campbell Microanalytical Laboratory, 
University of Otago.  
 
Nuclear Magnetic Resonance  
 
1H and 13C NMR spectra were recorded on Varian Unity 300, Agilent 400–MR, or Varian 
500 INOVA instruments operating for 1H NMR at 400 and 500 MHz, respectively and at 
75, 100 and 125 MHz, respectively, for 13C NMR. All the 1H NMR spectra recorded in 
deuterated solvents were referenced to the solvent peak or TMPS: CDCl3, 7.26 ppm; 
CD3CN, 2.0 ppm; CD3OD, 3.3 ppm; DMSO, 2.6 ppm. 13C NMR were all referenced to their 
solvent peaks: chloroform, 77.0 ppm; acetonitrile, 36.8 ppm; methanol, 49.3 ppm; 
DMSO, 39.6 ppm. When required, gCOSY, 1–D TOCSY, HSQC and HMBC experiments 
were performed using standard pulse sequences. The assignments for the compounds 
are denoted with primes to indicate the symmetry equivalence ligands and with letters 
to distinguish the pyridine rings.  
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Mass Spectrometry  
 
Mass spectra were recorded by Dr. Marie Squire, Dr. Meike Holzenkaempfer, Dr. 
Alexandra Goroncy or Dr. Amelia Albrett on either a DIONEX Ultimate 3000 or Bruker 
MaXis 4G spectrometer, operated in high resolution positive ion electrospray mode. 
Samples were prepared by dissolving in an appropriate solvent at the required 
concentration.  
 
Infrared Spectroscopy  
 
Infrared spectra were recorded on a Perkin–Elmer Spectrum One FTIR instrument 
operating in diffuse reflectance mode with samples prepared as KBr pellets (KBr) or on 
Bruker FTIR spectrometer with Alpha’s Platinum ATR single reflection diamond where 
the neat samples were recorded. The following abbreviations are used: vs: very strong, 
s: strong, m: medium, w: weak, sh: sharp, br: broad. 
 
UV/Visible Spectroscopy  
 
UV / visible spectra were recorded on a Varian CARY Probe 50 UV / visible 
spectrometer (range 200 – 800 nm) at room temperature. Quartz cuvettes of 1cm path 
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X-Ray Crystallography  
 
X-Ray data were collected on an Oxford-Agilent Supernova instrument with a focused 
microsource Mo Kα [λ = 0.71073 Å] or Cu Kα [λ = 1.5405 Å] radiation and an ATLAS CCD 
area detector. CrysAlisPro 171.37.31 was used for the data collection and data 
processing. Multi-scan absorption corrections were applied using SCALE3 ABSPACK. 
The crystals were mounted on a nylon loop using a perfluorinated polyethylene glycol. 
Each crystal was kept at 120.00(10) K during data collection. All structures were solved 
using direct methods with SHELXS-358 and refined on wF2 using all data by full matrix 
least square procedures with SHELXL-14 using OLEX-2.359 for visualisation. Hydrogen 
atoms were included in calculated positions for carbon atoms and manually located 
from residual electron density for heteroatoms, with isotropic displacement parameters 
1.2 or 1.5 times the isotropic equivalent of their carrier atoms. Heteroatom hydrogen 
atoms were fixed at distances, O-H 0.84 Å and N-H 0.90 Å. Graphical presentation of 
crystallographic data was prepared using OLEX-2.359. 
 
Powder X-ray Diffraction 
 
X-ray powder diffraction data were collected using an Oxfort-Agilent SuperNova 
instrument using Cu Kα (λ = 1.5418Å) radiation and an ATLAS CCD area detector. 
Samples were dried at 60°C overnight and stored under vacuum prior to analysis. 
Approximately 5 mg of sample were prepared for analysis by grinding. The powder was 
filled in a 1cm long CG column and mounted on to the goniometer head. The sample was 
centred directly in the X-ray beam path and the diffraction data were recorded using 
averaged 360° scan in ɸ with 150 second exposure time per rotation frame. The 
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diffraction data were integrated radially and a background correction was manually 




Fluorescence data was collected using HORIBA JOBINXVOW, Fluorolog FL3-22 
fluorimeter. 
 
6.2  Synthesis of precursors and ligands 
 
The following compounds were prepared according to the literature procedures. 
[Ru(bpy)2Cl2][151], [Ru(bpy)2(phendione)]2+[159], [Ru(dmbpy)2(phen)]2+[164], 
{Ru(dmbpy)2Cl2][165], [Ru(dmbpy)2(phendione)]2+[164], [Ru(bpy)2(pytp)]2+[113], 
[Ru(dcbpy)2Cl2]2+[166], [152][Ru(dcbpy)2(phendione)]2+[160], [Co(tren)(NO2)2]+[150], 
[Co(tren)(OTf)2]+[125], [Ru(decbpy)2Cl2], [Ru(decbpy)2(phendione)]2+[167], [Co(NH3)6]Cl3 
was obtained from (CHEM 111) undergraduate chemistry laboratories. 
4,4’-dicarboxy-2,2’-bipyridine[156], pyridine-2-carbohydrazonamide, 4,4’-diethoxy-          
-carbonyl-2,2’-bipyridine[168], [169], 2,2’-(ethane-1,2-diylbis(azanediyl)diethanol[144] 2-
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6.3  Synthesis of chapter 02 compounds  
 
 [Co(L1)2(NO2)2]NO3, 2.06, 
 
Co(NO3)2·6H2O, (11.64 g, 0.04 mol) and NaNO2,( 6 g, 
0.09 mol)) were dissolved in H2O (20 mL) and 
placed in a bubbler. In a separate beaker L1, (8.30 g, 
0.08 mol) was dissolved in distilled water (10 mL) 
and conc. HNO3 (3 mL) was added dropwise. The 
two solutions were mixed and air was vigorously 
bubbled through the solution for 1 hr. The reaction 
mixture was left at 4 °C overnight. The yellow 
crystalline powder that deposited overnight was 
separated by filtration through a sintered crucible. The solid material was washed with 
diethyl ether (2×20 mL) and dried under vacuum. Yields: 11.52 g (79%), M. p: 140-
142°C. 
1H NMR (400 MHz; D2O): δ 3.95 (1H, m, H1), 3.74 (1H, m, H1), 3.01 (4H, m, H3, H4), 2.81 
(2H, m, H2), 2.59 (2H, m, H3) 2.46 (4H, m, H2, H4). 13C NMR (100 MHz, D2O): δ 59.54 
(C1), 56.39 (C2), 54.32 (C3), 46.13 (C4). ESI-MS: Calc. for [C8H24N6O6Co]+: 359.1084, 
Found: 359.1084. IR υmax 3357(br), 3229(br), 3157(br), 906(s), 823(s), 751(s), 692(m), 
558(m), 525(s), 521(s) cm-1. UV/vis (CH3OH) 357, 260 nm Analysis Calc for 
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 [CoCl(L3)2(NO2)]Cl, 2.07, 
 
[Co(L1)2(NO2)2]NO3, 2.06, (2.0 g, 4.75 mmol) was 
dissolved in DMF (0.5 mL) and SOCl2 (10.0 mL) was 
added drop-wise. The reaction mixture was stirred at 
room temperature for 5 hrs and excess SOCl2 was 
removed under reduced pressure. The obtained pink 
solid material was recrystallized from ethanol /water 
mixture. Yield: 1.7 g (79.5%). M.p: 155 °C. 
 1H NMR: (400MHz; DMSO-d6) δ 3.84 (2H, m, H1), 2.90 
(4H, m, H2. H4, H3), 2.50 (1H, m, H3), 2.29 (1H, m, H2). 13C NMR (100MHz; DMSO-d6) δ 
52.99 (C2), 51.93 (C4), 43.16 (C3), 40.53 (C1). ESI-MS: Calc for 
[C8H22N5O2Cl3Co1]+:384.0168, Found:384.0166. IR: ʋmax 3214(br), 3139(br), 1584(sh), 
1409(sh), 1321(s), 1178(s), 1002(sh), 749(m). cm-1. UV/vis(CH3OH): 350, 256 nm. 
Analysis: Calc for (C8H22N5O2Cl4Co1): C, 22.82; H, 5.27; N, 16.63%. Found: C, 22.83; H, 





All the reagents and reaction vessels were cold below 
0°C, before start of the reaction.  
[Co(L1)2(NO2)2]NO3, 2.06, (2.0 g, 4.75 mmol) was 
stirred in SOCl2 (5.0 mL) in an ice-salt bath and DMF 
(0.5 mL) was added dropwise to the above solution and 
stirred for 5 hrs, while bubbling N2 gas in to the 
reaction mixture. Excess SOCl2 was removed under 
vacuum, while keeping the reaction mixture in ice salt-
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bath. The resulting yellow solid was dissolved in a minimum amount of cold methanol 
while keeping the reaction vessel in dry ice / acetone bath, and dropwise addition of the 
methanolic solution of the complex into the ice-cold ether solution yielded a yellow 
coloured powdered material.  
The solid material was solved with water (300 mL) and the mixture separated using a 
Sephadex SP-C25 cation exchange column (60×3.5 cm). The yellow band first eluted 
with 0.02 M NaCl was collected and evaporated to dryness and the characterisation was 
done after removing the salt, by a few methanolic extractions followed by G-10 size 
exclusion column chromatography and the compound was collected as the first yellow 
band eluted from the column. Yield: 1.40 g (63.6%) 
 
Method 02 
[CoCl(L3)2(NO2)]Cl, 2.07 (5.0 g, 0.01 mol) was completely dissolved in a minimum 
amount of warm water and filtered. NaNO2 (5.0 g) was added to the reaction mixture 
while stirring. The stirring was continued for 8 hrs. The obtained yellow solution was 
filtered and kept in the fridge to obtain yellow crystals over a week. Yield: (3.54 g, 69%). 
M.p: 139 °C 
1H NMR: (400 MHz, D2O) δ 4.01 (1H, m, H1), 3.95 (1H, m, H1), 3.06 (2H, m, H2, H3), 2.97 
(1H, m, H4), 2.76 (1H, m, H4), 2.61 (1H, m, H2), 2.49 (1H, m, H3). 13C NMR: (25 MHz, 
D2O) δ 55.90 (C2), 54.02 (C3), 46.44 (C4), 43.48 (C1). ESI-MS: Calc for 
[C8H22N6O4Cl2Co]+: 395.0406, Found: 395.0414. IR: ʋmax 3253 (br), 1582 (s), 1397 (m), 
1313 (sh), 1189 (s), 1015 (m), 825 (m) cm-1. UV/vis(CH3OH): 353, 256 nm. Analysis 











[CoCl(L3)2(NO2)]Cl, 2.07, (2.0 g, 5.51 mmol) was 
suspended in 25 mL ethanol and conc HCl (20 mL) 
was added. The reaction mixture was heated for 48 
hrs at 70 °C in the presence of 0.3 g of LiCl. The 
resulting dark green reaction mixture was filtered 
and dried under the reduced pressure.  
The resulting green coloured solid material was 
washed few times with cold ethanol and the 
remaining solid was recrystallized from warm 
ethanol. The crystals were filtered and washed with cold ethanol followed by diethyl 
ether to obtain the pure product. Yield: 0.63 g (30%). 
 
Method 02 
[Co(L1-H)2]+, 2.15, (3.0 g, 7.31 mmol) was suspended in DMF (1.0 mL) and stirred in 
room temperature. SOCl2 (10 mL) was added dropwise to the stirring solution and the 
reaction mixture was left stirring at room temperature for about three hours. Then the 
reaction mixture temperature was increased to 70 °C and left stirring overnight. The 
green thick slurry obtained was dried under vacuum to remove excess SOCl2. The 
obtained green paste was washed with cold ethanol and remaining solid was dissolved 
into a minimum amount of ethanol to obtained a light green powdered material. The 
powder was extracted by filtering and dried under the vacuum to obtain the pure 
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Method 03 
[CoCl2(L1)2]Cl, 2.12 (2.0 g, 5.53 mmol) was suspended in DMF (1.0 mL) and stirred at 
room temperature. SOCl2 (5.0 mL) was added dropwise to the stirring reaction mixture. 
The reaction was continued for 5 hrs and the excess SOCl2 was removed under vacuum. 
The obtained green slurry was washed a few times with cold ethanol to remove bluish 
washings. The remaining green solid was slowly dispersed in ethanol to yield a green 
powdered material. Yield: 0.98 g (38%) 
 
Method 04 
[Co(L3)2(NO2)2]Cl, 2.08 (1.50 g 3.48 mmol) was suspended in ethanol (25 mL) and LiCl 
0.30 g was added while stirring. Conc. HCl, (10 ml) was added dropwise to the reaction 
mixture while stirring at room temperature. The reaction mixture was heated to 70 °C 
and stirring was continued overnight. The reaction was monitored by mass 
spectrometry to confirm the completion of the reaction. The obtained green coloured 
reaction mixture was dried under vacuum to remove excess HCl and ethanol. (Bubbling 
nitrogen in to the reaction mixture to remove excess HCl is also suggested as the 
compound tends to decompose under high acidic conditions in vacuum). 
The obtained solid material was dissolved into cold ethanol to obtain the compound as a 
green powdered material. Yield: 0.81 g (48%). M.p: 205°C.  
1H NMR: (400MHz; DMSO-d6) δ 6.32(1H, m, N6), 5.91(1H, m, N6), 5.30(1H, m, N3), 
3.98(2H, t, H1), 3.04(2H, m, H2), 2.79(3H, m, H5, H4), 2,61(1H, m, H4).13C NMR: (25 
MHz, DMSO-d6): δ 52.48 (C4), 52.25 (C2), 43.36 (C5), 40.87 (C1). ESI-MS: Calc for 
[C8H22N4Cl4Co]+: 374.9896, Found: 374.9896  IR: υ max 1535(w), 1387(br), 932(w), 
896(w), 722(m), 681(m), 530(sh) cm-1. UV/vis (CH3OH) 625.00, 484.00 and 396.00 nm: 
Analysis Calc for C8H22N4Cl5Co (410.40): C, 23.44; H, 5.46; N, 13.52%. Found: C, 23.41; 








The complex [CoCl(L3)(NO2)]Cl, 2.07 was synthesised 
according the procedure reported above and crystals 
of 2.07 was obtained by recrystallizing the pink crude 
product using 1:1, EtOH:H2O mixture. After separating 
the pink crystals of the complex the 2.07, the warmed 
filtrate was left for slow evaporation, which yielded 
bluish green crystals. These crystals were filtered and 
washed with cold ethanol solution. Yield: 0.093 mg 
(0.05%). ESI-MS: Calc for [C8H24N4Cl4Co1]+ 374.9798, 
found: 374.9897. Mp: 204.5°C. The crystals were 




A suspension of [Co(L1)2(NO2)2]NO2, 2.06, (0.50 g, 
1.19 mmol) in MeOH (20 mL), was added to dil. HCl 
(10 mL) and stirred at room temperature for about 
10 hours. The resulting orange solution was filtered 
and concentrated. The concentrated solution was 
added dropwise into cold diethyl ether solution to 
yield a fine orange powdered material. The obtained 
powder material was separated on a Sephadex SP-
C25 cation exchange column (60×3.0 cm) using 0.02 
M NaCl as an eluent. The third yellow band was collected, desalted and passed through 
the G-10 size exclusion column to obtain the yellow aqueous solution. The sample was 
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1H NMR (400 MHz; D2O): δ 3.96 (1H, m, H1), 3.75 (1H, m, H1), 3.01 (4H, m, H3, H4), 
2.811 (2H, m, H2), 2.58 (2H, m, H3) 2.44 (4H, m, H2, H4). 13C NMR (100 MHz, D2O): δ 
59.56 (C1), 56.40 (C2), 54.30 (C3), 46.14 (C4); ESI-MS: Calc for [C8H24N5O4ClCo]+ 
348.0839, Found: 384.0843. IR:ʋmax 3214(br), 3139(br), 1584(m), 1441(sh), 1409(sh), 
1321(s), 1271(s), 1178(s), 1078(m), 1045(m), 1002(s), 984(s), 939(m), 881(m), 




A solution of [Co(L1)2(NO2)2]NO2, 2.06, (2.0 g, 4.75 
mmol) in EtOH (50.0 mL) was mixed with conc. HCl 
(25.0 mL) and LiCl (0.3 g ) and refluxed overnight. 
The reaction was monitored by mass spectrometry 
for the complete disappearance of the starting 
material, to confirm the completion of the reaction. 
Once the reaction was complete, the reaction 
mixture was cooled to room temperature and 
filtered. The solution was evaporated under vacuum. 
The collected solid material was stored under ethanol to collect the green powdered 
material. Yield: 0.86 g (45%). M.p:204-206 °C  
1H NMR: (400 MHz; DMSO-d6) δ 6.31 (1H, s, NH), 5.89 (1H, s, NH), 5.28 (1H, s, NH), 3.97 
(2H, m, H1), 3.24 (1H, m, H1), 3.07 (2H, m, H2), 2.76 (3H, m. H3, H4), 2.56 (1H,m, H3). 
13C NMR: (100MHz, DMSO-d6) δ 52.74 (C4), 52.33 (C1), 49.11(C2), 43.60 (C3). ESI-MS: 
Calc for[C8H24N4O2Cl2Co]+ 337.0603. Found: 337.0607. IR: ʋmax 3216 (m), 3140 (m), 
1548 (sh), 1440 (m), 1362 (m), 1289 (m), 1176 (m), 1158 (m), 1081 (m), 1048 (m), 998 









The green powdered material obtained for the 
complex 2.12 (0.5g, 0.013 mol) was dissolved into 
methanol (5.0 mL) to make a concentrated solution 
and filtered. The filtered solution was separated into 
two different glass vials and set for slow diffusion 
crystallisation. After about a months’ time feather like 
bluish crystals appeared in the vials and were 
collected and washed with diethyl ether. Yield: 1.5 mg 
(0.03%) 
ESI-MS: Calc for[C8H24N4O2Cl2Co]+ 337.0603. Found 337.0607. UV/vis(CH3OH):498, 
358, 348 nm  




The crystalline material of the complex [Co(L1-H)2]+, 2.15, (0.5 g, 0.0962 mmol) was 
dissolved in methanol (15 mL) while stirring. To the methanolic solution of the complex, 
a few drops of a concentrated solution of methanolic ammonium 
hexafluoridophosphate were added dropwise while stirring. The reaction mixture was 
warmed up for about 30 minutes and filtered hot. 
The methanolic solution of the complex was separated into few glass vials and set for 
the diffusion crystallisation with diethyl ether. After about a month time a few red 
crystals appeared and were separated from the solution. Yield: 0.02 g (5%) 
ESI-MS: Calc for [C8H22N4O2Co]+ 265.1073, Found 265.1072, The X ray crystallographic 
analysis of the 2.16 is reported in chapter 02. 
 
 




Finely powdered [Co(NH3)6]Cl3 (5.3 g, 0.02 mol) was 
mixed with activated charcoal (1 g), and concentrated 
ammonium hydroxide (5.0 mL) and L1 (4.28g 0.04 mol) 
was added to the solid mixture. The reaction mixture 
was heated on the steam bath until the odour of 
ammonia could no longer be detected. The precipitate 
which forms was separated from the carbon by heating 
the mixture with 40 mL of hot water and filtering. The 
solution was concentrated to ~15 mL under vacuum and a concentrated aqueous 
solution of LiI (5 mL) was added and left for slow evaporation. The precipitated 
crystalline solid material was collected by filtration and washed with water. Yield: 2.67 
g (20.7 %). M.P: stable over 240°C 
ESI-MS: Calc for [C8H22N4O2Co]+ 265.1073, Found 265.1072, IR: ʋmax 3211 (br), 
3135(br), 1583 (sh), 1440 (w), 1282 (w), 1170 (w), 1041 (vs) cm-1 UV/vis (CH3OH): 
511, 252 nm. Analysis Calc for (C8H23N4O2Co1I2·2H2O): C, 17.86; H, 4.68; N, 10.41 %. 
Found: C, 17.83; H, 4.65; N, 10.43 %. 
 
[Co(Cl)5(L1-H)2Zn2], 2.20 and 2.21, 
 
The crystalline powder of 2.19 (0.5 g, 0.77 mmol,) was dissolved in warm methanol (20 
mL) while stirring. Methanolic solution of ZnCl2 (0.5 g, 3.7 mmol) was added dropwise 
to the reaction mixture while stirring. The reaction was continued for 20 minutes and 
filtered hot and left for slow evaporation to yield pink crystals. Yield: 0.90 g, (22%), Mp: 
˃ 250 °C 
ESI-MS: Calc for [C8H22N4O2Co1]+ [Co(L1-H)2]+, 265.1074, found: 265.1050; Calc for 
[C8H22N4O2Cl2Zn1Co1]+, 398.9873, found: 398.9721, Calc for [C8H22N4O2Cl4Zn2Co1]+, 
532.8411, found: 532.8406, IR: ʋmax 1583 (sh), 1445 (w), 1283 (s), 1170 (w) cm-1 
UV/vis (CH3OH): 511, 252. 
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The crystalline powder of 2.19 (0.5 g, 0.77 mmol,) was dissolved in warm methanol (20 
mL) while stirring. Methanolic solution of MnCl2·4H2O (0.5g, 2.5 mmol) was added 
dropwise to the reaction mixture while stirring. The reaction was continued for 20 
minutes and filtered hot and left for slow evaporation to yield pink crystals. Yield: 0.05 
g, (15%), Mp: ˃ 250 °C 




[CoCl(L3)(NO2)]+, 2.07 (1.5g, 5.30 mmol) was dissolved in warm water (15 mL) and 
filtered. The aqueous solution of 2.07 was brought to 0°C in an ice bath and 35% NH4OH 
(10 mL) and NaNO2 (0.5 g, 7.24 mmol) were added. The mixture was stirred for 
complete dissolution and kept at 4 °C to obtain large yellow crystals over a period of 
three days. Yield: 0.8 ng (56%) 
The crystals were suitable for the X-ray crystallographic analysis. The crystal structure 
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6.4  Synthesis of chapter 03 compounds  
 
 [Co(L4-H)3], 3.01, 
 
[Co(NH3)6]Cl3, (5.0 g, 0.019 mol) was dissolved in 
concentrated ammonium hydroxide (20 mL) solution 
and activated charcoal (1.0 g) and L4 (4.00 g, 0.07 mol) 
was added to the reaction mixture. The reaction 
mixture was placed on the steam bath for 5 hrs. The 
obtained red reaction mixture was filtered while the 
solution is warm to remove the activated charcoal. The 
filtrate was dried under vacuum and redissolved in 
methanol (10 mL). The red coloured methanolic 
solution is filtered and left for slow evaporation to 
obtain red coloured plate like crystals. Yield: 2.184 g, (65%). M.p:˃240 °C.  
1H NMR: (400MHz; D2O) δ 3.83 (2H, t, H1), 3.15 (2H, t, H2). 13C NMR (100MHz;D2O) δ 
60.50(C1), 44.10(C2). UV/vis(CH3OH): 531 nm. IR:ʋmax 2912.78(br), 1587(w), 1433(w), 
1050(vs) cm-1 Analysis Calc for (C6H18N3O3Co1H2O·CH3OH) C, 29.07; H, 8.36; N, 16.34%. 
Found C, 30.01; H, 8.34; N, 16.33%. 
 
 [Co(L5-H)2]I, 3.02, 
 
L5 (4.49 g, 0.043 mol) was added dropwise to a 
stirred solution of CoSO4·7H2O (4.0 g, 0.014 mol) in 
an aqueous-ethanol mixture (20 mL of ethanol and 10 
mL of water). The ethanol solution was completely 
evaporated under vacuum and obtained red sticky 
solid material was dissolved in to a warm methanol 
solution containing LiI. The warm methanolic 
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solution was filtered and left for slow evaporation. After a few days the solution yielded 
plate like red crystals. The precipitated red plate like crystals of compound [Co(L5-H)2]+ 
were filtered off and washed with ethanol and ether. Yield: 2.58 g, (68%). M.p: ˃ 240°C. 
1H NMR: (400MHz; D2O) δ 3.17 (3H, m, H1, H2, H4), 3.02 (2H, m, H1,H3), 2.91 (1H, m, 
H3 ), 2.66 (1H, m, H4), 2.51 (1H,m, H2). 13C NMR (100MHz;D2O) δ 67.104 (C1), 57,25 
(C2), 55.44 (C4), 44.83 (C3) . ESI-MS: Calc for [C8H20N2O4]+ 267.0755, Found: 267.0725. 
IR: 3306(w), 3158(w), 2912(m, sh), 2838(m, sh), 2787(m, sh), 1615(m), 1460(m), 
1432(m), 1090(w), 1030(s), 811(s), 590(s), 524(s), 499(s), 456(s) cm-1. UV/Vis: 556, 
402 nm Analysis Calc for: C8H18N2O4I3Co1.H2O: C, 23.32; H, 5.38; N, 6.80%. Found: C, 




[Co(NH3)6]Cl3 (3.0 g, 0.01 mol) was added to concentrated ammonium hydroxide (20 
mL) and activated charcoal (1.0 g). To the reaction mixture L5 (3.0g, 0.03 mol) was 
added and placed on the steam bath for about 5 hrs. The reaction mixture was filtered 
and left for low evaporation to yield a bluish green powder. The powder was separated, 
washed and dried. Then the bluish powder was dissolved in MeOH (10 mL) and warmed 
up while stirring. MnCl2.4H2O (4.0 g, 0.02 mol) was added and stirring was continued 
for another 10 min. The solution was filtered and left for slow evaporation to obtained 
X-ray quality pink crystals. The yields of these crystals were insufficient to carry out 




Commercially available L6 (3.346 g, 0.02 mol) was dissolved in concentrated 
ammonium hydroxide (20 mL). [Co(NH3)6]Cl3 (3.0 g, 0.01 mol) and activated charcoal 
(1.0 g) were added to the ammonium hydroxide solution. The reaction mixture was 
placed on the steam bath for about four hours. The reaction mixture was filtered and 
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the filtrate left for slow evaporation. Blue coloured crystals appeared overnight. Yield: 
0.57 g (21%). Mp:˃ 250 °C. 
IR: 2836(w), 1453(m), 1369(m), 1269(m), 1073(sh), 887(sh), 608(m), 557(m) cm-1. 





Commercially available L6 (3.35 g, 0.02 mol) was dissolved in concentrated ammonium 
hydroxide (20 mL). [Co(NH3)6]Cl3 (3.0 g, 0.011 mol) and activated charcoal (1.0 g) were 
added to the reaction mixture. The reaction mixture was placed on the steam bath for 
about four hours for the completion of the reaction. The reaction mixture was filtered 
and dried under vacuum. The solid residue obtained was dissolved in warm methanol 
(10 mL) while stirring. A methanolic solution of ZnCl2 was added to the warm reaction 
mixture while stirring. The reaction was continued for about 30 min and filtered. The 
purple reaction mixture was left for slow evaporation to give purple coloured crystals. 
Yield: 1.26 g (18%). M.p: 140-143 °C. 
IR: ʋmax 2876.09(br), 1621.09(s), 1052.15(sh), 906.08(s), 660.91(s) cm-1. UV/vis(H2O): 
558 nm. Analysis: Calc for (C14H32N2O8Cl4Zn2Co2·2CH3OH·2H2O) C, 22.69; H, 5.24; N, 












[Co(NH3)6]Cl3 (0.956 g, 3.574 mmol) was reacted with L7, 
synthesised according to the literature procedure, (1.089 
g, 7.14796 mol) in the presence of concentrated 
ammonium hydroxide (20 mL) and activated charcoal 
(0.8 g). The reaction mixture was heated on a steam bath 
for ~5 hrs and the obtained pink coloured solution was 
filtered hot. The pink solution was concentrated and a few 
drops of concentrated ammonium hexafluoridophosphate 
were added. The pink powder that resulted was filtered 
and washed with cold acetonitrile followed by cold 
ethanol. Yield: 1.03 g (80%). M.p:˃200 °C.  
IH NMR:(400 MHz, DMSO-d6) δ 8.76 (1H, d, H1), 8.14 (1H, t, H3 ), 7.69 (1H, t, H5), 7.31 
(1H, d, H2), 5.03 (2H, dd, H8), 4.16 (2H, d, H6), 2.58 (2H, d, H7)13C NMR:(100MHz, 
DMSO) δ).150.13 (C5), 158.01 (C4), 133.98 (C3), 137.14 (C1). ESI-MS: Calc for 
[C16H22N4O2Co1]+ 361.1069. Found 361.1062. IR: υmax 3306(w), 820(s, sh), 555(sh), 
464.87(w) cm-1. UV/vis(CH3OH):513, 257, 218 nm. Analysis: Calc for: 
(C16H23N4O2(PF6)2Co1·CH3CN) C, 31.18; H, 3.78; N, 10.10%. Found: C, 31.20; H, 3.79; N, 
10.06. 
 
 [Co(L2-H)2]I3, 3.13, 
To finely powdered [Co(NH3)6]Cl3,(1.80 g, 6.7 mmol) was 
added activated charcoal (0.5 g), followed concentrated 
ammonium hydroxide (10.0 mL) and L2(1.82 g, 0.04 
mol). The mixture was heated in the steam bath until the 
odour of the ammonia could no longer be detected. The 
formed precipitate was separated from the carbon by 
heating the mixture with hot water (40 mL) and filtering. 
The solution was concentrated to ~15 mL under vacuum 
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and a concentrated solution (~2 molL-1) of LiI (3 mL) was added and left for slow 
evaporation. The yellow crystalline material formed over the time was collected by 
filtration and washed with water. Yield: 3.47 g (70%). M.p: 170°C. 
ESI-MS: Calc for [C12H30N4O4Co1]+ 353.1594, Found: 353.1608. IR: 3136(br), 1588(w, 
br), 1433(w), 1014(vs) cm-1. UV/vis: 360, 288 nm Analysis Calc for: C12H30N4O4I3Co1: 





2-(2-aminoethylamino)ethanol, L1, (20.8 
g, 0.2 mol) was added to 2-chloroethanol 
(16 g, 0.2 mol). Powdered Na2CO3 (16.96g, 
0.2 mol) was added and the mixture was 
stirred at 135 °C for 25 hrs. After cooling 
the reaction mixture to room temperature 
MeOH (300 mL) was added and the 
mixture was filtered. The methanolic 
solution was evaporated under vacuum to 
obtain the crude product. The yellow oil was recrystallized twice from THF to obtain the 
L2 as a product from the yellow reaction mixture. After recrystallization of the L2 
ligand, the remaining crude oil, which was composed of L8 and L9, was directly used for 
the next step of the reaction.  
[Co(NH3)6]Cl3 (4.169 g, 0.016 mol) was mixed with the crude oil (3.0 g). Ammonium 
hydroxide (20 mL) and activated charcoal (1.0 g) was added to the mixture. The 
reaction mixture was heated on the steam bath for five hours and filtered hot. The 
collected solution was reduced in volume under vacuum to ~15 mL and an aqueous 
solution of LiI (1 mL) was added. The aqueous solution was left for slow evaporation. 
The precipitated red crystalline solid was collected and washed with cold water and 
dried under vacuum. Yield: 5.62 g (40%). M.p: 210°C. 
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1H NMR:(400MHz, D2O) δ 4.20 (1H, m, H1), 3.69 (2H, m, H1, H7), 3.46 (2H, m, H5, H8), 
3,24 (2H, m, H2, H6), 3.09 (3H, m, H4, H3, H5), 2.82 (1H, dd, H3 ), 2.67 (2H, m, H7, H4), 
2.59(2H, m, H2, H7), 2.29 (1H, m, H6). 13C NMR:(100MHz, D2O) δ 68.41(C8), 67.91(C3), 
66.88(C1), 65.11(C7), 64.90 (C6), 64.10(C4), 58.59(C2), 56.77(C5). ESI-MS: Calc 
[C8H18N2O3Co1]+ 250.0722, Found:250.0704. IR: υmax 3220(br), 1459(w), 1383(w), 
1034(m), 1003(m), 825(s), 555(sh), 492(w) cm-1 UV/vis(CH3OH):569, 258, 226 nm. 
Analysis: Calc for:C16H36N4O6I6Co2·H2O C, 15.06; H, 2.84; N, 4.39%. Found: C, 15.00; H, 
2.84; N,.4.38%.  
 
[Co(L8-3H)(ZnCl2)]2, 3.16, 
3.17(2.0 g, 1.6 mmol) was dissolved in MeOH (10 
mL) and ZnCl2 (0.3 g, 2.2 mmol) was added to the 
methanolic solution. The reaction mixture was 
warmed and stirred for about 10 minutes. The 
reaction mixture was filtered and left for slow 
evaporation to yield pink crystals. Yield: 1.10 g, 
(80%), M.p: 215-220°C. 
IR: ʋmax 1550(sh), 1200(s), 987(w), (850(s) cm-1 
UV/vis(CH3OH): 568, 255 nm. Analysis: Calc for: 
C16H34Cl4N4O6Co2Zn2·CH3OH C, 25.49; H, 4.78, N 6.99%. Found: C, 25.48, 4.81, 6.95%. 




[Co(L2-H)2](I3), 3.15, (0.98 g, 2.52 mmol) was dissolved in SOCl2 (10.00 mL) and DMF 
(0.5 mL) was added while stirring. Stirring was continued at room temperature for 
about 5 hrs. The temperature of the reaction mixture was slowly brought up to 70 °C. 
The stirring was continued overnight and reaction was monitored by mass 
spectrometry for the complete disappearance of starting material to confirm the 
completion of the reaction. The obtained green slurry was dried under vacuum to 
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remove excess thionyl chloride. The obtained thick green solid was dissolved in ethanol 
and first few bluish coloured washing were discarded. The green coloured powdered 
material left was filtered and washed with cold ethanol to obtain the pure material. 
Yield: 0.54 g, (40%). M.p: 165-170 °C. 
1H NMR: (400MHz, CD3OD) δ 4.059 (2H, m, H1), 3.02 (4H, m, H6), 3.50 (1H, m, H2), 3.40 
(1H, m, H5), 3.10 (2H, m, H3, H4), 2.90 (2H, m, H2, H5), 2.76 (2H, m, H3, H4. 13C NMR 
(100MHz, CD3OD) δ 39.39(C1), 39.44(C6), 52.43(C2), 52.40(C5), 49.55 C3), 49.08(C4) . 
ESI-MS: Calc for [C12H28N4Cl6Co1]+ 498.9743, Found 498.9760. IR: 3176(br), 1584(m), 
1434.04(m), 1042(vs) cm-1. UV/vis (H2O):645, 413 nm. Analysis: Calc for 




(O.5 g, 1.2 mmol) of 3.17 was dissolved in to a warm EtOH (10 mL) while stirring and 
(0.2g, 1.5 mmol) of ZnCl2 was added to the ethanoic solution of the compound. The 
solution was warmed and stirred for about 5 min, filtered and left for slow evaporation 
to yield long green coloured crystals. The crystals were sepearted and washed with cold 
ethanol. Yield 0.21g (30%) 










Chapter 06  224 
 
6.5  Synthesis of chapter 04 compounds 
 
 [(dmbpy)2Ru(pytp)](PF6)2, 4.09b, 
 
[(dmbpy)2Ru(phendione)](PF6)2 (1.0 
g, 1.031 mmol) was dissolved into 15 
mL of methanol. Pyridine-2-
carbohydrazonamide (0.14 g, 1.03 
mmol) was dissolved in ethanol (5 
mL). The solutions were mixed 
together. The reaction mixture was 
then heated at reflux for 1hr and the 
reaction mixture was dried under 
vacuum. The crude material obtained 
was dissolved in the minimum 
amount of methanol and the product was precipitated as its hexafluoridophosphate salt 
by adding aqueous ammonium hexafluoridophosphate. The red powdered precipitate 
was chromatographed on a silica column to obtain the pure product. The acetonitrile 
fraction was collected and dried under vacuum and dissolved in the minimum amount 
of methanol and precipitated as a hexafluoridophosphate salt by adding aqueous 
solution of ammonium hexafluoridophasphate. Yield: 0.53 g (48%). M.p: decomposed at 
260-265 °C 
IH NMR:( 400MHz, CD3CN) δ 2.492(6H,s), 2.587(6H,s), 7.092(2H, m, H5AB), 7.319(2H, 
d, H5A’B’), 7.485(2H, m, H6A), 7.654(2H, d, H6A’B’), 7.693(1H, m, H4E), 7.960(2H, m, 
H5CC’), 8.150(1H, t, H5E), 8.314(2H, dd, H6CC’), 8.369(2H, s, H3AB), 8.406(2H, s, 
H3A’B’), 8.927(1H, d, H3E), 8.979(2H, s, H6E), 9.710(1H, d, H4C’), 9.785(1H, d, H4C) 
ESI-MS: Calc for [C38H26N10Ru1]2+ 362.0692, Found: 362.0690 IR: υ max 407.20(sh), 
833.46(s),1368.32(w), 1618.11(w) cm-1 UV/vis: 444, 283 nm. Analysis: Calc for 








[(decbpy)2Ru(phendione)](PF6)2 (1.0 g, 
0.83 mmol) was dissolved in methanol 
(15 mL). Pyridine-2-carbohydrazonamide 
(0.14 g, 1.03 mmol) was dissolved in 
ethanol (5 mL). The two solutions were 
mixed together. The reaction mixture was 
then heated at reflux for 1 hr and dried 
under vacuum. The crude material 
obtained was dissolved in a minimum 
amount of methanol and the product was 
precipitated as its hexafluoridophosphate 
salt by adding aqueous ammonium hexafluoridophosphate. The red powdered 
precipitate was chromatographed on a silica gel column using (1:1, ethanol:10% NaCl) 
as an eluent. The second red band was collected, dried under vacuum and dissolved in 
the minimum amount of water. The product was extracted into dichloromethane while 
adding concentrated aqueous ammonium hexafluoridophosphate (5-10 mL) into the 
separatory funnel. The collected extracts were dried under vacuum to obtain the pure 
product as a hexafluoridophosphate salt.  
Yeild: 0.325g (30%). M.p:˃240°C 
 IH NMR:(400MHz, CD3CN) δ 1.41 (15H, m), 4.46 (8H, m), 7.69 (1H, dd, H5E), 7.73 (2H, 
m, H5A), 7.89 (2H, d, H5’A), 7.91 (2H, d, H5’A), 7.97 (m, 2H, H’5C), 8.03 (2H, d, H5’A), 
8.15 (m, 1H, H5E), 8.24 (2H, dd, H6C, H6C’), 8.94 (1H, d, H3E), 8,98 (1H, d, H6E), 9.77 
(1H, dd, H4C’), 9.88 (1H, dd, H4C). ESI-MS: Calc for [C50H42N10O8Ru1]2+ 506.1170, 
Found: 506.1140. IR: υmax 556(sh), 765(sh), 833(w), 1015(s), 1127(sh), 1251(m), 
1320(s), 1369(m), 1432(s), 1722(sh). UV/vis: 466, 305 nm. Analysis: Calc for, 








[RuCl2(dmbpy)2].2H2O (0.33 g, 1.85 mmol) and 
1,10-phenanthroline were heated at 70°C in ethanol 
(50 mL). The solution was concentrated to ≈20 ml 
and then water (50 mL) was added. The product 
was precipitated by addition of a saturated 
methanolic solution of NH4PF6 (1.0 mL). The 
precipitate was collected by vacuum filtration and 
washed with cold (0˚C) ethanol. The product was 
further purified using a silica gel column (2.5 cm 
diameter and 1.5 m length) packed using ethyl 
acetate. The mixture was loaded on to the column bed after adsorbing it on to a small 
amount of silicagel. Acetonitrile was used as the eluent. The middle red band was 
collected and precipitated using methanolic ammonium hexafluoridophosphate. The 
resulting orange-red solid was filtered off, washed with cold water and diethyl ether 
and then dried under vacuum. Yield 1.22 g, (70%). M.p:142-143 °C 
1H NMR: (400 MHz, CD3CN):δ 8.60 (2H,d), 8.39 (2H, s), 8.34 (2H, s), 8.24 (2H, s), 8.10 
(2H, d), 7.75 (2H, dd,) 7.67 (2H, d), 7.34 (2H, d), 7.29 (2H, d), 7.04 ( 2H, d) 2.58 (6H, s, 
CH3), 2.48 (6H, s, CH3). ESI-MS:Calc for [C36H32N6Ru]2+795.13, Found (M/z)325.08. 
IR:ʋmax 3639(w), 1619(m), 1479(m), 1431(m), 821(sh), 721(m), 555(s), 526(m) cm-1. 
UV/vis(CH3CN): 455nm. Analysis: Calc for (C36H32N6RuP2F12) C, 46.01; H, 3.4; N, 8.14%. 
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Appendix – Crystallography 
 
Table A–H list the crystal data and X–ray experimental details for the twenty three 
crystal structures discussed in this thesis. Selected bond lengths and bond distances are 
listed in the discussion of the structures, while the remaining distances and angles, as 
well as the atomic coordinates, anisotropic displacement parameters and hydrogen 
atom coordinates are available on request from the Department of Chemistry, 
University of Canterbury.  
All the X–ray crystallographic data was collected on either a Bruker APEX–II instrument 
with graphite–monochromatised Mo Kα (λ = 0.71073 Å) radiation or on an Oxford–
Agilent SuperNova instrument with focussed microsource Mo Kα (λ = 0.71073 Å) and 
Cu Kα radiation (λ = 1.5418 Å) and ATLAS CCD area detector. The structures were 
solved using direct methods with SHELXT[172] and refined on F2 using all data by full–
matrix least square procedures with SHELXL.[173] Multiscan absorption corrections 
were done using SADABS or SCALE3 ABSPACK. The non–hydrogen atoms were refined 
with anisotropic displacement parameters. All the hydrogen atoms were included in 
calculated positions with isotropic displacement parameters 1.2 or 1.5 times the 
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Table B. Crystal data and X–ray experimental data for complexes 2.09, 2.12 and 2.13 
Identification code 2.09 (KJK 48a) 2.13 (KJK35ab)                                                                     2.12 (KJK46a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.3873 × 0.1887 × 0.173  
MoKα (λ = 0.71073)  
5.472 to 74.996 
244186  
11307 [Rint = 0.0523, Rsigma = 0.0149]  
11307/8/253  
1.173  
R1 = 0.0319, wR2 = 0.0724  


















0.1147 × 0.0697 × 0.0572  
CuKα (λ = 1.54184)  
9.642 to 153.088 
11823  
3154 [Rint = 0.0610, Rsigma = 0.0510]  
3154/9/172  
1.015  
R1 = 0.0452, wR2 = 0.1037  


















0.1379 × 0.1054 × 0.1017  
CuKα (λ = 1.54184)  
9.896 to 153.714 
15569  
3374 [Rint = 0.0474, Rsigma = 0.0329]  
3374/10/194  
1.103  
R1 = 0.0411, wR2 = 0.1214  
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Table C. Crystal data and X–ray experimental data for complexes 2.16, 2.19 and 2.20. 
Identification code 2.16 (KJK33ab) 2.19 (EXP 72a) 2.20 (exp 76 a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.2612 × 0.2139 × 0.1609  
CuKα (λ = 1.54184)  
9.484 to 152.63 
6979  
1564 [Rint = 0.0379, Rsigma = 0.0278]  
1564/5/121  
1.041  
R1 = 0.0379, wR2 = 0.1054  


















0.1988 × 0.082 × 0.0342  
MoKα (λ = 0.71073)  
5.22 to 61.01 
37497  
4277 [Rint = 0.0462, Rsigma = 0.0231]  
4277/9/174  
1.097  
R1 = 0.0207, wR2 = 0.0448  


















0.1529 × 0.1025 × 0.0697  
CuKα (λ = 1.54184)  
6.982 to 153.59 
17370  
3851 [Rint = 0.0629, Rsigma = 0.0374]  
3851/4/199  
1.149  
R1 = 0.0822, wR2 = 0.2970  
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Table D. Crystal data and X–ray experimental data for complexes 2.21, 2.22 and 2.25. 
Identification code 2.21 (exp_84) 2.22 (exp 85 a) 2.25 (exp92a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  



















3.2731 × 0.757 × 0.2278  
CuKα (λ = 1.54184)  
6.836 to 134.976 
34884  
3453 [Rint = 0.0651, Rsigma = 0.0272]  
3453/1/237  
1.077  
R1 = 0.0272, wR2 = 0.0688  



















0.2204 × 0.0855 × 0.0572  
CuKα (λ = 1.54184)  
7.566 to 134.998 
30764  
5915 [Rint = 0.1169, Rsigma = 0.0628]  
5915/2/343  
1.138  
R1 = 0.1145, wR2 = 0.2768  


















0.1868 × 0.1463 × 0.0709  
CuKα (λ = 1.54184)  
7.98 to 134.92 
14770  
1651 [Rint = 0.1015, Rsigma = 0.0356]  
1651/0/101  
1.058  
R1 = 0.0836, wR2 = 0.2146  






Appendix        232 
 
 
Table E. Crystal data and X–ray experimental data for complexes 2.08, 3.02 and 3.03. 
Identification code 2.08 (exp 98a) 3.02 (kjk106a) 3.03 (kjk103b) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.4345 × 0.2133 × 0.1539  
CuKα (λ = 1.54184)  
6.658 to 153.986 
42586  
12257 [Rint = 0.0826, Rsigma = 0.0586]  
12257/14/770  
0.908  
R1 = 0.0834, wR2 = 0.2624  


















0.0998 × 0.0863 × 0.0254  
CuKα (λ = 1.54184)  
10.134 to 153.542 
5819  
2656 [Rint = 0.0604, Rsigma = 0.0659]  
2656/4/161  
1.058  
R1 = 0.0927, wR2 = 0.2507  


















0.235 × 0.1392 × 0.0404  
CuKα (λ = 1.54184)  
8.246 to 134.14 
16466  
3023 [Rint = 0.0534, Rsigma = 0.0328]  
3023/0/204  
1.095  
R1 = 0.0581, wR2 = 0.1839  
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Table F. Crystal data and X–ray experimental data for complexes 3.08, 3.09 and 3.10. 
Identification code 3.08 (kjk111a) 3.09 (exp 107a) 3.10 (kjk105a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.2236 × 0.1859 × 0.0542  
CuKα (λ = 1.54184)  
10.47 to 172.446 
15674  
850 [Rint = 0.0615, Rsigma = 0.0182]  
850/0/86  
1.129  
R1 = 0.0428, wR2 = 0.1157  


















0.0991 × 0.0786 × 0.0591  
CuKα (λ = 1.54184)  
10.356 to 148.926 
6472  
2916 [Rint = 0.0368, Rsigma = 0.0503]  
2916/3/177  
1.069  
R1 = 0.0567, wR2 = 0.1557  


















0.1193 × 0.0696 × 0.046  
CuKα (λ = 1.54184)  
10.706 to 134.16 
24622  
2397 [Rint = 0.0442, Rsigma = 0.0181]  
2397/2/181  
1.041  
R1 = 0.0266, wR2 = 0.0698  
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Table G. Crystal data and X–ray experimental data for complexes 3.11, 3.12 and 3.13. 
Identification code 3.11 (kjk109a) 3.12 (exp 65a) 3.13 (74a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.0762 × 0.0653 × 0.0446  
CuKα (λ = 1.54184)  
8.594 to 148.992 
19771  
2422 [Rint = 0.0857, Rsigma = 0.0420]  
2422/5/199  
1.084  
R1 = 0.0735, wR2 = 0.2076  


















0.5721 × 0.3144 × 0.2727  
CuKα (λ = 1.54184)  
11.312 to 133.87 
6972  
716 [Rint = 0.0299, Rsigma = 0.0091]  
716/0/47  
1.151  
R1 = 0.0469, wR2 = 0.1250  


















0.1639 × 0.0747 × 0.0353  
MoKα (λ = 0.71073)  
5.868 to 60.802 
27187  
3126 [Rint = 0.0441, Rsigma = 0.0255]  
3126/0/113  
1.083  
R1 = 0.0257, wR2 = 0.0488  
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Table H. Crystal data and X–ray experimental data for complexes 3.14, 3.17 and 3.22. 
Identification code 3.14 (exp 86 a) 3.17 (exp 87a) 3.22 (exp 94a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.1296 × 0.0647 × 0.0249  
CuKα (λ = 1.54184)  
7.412 to 134.15 
10982  
4198 [Rint = 0.0864, Rsigma = 0.0803]  
4198/0/237  
1.084  
R1 = 0.0869, wR2 = 0.2384  


















0.4698 × 0.0793 × 0.0656  
Cu Kα (λ = 1.54184)  
5.62 to 124.94 
18949  
3631 [Rint = 0.0445, Rsigma = 0.0305]  
3631/4/282  
1.041  
R1 = 0.0453, wR2 = 0.1268  


















0.2861 × 0.2077 × 0.1463  
Cu Kα (λ = 1.54184)  
7.38 to 134.16 
19642  
8225 [Rint = 0.0449, Rsigma = 0.0438]  
8225/0/200  
2.463  
R1 = 0.1016, wR2 = 0.3016  
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Table I. Crystal data and X–ray experimental data for complexes 3.15 and 3.16. 
Identification code 3.15 (exp36a) 3.16 (EXP102a) 
Empirical formula  
Formula weight  
Temperature/K  
Crystal system  










μ/mm 1  
F(000)  
Crystal size/mm3  
Radiation  
2Θ range for data collection/° 
Reflections collected  
Independent reflections  
Data/restraints/parameters  
Goodness-of-fit on F2  
Final R indexes [I>=2σ (I)]  
Final R indexes [all data]  

















0.1656 × 0.0339 × 0.0264  
CuKα (λ = 1.54184)  
8.584 to 134.132 
7341  
2821 [Rint = 0.0425, Rsigma = 0.0441]  
2821/5/161  
1.050  
R1 = 0.0442, wR2 = 0.1187  


















0.1894 × 0.1324 × 0.1049  
CuKα (λ = 1.54184)  
9.006 to 134.142 
7823  
2583 [Rint = 0.0410, Rsigma = 0.0356]  
2583/0/181  
1.068  
R1 = 0.0658, wR2 = 0.1905  










A suitable crystal were selected and mounted on a SuperNova, Dual, Cu/Mo at zero, Atlas diffractometer. The crystal was kept at 
120.01(10) K during data collection. Using Olex2 [174], the structure was solved with the ShelXT [172] structure solution program using 
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